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ABSTRACT 
Embryonic stem (ES) cells are continuous cell lines derived from the inner 
cell mass of early mouse embryos and are capable of multilineage differentiation. ES 
cells can therefore be used to study events occurring during both the self renewal and 
differentiation processes in mice. However, many of the genes involved in ES cell 
differentiation or indeed self renewal have not been identified. 
Loss of function analysis such as mRNA ablation strategies have been used 
as a way of determining the function of a gene. mRNA ablation strategies such as 
antisense RNA, ribozymes and more recently dsRNA have been used successfully to 
determine functions of various genes both in vitro and in vivo. Antisense RNA has 
been one of the predominant methods of ablation in previous studies but has shown a 
very variable rate of ablation. Ribozymes are a potentially more powerful ablation 
tool than antisense, as they are able to cleave their targets and be recycled for further 
use. Double stranded RNA mediates RNA interference (RNAi) which is the process 
of sequence specific degradation and silencing of genes in animals and plants. For all 
these ablation strategies the efficiency of gene silencing in ES cells is unknown. 
The aim of the work presented in this thesis is to investigate mRNA ablation 
systems for assignment of gene function in ES cell self renewal and differentiation. 
Such a technology could be used to determine the potential role of candidate genes or 
to identify new genes in a functional library screen. My strategy was to express 
antisense RNA, ribozymes or double stranded hairpin RNA using a high efficiency 
episomal transduction and expression system. Antisense RNAs were targeted against 
the 5' and 3' UTRs of LIFR, STA T3 and Oct4 genes required for the self renewal of 
ES cells. However, stable expression of these antisense RNAs did not result in the 
expected differentiation phenotype when cells were maintained in the presence of 
LW. Ribozyme ablation was also ineffective when targeting the coding region of the 
p300 gene target, using a ribozyme reported previously to be effective in embryonal 
carcinoma cells. 
In contrast the operation of RNAi in ES cells was established. This was 
demonstrated by the specific suppression of luciferase expression from reporter 
plasmids co-transfected with 21 nt specific short interfering RNAs, siRNAs. The 
feasibility of an RNAi strategy by in situ production of dsRNA from stable 
electroporation of an episomally maintained vector harbouring long inverted repeats 
to the coding regions of eGFP, LIFR and SOCS3 targets was then investigated. 
dsRNA to eGFP appeared to produce sequence specific RNAi against a 
chromosomal eGFP gene randomly integrated in ES cells, where up to a 33% 
reduction of eGFP expression was observed. However, I found that the cells 
expressing reduced eGFP were dying as determined by staining with Annexin V and 
7-AAD, so that reduced flourescence may be a secondary consequence. Cell death 
could be attributable to activation of an interferon response as it is known that long 
dsRNAs in mammalian cells are capable of inducing apoptosis. Evidence of ablation 
of the other targets was not observed, as there was neither phenotypic ablation of the 
LIFR target nor a reduction of SOCS3 rnRNA. Compared to cells expressing eGFP 
dsRNA there was less cell death observed with SOCS3 dsRNA expression, which 
may be attributable to the higher transcript levels noted for eGFP dsRNA. The lack 
of dsRNA mediated ablation may be due to the choice of target site. 
In conclusion the data presented here determines that of the various ablation 
methods studied, only 21 nt siRNAs are reliable and are a potential ablation tool to 
define or discover gene function in ES cells in the future. 
Chapter 1: Introduction 
1.1.Embryonic Stem Cells 
1.1.1. Background 
Embryonic stem cells (ES cells) are cell lines derived from the inner cell 
mass (1CM) of the early mouse embryo (Evans and Kaufman, 1981; Martin, 1981; 
Brook and Gardner, 1997). ES cells retain the pluripotent state of the cells that 
constitute the 1CM, which is the key underlying feature that is essential to the 
generation of transgenic mouse lines and multilineage differentiation. In vitro ES 
cells are capable of multilineage differentiation, and are consequently used to 
study lineage commitment and differentiation of various cell types from ES cells, 
including neuronal precursors, neurons and cells from the haematopoietic lineage 
(Bain et al.1995; Okabe et al.1996; Li et al.1998; Wiles and Keller 1991; Kennedy 
et al.1997). Pluripotency of ES cells has been demonstrated in vivo by 
reintroducing ES cells into a mouse embryo by injection of ES cells into a 
blastocyst. ES cells incorporate into the 1CM, and contribute to all tissues 
including the germ cells resulting in a chimeric mouse (Bradley et al.1984; 
Nichols et al. 1990). Germline transmission has allowed the development of 
sophisticated ES cell gene targeting strategies to generate mice with defined 
genomic changes and has become standard practice in researching gene function. 
A current limitation however, is the time consuming and labour intensive nature 
of gene knockouts in mice by homologous recombination. As a direct result it 
would be of considerable use to determine if alternative messenger RNA (mRNA) 
ablation strategies can be employed to determine gene function more quickly yet 
accurately in ES cells. Current mRNA ablation strategies include antisense RNA, 
ribozymes and double stranded RNA. The mechanisms involved as well as current 
evidence of their effectiveness as ablation strategies will now be discussed. 
I .2.Ablation Strategies 
1.2.1. Background 
Gene "knockout" technology is the traditional method for determining the 
role of a gene in mice. Though an effective approach the major drawback is that 
this method is slow and labour intensive. Appropriate targeting constructs have to 
be generated followed by targeting of ES cells and isolation of correctly targeted 
clones before these can be injected into mouse blastocysts and bred to make mice 
homozygous for the desired mutation. With the recent rapid expansion of 
available gene sequences through such projects as the "genome project", quicker 
yet reliable strategies for discovering gene function are required. mRNA ablation 
strategies have been proposed. These ablation strategies have potential not only 
for discovering the function of a cloned gene of interest but for the identification 
of new genes by an in vitro screening approach. I have focused on three 
approaches: antisense RNA; ribozymes; and double stranded RNA (dsRNA). 
1.2.2. Antisense RNA 
1.2.2.1. Background 
Antisense RNA is RNA that is complementary to a target mRNA. It exists 
naturally in both prokaryotes and eukaryotes and is usually transcribed from the 
same locus as sense RNAs but in the opposite direction (reviewed by Vanhee- 
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Brossollet and Vaquero 1998). Antisense RNA acts to control gene expression by 
hybridising specifically to the targeted mRNA through Watson-Crick base pair 
interactions. 
The first demonstration of antisense RNA or DNA selectively preventing 
gene expression experimentally in eukaryotic cells was provided by Izant and 
Weintraub (1984). Expression of a thymidine kinase gene injected into mouse L 
cells (that are thymidine kinase negative) was significantly reduced when a 
plasmid directing synthesis of antisense thymidine kinase RNA was co-injected. 
Although antisense RNA has been used for some time as a tool for 
silencing gene expression, the mechanisms involved are still not fully understood. 
It is thought that the duplex formation between antisense and sense RNAs 
interferes with one or more steps in the gene expression pathway including 
transcription, RNA processing, mRNA transport, translation and mRNA turnover 
(see figure 1.1.). However, whilst antisense RNA may interfere with transcription 
there is little evidence of this in the literature. Examples of antisense RNA 
interfering with some of the other steps of gene expression are described in the 
text below. 
Antisense RNA has been shown to inhibit splicing of human -globin pre-
mRNA in vitro by Munroe (1988). Splicing reactions were performed in HeLa 
cell nuclear extracts. Antisense RNAs complementary to sequences between 80-
140 nucleotides downstream of the globin 3' splice site inhibited splicing as 
efficiently as antisense RNAs complementary to the 5' splice site. Antisense RNA 
was shown to anneal directly to the pre-mRNA substrate by the formation of TI 
RNase resistant duplexes. A reduction in splicing inhibition observed following 
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late addition of antisense RNA reflected a reduction in the formation of these 
duplexes. However, the mechanism by which an RNA duplex inhibits splicing 
remains to be established. 
The next stage in the gene expression pathway is the export of mature 
mRNA transcripts out of the nucleus. Antisense induced inhibition of the transport 
of transcripts out of the nucleus has been demonstrated experimentally in 
transfected cells (Kim and Wold 1985). Antisense RNA against thymidine kinase 
(TK) reduced TK activity by 80%-90% in a generated TK positive L cell line 
(Kim and Wold 1985). Antisense TK was expressed as a fusion with dihydrofolate 
reductase (DHFR), which allowed higher levels of antisense expression by 
selecting cells resistant to methotrexate that overproduce DHFR. The observed 
reduction in TK activity was due to greater than 95% of the TK mRNA being 
localised to the nucleus. Antisense RNA in this instance is causing inhibition by 
hybridising to its target in the nucleus preventing subsequent transport to the 
cytoplasm. However, the mechanism of how antisense hybridisation prevents TK 
mRNA export was not determined by Kim and Wold (1985). 
Alternatively, inhibition by antisense RNA can occur at the translational 
level, preventing initiation, elongation or termination. For example, translation 
initiation of exogenously added 3-globin mRNA was specifically blocked in frog 
oocytes injected with antisense RNA to the 5' untranslated region (UTR) of 3-
globin eDNA (Melton et al.1985). This was determined by labelling newly 
synthesised proteins by incubating oocytes in 35S methionine. Antisense RNAs 
that were specific to the 3' half of 3-globin were unable to block protein synthesis 
in this instance. Repression of ribosomal protein Li synthesis however, was only 
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observed when antisense RNAs were complementary to the 3'-terminal region, 
indicating that antisense mediated inhibition was interfering with translation 
termination (Wormington 1986). Again this was demonstrated by incubating 
antisense injected Xen opus oocytes in 35S methionine. 
In addition RNA degradation is also thought to assist antisense RNA 
mediated inhibition in some cases. For example RNA degradation by RNase H 
has been reported for antisense oligonucteotides. RNase H is a ubiquitous enzyme 
that specifically degrades the RNA strand of RNA-DNA hybrids. For example 
inhibition of ICAM-1 expression, an intercellular adhesion molecule, by an 
antisense oligonucleotide was found to be due in part to RNase H mediated 
cleavage of the target mRNA (Chiang et al.1991). Chiang et al.(1991) 
demonstrated that a 2'-O-Methyl analogue, which does not support RNase H, 
failed to inhibit ICAM-1 expression in both human umbilical vein endothelial 
cells and a human lung carcinoma cell line. 
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Figure 1.1. Potential modes of action of antisense in eukaryotic cells. 
Antisense RNA can interfere with one or more steps in eukaryotic gene 
expression, including: a) transcription by binding to one strand of duplex DNA at 
an open loop (1) or by hybridisation to nascent RNA (2); b) pre-mRNA 
processing by blocking 5' cap addition (3), splicing (4), or polyadenylation (5); c) 
transport of target niJ1'TA from the nucleus to the cytoplasm (6); d) translation by 
interfering with ribosome binding (7), prevention of translation initiation (8), or 
truncation of translational elongation (9). All RNA-RNA hybrids formed during 
these steps may be degraded by double strand RNA specific RNase (10) Taken 
from Arndt and Rank 1997. 
Antisense oligonucleotides and their analogues have been developed in 
parallel with antisense RNA studies and show similar potential for inhibiting gene 
expression in eukaryotic cells (reviewed in Colman 1990). Antisense 
oligonucleotides are short stretches of nucleotides that are complementary to a 
region of targeted mRNA, which can specifically suppress expression of that 
particular transcript. In some cases chemical modifications have been made to the 
phosphate-sugar backbone to render the oligonucleotides resistant to nuclease 
action i.e. substitution of one of the non-bridging oxygen atoms bound to 
phosphorus for a sulphur atom, generating phosphorothioate oligonucleotides. 
Phosphorothioate oligonucleotides act predominantly by an RNase H mechanism 
where the RNA strand of a DNA/RNA duplex is cleaved. The other antisense 
oligonucleotides act independently of RNase H and are generally thought to 
hybridise directly to the target mRNA and prevent translation (reviewed in Crooke 
1992). 
Morpholino oligos are DNA oligonucleotides that are made from 
morpholine subunits (C4119NO) (Sunmerton and Weller 1997) which act by 
blocking translation. They are typically 25 mers in length and are complementary 
to regions within the 5' UTR or the first 25 bases 3' to the AUG translational start 
site. Morpholino oligos were initially developed to overcome the specificity 
problems of antisense oligonucleotides such as phosphorothioate linked DNA 
analogues which act primarily by an RNase H cleavage mechanism. Specificity 
problems arise because RNase H can cleave DNA/RNA duplexes as short as 5 or 
6 base pairs in length (Monia et al. 1993) which may result in non specific 
cleavage. Morpholino mediated ablation on the other hand is RNase H 
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independent. In addition targeting the 5' UTR, which is less conserved than 
coding regions and the fact that morpholinos are sensitive to several mismatched 
nucleotides reduces the problem of non specific ablation. Morpholinos have also 
been shown directly to be more efficient than antisense oligonucleotides 
(Summerton et al.1997). Summerton et al.(1997) demonstrated in HeLa cells that 
two morpholinos targeting globin were able to effectively inhibit translation at 
300 nM, while phosphorothioate oligonucleotides were unable to produce 
significant inhibition of the target when using up to 3000 nM. However, high 
concentrations of morpholinos can result in non specific effects such as cell death 
(Braat et al.2001). To compensate for this control mRNA rescue experiments or 
the inclusion of two morpholinos complementary to different parts of the 5' UTR 
are required to investigate gene function. In addition the other major disadvantage 
of antisense oligonucleotides and morpholinos are that unlike antisense RNA they 
cannot be introduced into cells by stable expression from a vector making these 
ablation strategies less versatile than antisense RNA. 
1.2.2.2. Methods for identifying optimal target sites 
The efficiency of antisense ablation is highly dependent upon the region 
of the gene targeted. This is because mRNA not only possesses secondary 
structure but it is bound by cellular proteins. As a result the target site may be 
occluded, consequently reducing accessibility to the antisense reagent. There are 
methods available for selecting optimal hybridisation sites, although they are not 
trivial. The current methods available are RNase H mapping, combinatorial arrays 
and prediction of mRNA secondary structure by computational methods. RNase H 
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mapping of accessible sites within the target mRNA involves the hybridisation of 
a random oligonucleotide library and subsequent cleavage by RNase H, which 
cleaves the RNA strand of an RNA-DNA duplex. Fragments are then sequence 
analysed to identify accessible sites. This method has been shown to be 
successful, as oligonucleotides targeted to every accessible site found by RNase H 
mapping were shown to be active (Ho et al. 1998). Combinatorial arrays is a 
technique where all possible oligonucleotides of a chosen length targeting a 
specific mIRNA are synthesised on a glass plate (Milner et al.1997). Accessible 
target sites of the targeted mRNA can be determined by radioactively labelling the 
target message and then hybridising it to the combinatorial array. Milner et 
al.(1997) found that the heteroduplexes identified by combinatorial arrays 
correlated well with sites identified by RNase H mapping of the rabbit 3-globin 
target. Secondary structure analysis by computational methods usually predict 
secondary structures of RNA based upon the lowest free energy. However, 
computational methods are unable to account for interactions of the mRNA with 
possible RNA binding proteins present in the cell nor is it able to predict the 
secondary structures that form as the message is being transcribed. These 
comprehensive approaches for the identification of optimal hybridisation sites are 
however, often not adopted when a number of messages are being targeted 
primarily because of time constraints. Instead a number of antisense RNAs 
targeting different regions of the n -iRNA can be tested to determine the most 
effective site(s). 
Optimal hybridisation sites for antisense RNA vary for different mRNAs. 
For example the optimal antisense RNA sequence for the 3-globin message is 
specific to the 5' UTR (Melton 1985). Melton (1985) found that only antisense 
RNA, which included the 5' UTR was able to prevent translation of f3-globin 
mRNA when injected into the cytoplasm of frog oocytes. Antisense transcripts 
complementary to the entire or 3' terminal coding region of Ll mRNA of 
Xenopus on the other hand were most effective at repressing translation 
(Wormington 1986). A review of ablation efficiencies obtained when targeting 
different regions within messages in transgenic animals is described by Sokol and 
Murray (1996). In general Sokol and Murray (1996) found that targeting the 
UTRs or coding sequence resulted in similar levels of either mRNA or protein 
reduction. 
1.2.2.3. Target regions of antisense- specifically untranslated regions 
Targeting accessible sites within the mRNA is not the only consideration 
when generating an effective antisense RNA. Non-specific effects due to cross-
hybridisation of antisense RNA to a related gene transcript may also be a problem. 
However, specific antisense ablation is often difficult to demonstrate conclusively 
except when antisense RNAs target either the 5' or 3' untranslated regions 
(UTRs). In this instance transfection of the coding sequence for the targeted 
message should result in phenotypic rescue. How targeting either the 5' or 3' 
UTRs of the mRNA with antisense RNA is thought to interfere with gene 
expression is now described. 
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Antisense to 5' UTRs are thought to interfere with translation initiation. 
Translation initiation involves the association of the mRNA with the 43-S 
preinitiation complex. Several eukaryotic initiation factors (elFs) are involved in 
the interaction of the mRNA with the 43-S preinitiation complex. The initial 
interaction involves the binding of the eukaryotic initiation factor-4F (eIF-4F) 
multiprotein complex to the cap at the 5' end of mRNA. The complex includes 
eIF-4E, which directly binds to cap structures and eIF-4A, which possesses RNA 
unwinding activity that is ATP dependent and requires eJF-413. eIF-4F binding 
facilitates binding of the 43-S preinitiation complex which can then migrate along 
the nIRNA until it reaches the initiation codon, where the 60-S ribosomal subunit 
associates to form the translating 80-S ribosome. This is the scanning model 
which predicts how the 43-S preinitiation complex associates with the initiation 
codon (Kozak 1978). Antisense RNA is thought to prevent appropriate binding of 
these molecules by hybridising to the mRNA and blocking access. Studies on the 
effect of mRNAIcDNA duplexes within the coding sequence of a and f3-globin 
mRNAs have shown that positions downstream of the 80-S formation site at the 
AUG are not sensitive to inhibition by antisense cDNA during translation in rabbit 
reticulocyte lysates (Liebhaber et al. 1984). This implies that the elongating 
ribosome is able to remove such blockages, an activity which may be critical for 
translation elongation. Hybridisation of cDNA fragments extending into the 5' 
UTR on the other hand were able to fully block translation. Translation is 
commonly inhibited by antisense molecules directed to the entire 5' UTR and a 
segment extending 20-30 nucleotides downstream of the AUG. For example 
additional analysis of a set of a or -globin niRNAIcDNA hybrids which differ 
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from one another in the extent of the mRNA exposed at the 5' end revealed that 
either the first 18 or 26 nucleotides 3' to the initiation codon have to be exposed to 
allow translation respectively (Shakin and Liebhaber 1986). Translation of these 
nIRNAIcDNA hybrids is associated with the complete removal of cDNA from the 
mRNA. However, this disruption of mRNAIcDNA duplex is blocked by inhibitors 
of translational initiation and elongation. 
Antisense to the 3' UTR region of a gene is thought to ablate gene 
function by interfering with both polyadenylation and removal of the last intron of 
the pre-mRNA. Efficient polyadenylation of a message requires polyadenylation 
signals. In mammals polyadenylation signals usually consist of a hexanucleotide 
consensus element AAUAAA and GU-rich downstream elements, located 14-70 
nucleotides downstream of the AAUAAA sequence (McDevitt et al.1984). The 
polyadenylation signal, AAUAAA is within the 3' UTR and so antisense directed 
to this region may disrupt the final processing of the transcript. In addition, there 
is evidence that both the AAUAAA and GU-rich downstream elements are 
coupled with splicing and are required for efficient splicing of the last exon 
(Berget 1995). Niwa and Berget (1991) have shown that in an in vitro splicing-
polyadenylation system, mutations in polyadenylation signal not only eliminate 
polyadenylation but decrease splicing (the removal of the last intron). Thus 
targeting the 3' UTR with specific antisense RNA may inhibit the final production 
of mature cytoplasmic RNA by preventing both polyadenylation and splicing to 
remove the last intron. 
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1.2.2.4. Antisense ablation in ES cells 
The premise that antisense technology is able to ablate gene function in 
ES cells is based upon a few indicative examples. For example, expression of 
antisense specific to the entire coding region of STAT3 resulted in a modest 
increase in the proportion of differentiated colonies grown in LW, although there 
was no direct determination of mRNA or protein (Niwa et al.1998). Another 
example of antisense ablation in ES cells again with STAT3 as the target gene, 
was shown by Ernst et al.(1 999). They used however, an 1 8bp phosphothioate 
antisense oligonucleotide directed to the 5' end of STAT3. They were able to 
show a -66% decrease in the proportion of undifferentiated ES cells when grown 
in the presence of LW. In addition the level of STAT3 protein was specifically 
decreased by more than 90% compared to controls. Antisense ablation in ES cells 
was also demonstrated with the inhibition of vav nRNA, a proto-oncogene 
expressed specifically in hematopoietic cells (Wulf et al. 1993). Stable integration 
of a transgene expressing antisense vav transcripts in ES cell lines prevented ES 
cell differentiation into hematopoietic cells. The level of vav niRNA had also 
decreased in clones stably expressing antisense directed against vav. The 
experiment was done by co-transfecting the PGK driven vav antisense vector 
directed to two thirds of the 5' end of the vav cDNA with a PGKneo vector and 
selecting for G418 resistant clones. These examples are indicative that antisense 
RNA can be used as a method of ablating gene function in ES cells. 
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1.2.2.5. Antisense Ablation library Screens 
An outcome of successfully establishing mRNA ablation in ES cells using 
antisense RNA is its potential use in a library screen to identify genes required for 
pluripotency or those that determine differentiation. Antisense RNA has been 
successfully used to identify novel genes in Dictyosielium discoideum (Spann et 
al.1996) and in mammalian cells (Levy-Strumpf and Kimchi 1998). Spann et 
al.(1996) transformed Dictyostelium cells with a cDNA library made from mRNA 
of vegetative and developing cells. 149 developmentally defective mutants were 
identified from an initial screen of 1426 transformants. Antisense eDNA 
fragment(s) were isolated and sequenced for 35 of these mutants and 6 found to be 
novel genes. Re-transformation of the corresponding antisense vectors produced 
the same phenotype and this was further confirmed by disruption of the 
corresponding genomic sequences. Levy-Strumpf and Kimchi (1998) identified 
genes involved in growth inhibition and apoptosis of HeLa cells. Cells were 
transfected with an antisense cDNA expression library derived from interferon y 
treated cells. Antisense cDNA fragments that protected cells from interferon y 
induced cell death were analysed. Of 7 cDNAs identified, S were novel. Full 
length sense cDNAs were then isolated and functionally characterised for four of 
the novel genes with overexpression studies which resulted in the death of HeLa 
cells. These examples demonstrate the ability of antisense to be used as a quick 




Ribozymes are RNA molecules with enzymatic activity that cleave 
themselves or other RNA molecules in a sequence specific manner. Like antisense 
reagents they hybridise to their target but their additional ability to cleave makes 
them more potent in principle, since this allows each molecule to inactivate 
multiple copies of the specific target. 
The study of RNA processing led to the initial discovery that RNAs 
possess enzymatic properties (Kruger et al.1982; Guerrier-Takada et al.1983). 
Since then several types of ribozymes have been discovered; group I and II 
introns, the RNA subunit of RNase P, hairpin, hepatitis delta virus ribozymes and 
hammerhead ribozymes (Altman 1989; Cech 1990; Symons 1992; Feldstein et 
a]. 1989). The hammerhead ribozyme is one of the best characterised ribozymes. It 
is the smallest and has minimal target sequence requirements. It was discovered in 
virusoids, which have a circular single stranded RNA genome that is replicated by 
a rolling circle mechanism as a polycistronic message subsequently requiring 
cleavage into individual RNA transcripts (Forster and Symons 1987). 
In vivo hammerhead ribozymes function in cis (intramolecularly), but 
have been engineered to work in trans (inter -molecularly) in vitro (TJhlenbeck 
1987; Haseloff and Gerlach 1988). This allows them to be designed to any target 
sequence making them potentially highly flexible tools for the inhibition of gene 
expression. The ribozyme sequence requirements consist of a catalytic domain 
and flanking sequences complementary to the target mRNA (helix I and III) 
(figure 1.2.). The optimal length of each of the flanking hybridising sequences are 
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9-12 nucleotides (Herschlag 1991) which are long enough to allow formation of a 
stable enzyme substrate complex, but short enough to allow a high rate of product 
release. The only sequence requirement of the target mRNA is a three base 
sequence, GIJX, where cleavage occurs after the X base which is any base but G 
(Haseloff and Gerlach 1988). However, the efficiency of inhibition by ribozymes 
within the cell is affected by a number of factors. These include secondary and 
tertiary structure of both the target and the ribozyme and colocalization of the 
ribozyme with the sequences targeted. Futhermore efficient delivery methods 
combined with maintenance of high levels of expression of the ribozyme have to 
be considered. 
Target mRNA 
--NNN — — — — NNNNNUX NNNNNN----NNN-- 
N "NNNNNA NNNNNN-- -- N 
Helix HI A 	C 	Helix I Ribozyme 	 A G 
G A 	A 
CG G 
CG 




Figure 1.2. Structure of a Hammerhead ribozyme. 
Helix I and III are the hybridising arms, while helix H is the catalytic domain 
required to catalyse cleavage of the mRNA target specified by an NUX sequence. 
N is any nucleotide and X is any nucleotide but G. The arrow denotes cleavage of 
the message. 
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1.2.3.2. Ribozyme expression vector 
Ribozymes are to be introduced into ES cells through the use of a 
ribozyme expression vector. The efficiency of ribozyme ablation is dependent 
upon the choice of promoter to ensure both high expression levels and minimal 
inclusion of additional sequences to the ribozyme transcript, as these could mask 
the short hybridising regions. The promoter of choice is a modified tRNA gene 
which is transcribed by polymerase III (pol In). tRNA genes are highly expressed 
in most tissues and are small in size making their promoter ideal for expressing 
ribozyme sequences. 
1.2.3.3. Ribozyme ablation in mammalian cells 
A potential use of an effective ribozyme ablation strategy in ES cells 
would be in a library screen identifying novel genes required for either ES cell self 
renewal or differentiation. Although the majority of ribozyme mediated inhibition 
has been investigated in non mammalian cells such as E.coli and frog oocytes 
there is some evidence of successful ribozyme ablation in mammalian cells. For 
example specific ablation of ct-lactalbumin expressed from a vector transfected 
into mouse C1271 mammary cells was observed with five ribozymes targeted to 
either the coding or 3' untranslated region (L'Huillier et al.1992). Ribozyme 
mediated ablation was detected as both a decrease in mRNA and protein levels. 
Ablation was attributed directly to the catalytic activity of the ribozyme rather 
than to antisense effects of the flanking aims for one of the ribozymes, due to the 
fact that a catalytically inactive variant had no or very little effect. In another 
example, two ribozymes targeted to the hepatitis B virus X protein, a protein that 
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is required to establish infection, were able to decrease hepatitis B virus RNA in 
established liver cell lines (Weinberg et al.2000). 
1.2.4. Double stranded RNA 
1.2.4.1. Background 
RNA interference (RNAi) is the process by which double stranded RNA 
induces the silencing of homologous genes post transcriptionally. The term RNAi 
was first introduced by Fire and colleagues in 1998 to describe the unexpected 
phenomenon that injection of both sense and antisense RNA into C.elegans 
silenced expression of unc-22 at least 10 fold more efficiently than either RNA 
strand alone. Previously however, RNAi had been observed when either antisense 
or control sense RNA to par-] gene in C.elegans produced an identical embryonic 
lethal phenotype (Guo and Kemphues 1995). This was due to RNA preparations 
being contaminated with small amounts of double stranded RNA (dsRNA). The 
biological significance of RNAi is to protect the genome against invasion by 
mobile genetic elements such as viruses and transposons, which produce dsRNA 
in the host cell or aberrant RNA when activated (Ketting et al.1999; Ratcliff et 
al. 1999). 
A characteristic feature of RNAi is its potency. Injection into C.elegans of 
only a few molecules of dsRNA per cell is sufficient to produce the null 
phenotype of unc-22 in 100% of worms (Fire et al.1998). This suggests that 
dsRNA either acts catalytically or undergoes an amplification step. RNAi ablation 
also possesses the characteristic in C.elegans that it is non cell autonomous, where 
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injection specifically into the gut of C.elegans caused silencing throughout the 
animal, which was then heritable to the Fl progeny (Fire et al.1998). RNAi 
suppresses gene expression by a post transcriptional mechanism, as dsRNA 
homologous to intron sequences is unable to produce RNAi (Montgomery et 
al.1998). Also dsRNA targeting one gene within an operon in C.elegans does not 
effect expression of a second within that operon, strongly indicating that RNAi 
occurs after transcription (Montgomery et al. 1998). 
Although originally discovered in C.elegans, RNAi has since been found 
in a wide variety of animals, including Drosophila (Kennerdell and Carthew 
1998), trypanosomes (Ngo et al. 1998), planaria (Sanchez-Alvarado and Newmark 
1999), zebrafish (Wargelius et al.1999), mice (Wialmy and Zemicka-Goetz 2000; 
Svoboda et al.2000) and post transcriptional gene silencing seen in plants 
(Waterhouse et al.1999) and Neurospora (Cogoni et al.1996). RNAi is most 
effective in C.elegans and Drosophila, and has become a valuable tool for reverse 
genetics in these organisms. In almost all cases, treatment of C.elegans with 
dsRNA phenocopies the genetic null mutant. RNAi has also been used 
successfully to study Drosophila embryology and gene function analysis in 
cultured Drosophila cells (Kennerdell and Carthew 1998; Clemens et al.2000). In 
addition dsRNA has been used specifically to interfere with gene function in 
mammals. Early mouse embryos display specific ablation. Ablation effects do not 
persist after implantation however, as the microinjections of dsRNA are diluted by 
an increase in cell number at this stage (Wianny and Zernicka-Goetz 2000; 
Svoboda et al.2000). Recently RNAi has been demonstrated in cultured 
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mammalian cells (Elbashir et al.2001b), including ES cells (Billy et al.2001; 
Paddison et al.2001; Yang et al.2001). 
1.2.4.2. Proposed model of RNAi ablation 
1.2.4.2.1. Biochemical investigation 
A key insight into a possible mechanism for RNAi ablation was 
uncovered by Hamilton and Baulcombe (1999). They identified a small RNA 
species of —25 nucleotides (nt) homologous to the gene being silenced that was 
only present in plants undergoing post transcriptional gene silencing. The 
importance of these small RNA species was evidenced by their subsequent 
discovery in cultured Drosophila cells induced with dsRNA (Hammond et 
al.2000), Drosophila embryo extracts carrying out RNAi in vitro (Zamore et 
al.2000) and in Drosophila embryos injected with dsRNA (Yang et al.2000). 
These small RNAs were thought to be the putative specificity determinants that 
act as guides to target specific mIRNA, as the —25 nt RNA species was found to be 
homologous to the target in Drosophila 52 cells (Hammond et al.2000). RNAi is 
due to specific mRNA degradation by nuclease digestion specified by the —25 nt 
RNAs as a nuclease co-fractionating with —25 nt RNAs was partially purified 
from Drosophila 52 cells transfected with dsRNA (Hammond et al.2000). The 
nuclease complex was found to have protein components and so was designated 
an RNA induced silencing complex (RISC). Zamore and colleagues (2000) using 
Drosophila embryo extracts found that both strands of the dsRNA were processed 
into 21-23 nt fragments and that this processing occurred independently of the 
targeted mRNA i.e. the dsRNA is cleaved first. The targeted mRNA is then 
P10] 
cleaved but only within the region of identity with the dsRNA and at 21-23 nt 
intervals. 
Based on the 21-23 nt length of the processed dsRNA it was speculated 
that a ENase III enzyme was the nuclease responsible for RNAi (Bass 2000). 
RNase III is the only characterised nuclease known to cleave dsRNA at specific 
sites to generate dsRNA fragments of discrete sizes. A candidate protein named 
Dicer was isolated from Drosophila S2 cells in which RNAi had been initiated by 
transfection with dsRNA (Bernstein et al.2001). Dicer is a member of the RNase 
III family of nucleases and contains an amino terminal ATP dependent RNA 
helicase domain, two RNase III domains and one dsRNA binding domain at the 
carboxyl terminus. Dicer is evolutionarily conserved in flies, worms, plants, fungi 
and mammals (Jacobsen et al.1999; Filippov et al.2000; Matsuda et al.2000). At 
present only a similar role for the Dicer homologue in C.elegans has been 
determined (Ketting et al.2001). 
Continued investigation of the RNAi mechanism using a Drosophila in 
vitro system (Tuschl et al.1999; Zamore et al.2000) mapped cleavage sites on the 
sense and antisense target RNA. The positioning of these cleavage sites revealed 
that both strands were predominantly cleaved 10 nt from the 5' end of the region 
covered by the dsRNA (Elbashir et al.2001a). Analysis of 21-23 nt fragments 
generated by processing of the target RNA revealed that the fragments possessed 
5' phosphate and 3' hydroxyl termini with staggered 3' ends. This is another 
indication that dsRNAs are processed by an RNase III enzyme which generates 
similar reaction products (Nicholson 1999). The first demonstration of the ability 
of synthetic 21 and 22 nt RNAs to mediate target RNA cleavage was also shown 
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by Elbashir et al.(2001a). These 21 and 22 nI RNAs were subsequently named 
short interfering RNAs, or siRNAs. Synthetic siRNAs with 2 or 3 nt overhanging 
3' ends were found to be more efficient than either blunt ended or dsRNAs with 4 
nt overhangs and the cleavage site is located near the centre of the spanned region. 
They also provide some evidence suggesting that the orientation of the siRNA 
duplex with respect to proteins in the RISC complex, may determine which of the 
two complementary strands cleaves the mRNA. 
1.2.4.2.2. Genetic investigation 
In parallel to increasing biochemical data, genetic screens have identified 
a number of genes required for RNAi, predominantly in C.elegans. Genes rde-1 
and rde-4 (where rde denotes "RNAi deficient") are essential for initiating RNAi 
as heterozygous worms exposed to dsRNA are able to transmit RNAi to 
homozygous mutant offspring (Tabara et al.1999). rde-2 and mut- 7 (mutator-7) 
mutants are required directly for RNAi, as heterozygous worms injected with 
dsRNA are unable to transmit RNAi to homozygous offspring (Grishok et 
al.2000). The RDE-I protein is homologous to the quelling defective, qde-2 gene 
in Neurospora (Cata!ananotto et al.2000) and to Argonaute, AGO-] in 
Arabidopsis (Fagard et al.2000), indicating that there is conservation between 
species. The role of rde-] gene is unknown although its gene product is similar to 
the mammalian translation initiation factor, eIF2C (Tabara et al.1999). No 
homologs of rde-4, rde-2 or ,nut-7 have been identified in other species. However, 
the ,nut-7 gene product is homologous to both RNase D of E.coli and to the 
22 
exonuclease domain of the human Werner syndrome protein, implicating its 
possible role as the nuclease degrading mRNA in C.elegans (Ketting et al.1999). 
The incredible potency and systemic effects of RNAi in C.elegans has led 
to the suggestion that RNA dependent RNA polymerases (RdRPs) may play a role 
in amplification of the silencing effect. This was confirmed by the discovery of 
qde-i gene in Neurospora (Cogoni and Macmo 1999), whose protein is a 
homologue of a previously characterised tomato RdRP (Schiebel et al.1993). 
Subsequently Arabidopsis and C.elegans hornologs have been identified, Sde-i 
and ego-] respectively (Dalmay et al.2000; Smardon et al.2000). 
One explanation for the potency of RNAi is that dsRNAs provide 
templates for RdRP in the production of copy RNA. However, it has since been 
determined that the templates are predominantly the target mRNA and that the 
primers are the 21-23 nt fragments generated by cleavage of dsRNA (Lipardi et 
al. 2001). 
1.2.4.2.3. RNA dependent RNA polymerase involvement in RNA! 
potency 
The presence of a 3'-hydroxyl group on the siRNAs (Elbashir et al.2001a) 
and its requirement for RINAi was an early indication that these siRNAs act as 
primers for an RCIRP activity. The role of siRNAs as primers was determined by 
the incorporation of 32P labelled GFP siRNAs into new full-length cognate 
dsRNA in a Drosophila embryo extract system (Lipardi et al.2001). Both single 
stranded (antisense RNA) and dsRNA served as templates for primer 





New dsRNA Secondary 
siRNA 
maximum level within 5-10 minutes. These newly formed dsRNAs were then 
themselves cleaved generating more siRNAs. Presumably these siRNAs act as 
additional primers for further dsRNA amplification. Full-length dsRNA appeared 
to be the dominant product formed from siRNA primed RdRP reaction. This may 
indicate that multiple partial length RdRP products are ligated on the full-length 
antisense strand, possibly by an RNA ligase. All these considerations are shown in 
the proposed model of RNAi as illustrated in figurel.3. 
Figure 1.3. A Model for RNAi. 
dsRNA is first cleaved into siRNAs by an RNase III related enzyme such as 
Dicer. The siRNAs act as RdRP primers upon target mRNA generating new 
dsRNA. This may occur by the alignment of one or many siRNA primers along 
the template strand and which are extended by RdRP. If many primers are used 
ligation by a putative RNA ligase is suggested as full length dsRNA appears to be 
the dominant product. New dsRNA are processed into secondary siRNAs which 
again act as primers to generate more dsRNA as well as mediate cleavage of the 
target mRNA. 
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1.2.4.2.4. Secondary siRNA and Transitive RNAi 
The nature of RdRP amplification of the target inRNA predicts that 
sequences upstream of the target will also be amplified, producing a population of 
secondary siRNAs. The existence of these secondary siRNAs was determined in 
C.elegans by RNase protection experiments using 32P labelled RNA probes 
specific to the siRNAs generated by the original dsRNA as well as regions both 
upstream and downstream of this region (Sijen et al.2001). As anticipated, 
synthesis of secondary siRNAs was limited to the region upstream of the trigger 
sequence, where abundance of the secondary siRNA molecules decreased as a 
function of distance from the primary trigger. Furthermore these secondary 
siRNAs were also able to induce secondary RNAi, a phenomenon termed 
transitive RNAi. This was demonstrated by targeting fused transgenes with a 
dsRNA specific to the downstream gene and observing a down regulation of 
expression of both. For example dsRNA specific for the lacZ region of a target 
rnRNA encoding a nuclear GFP-lacZ fusion protein reduced nuclear localised 
GFP expression (Sijen et al.2001). In addition the lacZ specific dsRNA also 
reduced the expression of a separate mitochondrial localised GFP in a C.elegans 
cell line carrying both transgene constructs. Transitive RNAi by secondary 
siRNAs is outlined in figure 1.4. 
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Figure 1.4. Transitive RNAi by Secondary s1RNA. 
siRNAs used as RdRP primers extend upstream of the original targeted site, 
generating secondary siRNAs which are capable of promoting transitive RNAi. 
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1.2.4.3. Expression of dsRNA hairpin from a vector 
Double stranded RNA can be introduced into cells by expression as a 
hairpin loop from an inverted repeat (IR) containing vector. The advantages of 
this are continuous, stable expression, allowing long term inhibition and the 
determination of the fanction of genes involved in the differentiation processes of 
cells. An inverted repeat transcript folds upon itself, hybridising to complementary 
regions so that the RNA is double stranded. 
Stable silencing has been induced by directed expression of long dsRNA 
in C. elegans and Drosophila (Tavernarakis et aI.2000; Kennerdell and Carthew 
2000; Piccin et al.2001). In vivo promoter driven RNAi reproduces null 
phenotypes with similar efficiency to direct injection of dsRNA, which had 
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previously been the method of introducing dsRNA. For example, in C.elegans 
ablation of C37A2.5, a gene essential for progression past L2 larval stage, resulted 
in 82%-100% L2 stage arrested Fl progeny by dsRNA injection, compared to 
49%-89% arrest observed with stable dsRNA expression (Tavernarakis et 
al.2000). 
Although long dsRNAs can trigger RNAi effectively in some mammalian 
cells, this is often masked by non-specific effects, which are mediated by the 
dsRNA dependent protein kinase, PKR and RNase L. These enzymes form part of 
the interferon defence pathways that are present in mammals and are activated by 
long dsRNA (reviewed by Stark et al.1998). PKR is a serine/threonine specific 
protein kinase that acts by phosphorylating the a subunit of the eukaryotic 
initiation factor (elF 2). The role of eIF-2 is to form a complex with a methionine 
charged tRNA and to present it to the ribosomal machinery for translation 
initiation (Merrick 1992). Phosphorylation of eIF2 prevents the exchange of elF 2-
GDP to the GTP bound form, catalysed by eJF2B. The resulting reduction in elF2-
GYP levels leads to an overall block of translation initiation. The other enzyme 
activated by dsRNA that produces a non-specific ablation effect is RNase L. 
dsRNA activates RNase L indirectly by first activating 2',5'-oligoadenylate 
synthetase which results in the increase of the synthesis of 2',5'-oligonucleotide 
required to activate RNase L. RNase L activation results in non-specific mRNA 
degradation (Floyd-Smith et al. 1981). 
Recently Tusehl and colleagues (Elbashir et al.2001b) demonstrated that 
RNAi can be provoked in numerous mammalian cell lines through the 
introduction of synthesised 21 nt siRNAs. These siRNAs avoid provoking a PKR 
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or RNase L response because dsRNA less than 35 bp are unable to activate these 
molecules (Manche et al.1992; Minks et al.1979). siRINAs are thought to be 
incorporated into RNAi by mimicking the products of the Dicer enzyme. 
Synthetic 21 nt siRNAs were able to specifically reduce expression of an 
exogenous luciferase gene expressed from a vector in NIHI3T3 mouse fibroblast 
cells, HeLa cells, 293 human embryonic kidney cells and COS-7 cells (Elbashir et 
al.2001b). The specific ablation observed for siRNAs contrasts with the 
nonspecific reduction of luciferase expression seen with longer dsRNAs of 50 bp 
and 500 bp in HeLa cells. siRNAs were also able to reduce protein levels of three 
out of four tested endogenous genes, lamin A/C, lamin B1 and nuclear mitotic 
apparatus protein, as visualised by antibody staining and Western blotting. So 
siRNAs provide an attractive alternative to ablate gene function in mammalian 
cells if expression of long dsRNA produces non-specific effects. However, the 
ablation efficiency of siRNAs still depends upon targeting an accessible site on 
the mRNA (Holen et al.2002). 
1.3. A Polyoma based episomal replication system for efficient gene 
expression in ES cells 
1.3.1. Background 
The polyoma based episomal replication system allows maintenance of 
exogenous DNA sequences on episomal plasmids, that is as non-integrated 
circular DNA. It relies upon the replication cycle of the polyoma virus, a mouse 
DNA virus, in which the double stranded circular DNA is replicated as 
W. 
unintegrated minichromosomes. The polyoma virus replicates and transforms its 
host by expression of four proteins, large tumor (T) antigen, middle T, small T 
and tiny T from its early region. These proteins are generated from alternative 
splicing of the same primary transcript. Only large T is essential for replication 
(Francke and Eckhart 1973), as middle T is required for cellular transformation 
(Treisman et al. 1981), small T has only a minor role in both (Asselin et al. 1984; 
Berger and Wintersberger 1986) and tiny T has an ill defined role (Riley et 
al.1997). Therefore the extrachromosomal maintenance of vectors constructed to 
express exogenous DNA requires only expression of large T protein, which can 
act in trans, by binding to and initiating replication from the polyoma origin of 
replication (on). 
A polyoma based episome (pMGD20neo, figure 1.5.) was originally 
constructed by Gassmann and colleagues (1995). pMGD20neo contains a 
polyoma early region modified to prevent expression of the transforming middle 
T, as well as a mutant enhancer region, PyF10I (Fujimura et al.1981), originally 
selected for the ability to replicate the polyoma genome in embryonal carcinoma 
cells. Electroporation of this plasmid in ES cells was reported to result in episomal 
replication in 15% of G418 resistant colonies. 
It was further reported that a particular ES cell clone containing episomal 
copies of pMGD20neo, designated MG1.19, was able to efficiently support the 
replication of a second polyoma ori containing episome. Episomal maintenance 
resulted in stable transfection efficiencies approaching 1% which is about 100-
1000 fold higher compared to non-episomal maintenance, and is termed 
supertransfection. Work in our laboratory has substantiated these findings (Niwa 
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et al.1998; I.Chambers unpublished). An ES cell line, E14IT has been established 
in which copies of the pMGD20neo vector are stably integrated. El 4/T cells have 
indistinguishable self renewal and differentiation properties from parental ES 
cells. cDNA sequences for the different mRNA ablation strategies to be 
investigated will be expressed from a second polyoma ori vector by transfection 
of the E14/T polyoma large T expressing ES cell line. 











Figure 1.5. The primary plasmid, pMGD20neo. 
pMGD20neo contains the mutant enhancer PyF 101, the polyoma wild-type on 
and modified polyoma early region (LT20) which is without the splice sites for 
processing of middle and small T mRNAs. The neomycin gene is expressed from 
the phosphoglycerate kinase (P0K) promoter, conferring resistance to 0418. 
Details of construction of pMGD20neo are described by Gassmann et at. (1995). 
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The basic design of the polyoma on episornal vector to be used for 
expression of ablation cDNA5 under investigation is shown in figure 1.6. The 
vector contains the polyoma ori and the mutated enhancer region, PyFIO1. The 
mutated enhancer is required for propagation of the polyoma ori vector in mouse 
ES cells. The promoter used to drive expression is CAG (Niwa et al.1991) 
consisting of the human cytomegalovirus immediate early (hCMV-IE) enhancer, 
and the AG promoter. This is a strong transcriptional regulator that is ubiquitous 
in a wide variety of cell lines, including ES cells. The AG promoter consists of 
sequences from chicken 13-actin including the promoter and first exon, which is 
untranslated, and most of the first intron, fused to the 3' portion of the second 
intron and part of the third exon from rabbit 3-globin. The vector is made 
selectable in ES cells with the inclusion of a PGK driven drug resistance gene 
encoding either hygromycin phosphotransferase or puromycin N-
acetyltransferase. An alternative to a separately driven drug resistance gene is to 
link transcription of a sequence of interest, cloned into the MCS by placing an 
internal ribosomal entry site (]IRES) linked drug resistance gene between the 3' 
MCS and the polyadenylation site immediately downstream. Propagation in 
bacteria is made possible with an ampicillin resistance gene and CoIEI ori present 
in the vector backbone. While the presence of an 5V40 origin of replication 
allows maintenance of the vector some transformed cell lines, such as COS-7 cells. 
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Figure 1.6. 
Plasmid map to illustrate all backbone components shown in subsequent 
vector maps and Cloning strategy diagrams. 
K-R pA 
pPyRCAGS-S Vector MCS 
;V40 pA 
PyF1O1 





• Py on - Polyoma origin of replication 
derived from Polyoma virus, for episomal replication of the vector 
• PyF101 - mutated enhancer 
Required for propagation of a polyoma ori vector in ES cells 
- Cytomegalovirus Immediate Early Enhancer 
E 	- Chicken beta-actin Promoter 
including the first exon, which is non coding, and most of the 
first intron 
[ Beta-globin - Rabbit beta-globin 
Includes splice acceptor sequence 
• Sequence of interest to be expressed surrounded by multiple 
cloning sites 
.4 pA- polyadenylation site eiter Beta-globin pA or bovine growth 
hormone pA 
SV40 ori and ColEl On 
• AmpR - Ampicillin resistance gene, a bacterial selection marker 
• PGK-R PA - phosphoglycerate kinase 1 promoter driven 
expression of a resistance gene either hygromycin or 
puromycin, selectable in ES cells, with a polyadenylation site 
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1.4. Inducible system for expression of ablation sequences 
1.4.1. Background 
Inducible systems are often employed to tightly regulate gene expression 
and would be favourable for the regulation of transcription of the ablation cDNA 
sequences under investigation. This is important for gene products required for 
cell viability, for gene function either during differentiation or once cells have 
differentiated or genes involved in self renewal. Having an inducible system will 
allow ablation to be controlled in a temporal manner. Also as differentiated cells 
cannot be propagated an inducible system would allow a replica plate of the 
uninduced cell population to be maintained for DNA extraction. 
1.4.2. Cre-IoxP recombination System 
The Cre-IoxP recombination system was chosen for conditional activation 
of expression because it is well characterised and functions efficiently in mouse 
ES cells (Gu et al.1993) as well as in transgenic mice (Urban et al.1992). 
Moreover it can be used in an episomal context. 
The Cre-loxP system is the recombination system from bacteriophage P1 
and is so called because it consists of a site on the DNA where recombination 
occurs called loxP, and the Cre protein, which mediates the reaction. The loxP site 
is 34 bp in length and consists of two 13 bp inverted repeats separated by an 8 bp 
asymmetric spacer region. Cre is a member of the integrase family of 
recombinases, which recognise specific nucleotide sequences, the inverted repeats 
within the loxP site in the case of the Cre protein. Upon binding to the inverted 
repeats, Cre synapses with a second lox site on the same segment of DNA, 
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cleaving the DNA in the 8 bp spacer region initiating strand exchange between the 
recombining loxP sites. Cre mediated recombination results in either the excision 
or the inversion of intervening sequences depending on whether the loxP sites are 
in direct or opposite orientation to each other. If the former occurs a single IoxP 
site is left at the site of excision. It is the excisional properties that are taken 
advantage of when generating an inducible expression system for sequences of 
interest. Inducible expression can be achieved by inserting a loxP flanked 
transcriptional terminating sequence upstream of the sequence to be expressed. 
The transcriptional terminating sequence prevents expression prior to induction 
with Cre. 
The action of Cre can be made inducible in two ways, either under the 
control of a tissue specific or regulatable promoter or by fusion to an inducible 
ligand binding domain, which controls the activity of the protein. An example of 
the latter is the fusion to a steroid hormone receptor binding domain. In particular 
a mutated oestrogen binding domain that binds the synthetic oestrogen analogue 
tamoxifen or 4-hydroxy tamoxifen. The Cre-estrogen receptor binding domain 
(Cre-ER) fusion proteins are inactive in absence of tamoxifen as they are bound 
and sequestered in the cytosol by heat shock proteins such as heat shock protein 
90 (Hsp90). However, addition of tamoxifen to cells displaces the heat shock 
proteins, allowing Cre to enter the nucleus and mediate site specific recombination 
(Mattioni et al. 1994). Currently a Cre-ER fusion protein designated CreERT2  has 
been developed which is —10-fold more sensitive to 4-hydroxy tamoxifen than the 
previously characterised CreERT  fusion protein (Indra et al. 1999). 4-hydroxy 
tamoxifen concentrations as low as 1 OnM are effective at inducing expression, 
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while there is no or very little background expression prior to induction (Vallier et 
al.2001). Conditional gene expression using this Cre-ER fusion protein has been 
demonstrated in ES cells as well as differentiated cells both in vitro and in vivo 
(Valuer et al.2001). 
1.5. Endogenous ablation targets in ES cells 
1.5.1. Background 
To investigate the feasibility of the mRNA ablation strategies to ablate 
gene function in ES cells an understanding of the genes and signalling pathways 
involved in ES cell self renewal and differentiation is required. Suitable ES cell 
gene targets whose functions are already established can then be targeted for 
ablation and provide a way of determining efficiencies of the different ablation 
strategies. 
1.5.2. Cytokine dependence of ES cells 
Historically, ES cells were initially co-cultured with mouse embryo 
fibroblasts (Evans and Kaufman 1981; Martin 1981), as removal from fibroblast 
cells caused differentiation of ES cells. Subsequently it was demonstrated that an 
isolated soluble glycoprotein, leukaemia inhibitory factor (L1F) (Gearing et 
al.1987) maintained ES cell pluripotency in the absence of fibroblasts (Smith et 
al.1988; Williams et al.1988; Smith and Hooper 1987). LIF is required for the 
propagation of self renewing ES cells in culture. In the absence of LIF, ES cells 
differentiate and pluripotency is not maintained. 
LIF is a member of a family of related cytokines including oncostatin lvi 
(Rose et al. 1994), ciliary neurotrophic factor (Conover et al. 1993), cardiotrophin-
1 (Pennica et al.1995), interleukin 6 (IL-6) and interleukin 11 (IL-11). LIF, 
Oncostatin M and cardiotrophin-1 are able to sustain self renewing ES cells as 
they bind to a heterodimeric complex consisting of two transmembrane 
glycoproteins, LIF receptor (L1FR) and gpI30 (reviewed in Taga and Kishimoto 
1997; Heinrich et a]. 1998). IL-6 and IL-Il are unable to promote self renewal, as 
the specific receptors are not expressed in ES cells. However, addition of a soluble 
form of the IL-6 receptor (sIL-6R) with TL-6 promotes self renewal (Nichols et 
al.1994; Yoshida et al.1994) by forming a hexameric receptor complex acting 
solely through a gp130 homodimer (Murakami et al.1993). This indicates that 
signals emanating from gpl3O are sufficient for self renewal. 
1.5.3. Activation of STAT3 signalling to maintain self renewal of ES 
cells 
LIFR and gp130 are members of the cytokine receptor superfamily. These 
molecules possess no intrinsic tyrosine kinase activity (Bazan 1990) but this 
function is provided by members of a tyrosine kinase family called the Janus 
kinases (JAKs) (Stahl et al. 1995). JAKs are constitutively associated with the 
receptor at protine rich conserved regions within the cytoplasmic domain (Darnell 
et al.I994). Ligand binding induces homo or hetero dimerisation of gp130 and 
other class I cytokine receptor family, bringing JAKs into close proximity, 
inducing their phosphorylation and activation. There are four Janus kinases, JAK 
1, JAK 2, JAK 3 and Tyk 2, of which, all except JAK 3 have been shown to bind 
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gpl30 (Stahl 1994). Activated JAKs phosphorylate tyrosine residues on the 
cytoplasmic domain of gp130, which form binding sites for Src homology 2 
(51-12) domain containing molecules (Stahl et al.1995) including the signal 
transducer and activator of transcription (STAT) family members 1, 3 and 5 (Stahl 
et al.1 995) and protein tyrosine phosphatase SHP-2 (Fuhrer et al. 1995). These 
molecules are thth activated by phosphorylation by JAKs. In addition to 
activation of STATs and SHP-2 other downstream signalling pathways are also 
activated including the mitogen activated protein kinase (MAPK) pathway (Yin 
and Yang 1994), the phosphatinositide-3' (P1-3') kinase pathway (Takahashi-
Tezuka et al.1998), Src-like kinases Hck and Btk (Ernst et al.1994; Matsuda et 
al.1 995) and insulin receptor substrate (IRS) family proteins (Argetsinger et 
al. 1995). 
STAT3 is the principle STAT factor activated by LIF or ILÔ plus s1L-6R 
in ES cells (I-locke et al. 1995). STAT proteins have a conserved amino terminus 
required for dimerization of activated STATs, a central DNA binding domain, an 
5H2 domain and transactivation domain at the C-terminus (Darnell 1997). Upon 
receptor binding, STAT3 is phosphorylated on a conserved tyrosine residue Y705, 
which is required for STAT3 dimerisation and translocation to the nucleus 
(Darnell et al.1994), where it binds specific DNA sequences, regulating 
transcription of target genes (Figure 1.7.). 
STAT3 activation is directly required for ES cell self renewal. Inhibition 
of STAT3 activation not only blocks self renewal but promotes differentiation 
(Niwa et al. 1998). This was demonstrated by mutation of STAT3 docking sites in 
gp130 and by using a dominant interfering mutant of STAT3, STAT317, where the 
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tyrosine residue at amino acid position 705 is mutated to phenylalanine. High 
expression of STAT3F blocks activation of endogenous STAT3 possibly by 
competing for receptor docking sites in myeloid and Ml leukemia cells (Minami 
et al.1996; Nakajima et al.1996). ES cells supertransfected with a STAT317 
expression vector resulted in predominantly differentiated colonies in the presence 
of LW. These colonies resembled differentiated colonies formed in the absence of 
LIF. Expression of marker genes further confirmed STAT31 7 expressing ES cells 
had differentiated (Niwa et al. 1998). The MAPK pathway is also activated 
downstream of gp130. However, ERK signalling unlike STAT3 signalling is not 




Figure 1.7. Figure showing STAT3 activation by LIF signalling 
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1.5.4. Negative regulator of STAT3 activation 
- Suppressor of Cytokine Signalling 3 (SOCS3) 
The duration and intensity of STAT signalling is tightly regulated by 
induction of STAT inducible STAT inhibitor molecules also referred to as 
suppressors of cytokine signalling (SOCS) proteins (Bousquet et al. 1999). The 
SOCS proteins consist of a family of eight members, SOCS1 through SOCS7 and 
the cytokine inducible 5H2 containing protein (CIS) (reviewed in Krebs and 
Hilton 2000). Each protein contains two regions of homology, a central 5H2 
domain and a 40 amino acid C-terminal motif designated the "SOCS box". Each 
has different expression patterns or activity against different signalling pathways. 
SOCS3 alone is significantly stimulated in ES cells by LIF (I.Chambers, 
unpublished) and is induced by gp130 signalling by cytokine stimulation, which 
activates the JAK-STAT pathway inducing SOCS3 transcription (reviewed in 
Krebs and Hilton 2000). SOCS3 acts by binding to tyrosine Y118 present on 
gpl30, blocking further activation (Nicholson et al.2000). Suppression of gp130 
signalling by SOCS3 was impaired in 293T fibroblast cells transfected with a 
chimeric receptor containing a mutated gp130 intracellular domain, where the 
tyrosine residue at position Y 118 was mutated to phenylalanine (Nicholson et 
al.2000). 
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1.5.5. Oct4 -Transcriptional regulator required for maintaining 
pluripotency of ES cells 
Oct4 is a member of a group of related POU transcription factors 
containing a particular type of bipartite DNA binding domain (reviewed in 
Ruvkun and Finney 1991). The POU family was originally defined by the 
sequence homology of three mammalian transcription factors and one nematode 
regulatory protein, Pitl/GHF1, Oct], Oct2 and Unc86 (Herr et al.1988). Oct4 is 
expressed in oocytes (Rosner et al. 1990) and the early embryo, where the maternal 
protein is present until the end of the two-cell stage (Palmieri et al. 1994). Between 
the four and eight-cell stage zygotic Oet4 gene expression is activated, and Oct4 
expression becomes confined to the inner cell mass (1CM) of the blastocyst and 
later becomes restricted to the germ cell lineage (Scholer et al.1990; Yeom et 
al. 1996). 
004 expression is essential in maintaining the identity and pluripotency 
of the 1CM of mouse blastocysts (Nichols et al.1998). Elimination of Oct4 
expression results in differentiation along an extraembryonic trophoblast lineage 
in Oct4 deficient embryos and in ES cells (Nichols et al.1998; Niwa et al.2O0O)3J.'. 
ES cells require a critical level of Oct4 to maintain pluripotency. Reduction of 
normal Oct4 levels by more than a half induces differentiation into the 
trophectoderm lineage, while less than a twofold increase results in the 
differentiation into endoderm and mesoderm (Niwa et al.2000). Oct4 is therefore a 
master regulator of pluripotency and can be used to unequivocally define 
undifferentiated ES cells. 
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1.6. Aims and Objectives 
The aim of this thesis was to investigate the effectiveness of ablation 
strategies for the determination of gene function in ES cells. The three mRNA 
ablation strategies investigated were antisense RNA, ribozymes and double 
stranded RNA. These methods of ablation have all been used successfully in 
many organisms and in vitro systems, which suggested their potential in 
determining gene function in ES cells. To maximise ablation, ablation sequences 
were stably expressed from episomally replicated vectors which allowed continual 
expression. Inducible vectors were also designed to make the system more 
versatile. Effectiveness of the different ablation strategies in ES cells was 
evaluated by ablating defined targets, chosen to give either easily scorable 
phenotypes or molecular readouts. The development of an effective ablation 
strategy has potential not only for discovering the function of a cloned gene of 
interest but for the identification of new genes in a screen. 
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Chapter 2: MATERIALS AND METHODS 
Unless otherwise stated, analytical grade chemicals were obtained from either 
Sigma or Fischer chemicals. Analytical grade agarose was supplied by 
Biowhittaker Molecular Applications. All bacterial media components were 
supplied by DIFCO laboratories. Synthetic oligonucleotides were synthesised by 
Oswel DNA Service (University of Southampton, U.K.). Radioisotopes were 
supplied by Amersham International plc (Little Chalfont,U.K.). 
2.1 Molecular Biology Methods 
General molecular biology techniques and the preparation of standard solutions 
were carried out according to Sambrook et al. (1989) unless otherwise stated. 
2.1.1. General Cloning Techniques 
2.1.1.1. Blunt ending of Wand 3' overhangs 
Cohesive ends were filled in with 1s1 of 25j.xM dNTPs (Amersham Pharmacia) 
using 1 1il of the Kienow fragment of DNA polymerase (2U/isl) (Roche) to a final 
volume of IOOpJ with dH20. The reaction was incubated for 5 minutes at room 
temperature and stopped by addition of 5mM EDTA. 
2.1.1.2. Gel purification of DNA 
2.1.1.2.1. Large fragments 
Large restriction fragments of up to 10kb were purified by first running the 
digested fragments on 1% agarose gels. These gels, containing 0.5pg/ml of 
ethidium bromide, were cast and run in IXTAE buffer (40mM Tris, 1mM EDTA, 
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pH adjusted to pH7.7 with acetic acid), which allows for better separation of 
larger fragments than TBE buffer. Single bands of interest were isolated from the 
gel with a scalpel under UV illumination. DNA was purified from the gel slice 
using QIAEX II gel purification kit (Qiagen) according to the manufacturers 
instructions. 
2.1.1.2.2. Small fragments 
The Oct4 5 'UTR PCR product of 83bp was isolated for subcloning by resolving 
on a 4% NuSieve GTG agarose gel. The gel contained 0.5igIm1 of ethidium 
bromide and was cast and run in 0.5XTBE buffer (44mM Tris, 44mM Boric acid, 
1mM EDTA). A PCR marker (Sigma) was loaded onto the gel as a size standard. 
The fragment was then isolated and purified as for larger fragments (see section 
2.1.1.2.1.). 
2.1.1.3. Ligations 
Appropriate plasmid vectors were digested and gel purified, as were restriction 
fragments (section 2.1.1.2.). Ligations were set up at either a 1:1 or 1:3 
vector:insert mola.rity ratio with 0.5pl of T4 DNA ligase (Roche) and 1.il of lox 
ligase buffer (Roche) to a final volume of 1Osl. Cohesive and blunt end ligations 
were incubated overnight at 4°C. Vector alone ligations including both T4 DNA 
ligase and ligase buffer were always included as a control for background vector 
re-ligation. 
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2.1.1.4. Preparation of Chemically Competent cells 
A colony from a freshly streaked Luria Broth (LB) agar (1.5% wlv agar in LB-1% 
wlv tryptone (Difco), 0.5% w/v yeast extract (Difco) and 5mM NaC1) plate of 
DH1OB cells was used to inoculate lomls of LB and grown overnight at 37°C 
with shaking. lml of overnight culture was added to lOOmi of LB and the culture 
grown to A550=0.3-0.6 to ensure the cells were in log phase. The culture was then 
spun at 3,000 x g for 5 minutes at 4°C. The cell pellet was resuspended in 5m1 of 
freezing solution (LB broth pH 6.1, 10% PEG, 5%DMSO, 10mM Magnesium 
chloride, 10mM Magnesium sulphate, 10% glycerol) at 4°C. Cells were then 
aliquoted at 500.tl into pre-chilled eppendorf tubes and snap frozen in liquid 
nitrogen before storage at -80°C. 
2.1.1.5. Transformation of Bacterial cells 
Transformations were carried out to obtain either newly ligated vectors or to re-
transform existing vectors from a diminished stock. Frozen competent bacteria 
were thawed on a mixture of ice and water. lOOjil of cells were mixed with a pre-
chilled mixture of 1xl of ligation reaction, 20j.tl of KCM (SOOmIvI KC1, 150mM 
CaC12 , 250mM MgC12) and made up to 100tl with water. This mixture was 
incubated on ice for 20 minutes and then at room temperature for 10 minutes. To 
this 800pJ  of LB was added and the mixture incubated at 37°C with shaking for 1 
hour. Aliquots were then plated onto LB agar plates (1.5% w/v agar in LB) with 
an appropriate drug selection e.g either 50g/ml of ampicillin or 25.tgIm1 of 
zeocin and incubated at 37°C. 
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2.1.1.6. TOPO TA Cloning 
TOPO TA Cloning was used to directly clone PCR fragments into pCR2.1 vector 
using the TOPO TA Cloning kit (Invitrogen) according to the manufacturers 
instructions. 
2.1.1.7. Screening transformants 
Recombinant bacterial colonies were screened for the presence of inserts by first 
preparing plasmid DNA (2.1.2.1.) and then cutting with appropriate restriction 
enzymes to produce informative digest bands when run on agarose gels. 
2.1.1.8. In vitro Cre recombinase reaction 
Cre recombinase was either from Invitrogen or was a gift from Dr. John Bishop. 
The Invitrogen enzyme was used according to the manufacturer's instructions 
with the exception that after inactivation at 65°C the reaction mix was 
phenol/chloroform extracted and ethanol precipitated. Reactions using Cre 
recombinase from Dr. John Bishop were performed as follows; I jig of substrate 
DNA was incubated with 2p1 lOx Buffer (50 mlvi NaCl, 10 m Tris-HCI, 10 m 
MgCl2, 1 mM dithiothreitol p1-I 7.9 at 25°C) and 2 psI of Cre recombinase to a 
final volume of 20psl for 15 minutes at 37°C. 
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2.1.2. Isolation of Nucleic Acids 
2.1.2.1. Plasmid Preparation 
Small scale plasmid preparation (miniprep) was performed using QLkprep 
miniprep plasmid isolation kit (Qiagen) using spin columns. 
Large Scale plasmid preparations (Maxiprep) were prepared using Qiagen's 
Maxiprep plasmid purification kit. 
2.1.2.2. Isolation of Total RNA 
2.1 .2.2.1. RNeasy minikit 
Total RNA was isolated from ES cells using an kNeasy minikit (Qiagen) 
according to manufacturer's instructions. RNA concentration was then determined 
by measuring absorbance at 260nm and purity monitored by measuring the 
A230 ratio. 
2.1.2.3. Isolation of polyA RNA 
PolyA RNA was purified from total RNA using Oligotex (Qiagen) according to 
the manufacturer's instructions. 
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2.1.3. Nucleic Acid transfer to membranes 
2.1.3.1. Northern Blot Analysis 
2.1.3.1.1. Formaldehyde gel electrophoresis for resolving RNA 
molecules 
RNA was electrophoresed on a denaturing gel prepared by dissolving 2g of 
agarose in 174 ml of water (1%) before addition of 20 ml of lOx 3-N-Morpholino 
propaneSulfonic acid (MOPS) buffer and 10.2 ml of 37% formaldehyde. lOx 
MOPS buffer contains 200 mM MOPS, 50 mM sodium acetate and 10 mM 
EDTA, pH 7. RNA samples were prepared for loading onto a formaldehyde gel 
by adjusting the volume to 10 jil and adding 25 gl of sample buffer and 0.125 tl 
of ethidium bromide (lOmg!ml). Sample buffer contains 50%v/v formamide, 
2.2M formaldehyde, lx MOPS, 5% glycerol and 0.125% bromophenol blue. 
Samples were heated to 70°C for 10 minutes and allowed to cool before loading. 
6.tg of 0.24-9.5kb RNA ladder (GibcoBRL-Life Technologies) was treated in the 
same way. Electrophoresis was performed at 80V for 4-5 hours. 
2.1.3.1.2. Northern Blotting 
Nucleic acids were transferred to Hybond-N nylon membrane (amersham 
pharmacia biotech) using a capillary transfer technique. This involves a dish 
containing 20x SSC with a sheet of 3MM paper pre-soaked in 20x SSC resting on 
a glass plate above the dish with the ends immersed in the SSC. The gel, washed 
in dH20, was inverted and placed on the 3MM paper onto which the pre-cut nylon 
membrane was placed. The top right hand corner of the filter was cut as an 
orientation aid. Ten sheets of 3MM paper cut to the same size as the gel and pre- 
soaked in 2x SSC were placed on the filter. Finally, paper towels were stacked on 
the 3MM paper and a weight was placed on top, ensuring good contact throughout 
the assembly. The transfer was left overnight before disassembly, when the filter 
was washed in 2x SSC and baked at 80°C for 30 minutes. 
2.1.4. Radiolabelling Probes 
2.14.1. DNA Probes 
20 ng of purified probe was made up to 12 p.1 with dH20 and denatured by boiling 
for 5 minutes. When cooled, 4 p.! of High Prime (Roche Molecular Biochemicals) 
and 4 p.1 of cz 32P dCTP (10 mCiIml; 3000Ci/mmol) were added and incubated at 
37°C for 30 minutes. The reaction volume was then adjusted to 100 p.d and 
unincorporated nucleotides were removed by centrifugation of the reaction 
through a G-50 column at 2000 x g for 2 minutes. Specific radioactivity of probes 
was determined by readings in ULTIMAGOLD using a liquid scintillation 
analyser (TRI-CARB®). 
2.1.4.2. Oligonucleotide Probes 
50 ng of synthesised oligonucleotide probe (Oswel, University of Southampton, 
UK.) was end labelled with 4 p.1 /ATP 32P (10 mCi/rn!; 5000Ci/mmol) by 
including 1 p.i of T4 polynucleotide kinase (Roche), 2 p.1 of lOx buffer (500 mM 
Tris-HCI, 100 mM MgCl2, 1 mM EDTA, 50 mM dithiothreitol, 1 mM 
spermidine) and 12 p.1 of dH20 in the reaction and incubated for 45-60 minutes at 
37°C. The reaction volume was adjusted to 100 p.1 and unincorporated nucleotides 
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were removed by centrifugation of the reaction through a 0-25 column at 2000 x 
g for 2 minutes. Specific radioactivity of probes was determined by readings in 
ULTIMAGOLD using a liquid scintillation analyser (TRI-CARB®). Probes with 
a specific radioactivity in the range of lx I0 lx 10 9 cpm per tg were used for 
hybridisation. 
2.1.5. Hybridisation 
2.13.1. Double stranded DNA Probes 
All hybridisations with DNA probes were performed at 65°C in Techne 
hybridisation bottles in a Teche RB-I oven. Filters were prehybridised for at least 
30 minutes in 50 ml of Church and Gilbert hybridisation buffer (0.5 M Na2HPO4; 
7% SDS; 1 mM EDTA). The double stranded radiolabelled probe was denatured 
at 100°C for 5 minutes, and added to the hybridisation buffer and incubated 
overnight. Following hybridisation, filters were washed for approximately 20 
minutes sequentially in three wash solutions, as required, (A- 44 mM Na2HPO4, 
5% SDS, 1 mM EDTA; B- 44 mM Na2HPO4, 1% SDS, 1 mlvi EDTA; C- 40 mM 
Na2HPO4 and 0.1% SDS). Filters were wrapped in Saran Wrap and exposed to 
either autoradiographic film at -70°C for an appropriate length of time until a 
signal appeared or a Phosphorimager screen for 1-2 days (FLA-3000 
PhosphorImager). 
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2.1.5.2. Single stranded Oligonucleotide Probes 
Hybridisation with an Oligonucleotide probe was performed as described for 
DNA probes except that the hybridisation temperature was 48°C. Filters were then 
washed twice in ÔX ssc at room temperature for 10 minutes. 
2.1.6. Stripping Membranes 
All membranes were stripped by submerging into 1% of boiled SDS (100°C), and 
allowed to cool to room temperature. The efficiency of stripping was checked by 
autoradiography prior to re-probing. 
2.1.7. DNA Sequencing 
2.1.7.1. Automated Cycle Sequencing 
Sequencing of DNAs was performed by the CGR sequencing facility. 
2.1.7.2. Sequencing Primers 
# Description Sequence 
36 T7 AAT ACG ACT CAC TAT AG 
37 T3 Afl AAC CCT CAC TTA AG 
164 CAG cassette downstream TGC TOG flG no TOC TOT 
(complementary to the 3' 
exon of rabbit f3-globin 
included in the CAG 
cassette)  
153 V9547 ACC ACC flC TOA TAG OCA 
(complementary to rabbit 
-globin polyadenylation 
sigiial)  
232 5'p300RIB GOT ITt flO TOT 000 Cfl GO 
233 3'p300RIB On AOC TCA CTC ATT AGO CA 
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2.1.8. Polymerase Chain Reaction (PCR) 
All PCRs were carried out on GeneAmp® PCR System 9700 (PE Applied 
Biosystems). Reactions were assembled on ice containing 100 ng DNA template, 
300 ng of each primer, 10 mM dNTPS (Amersham Pharmacia), 5 jil of lOx 
reaction buffer (provides a final concentration of 1.5 MM MgCl2) and 0.3 p.1 Taq 
Polymerase (1.5units; Qiagen) where the final volume is adjusted to 50p.l with 
dH20. PCRs were used to amplify the UTR sequences of LIIFR, STAT3 and Oct4 
from either vectors available in the lab with the appropriate cloned sequence or 
genomic DNA prepared from ES cells. The basic cycling parameters are 94°C 5 
mins, annealing temperature 12 s, 72°C 30 s and 72°C 10 mins. PCR products 
were analysed by gel electrophoresis. Details of the source and cycling parameters 
used that were individually determined are described below. Subsequently these 
fragments were cloned using the TOPO TA Cloning kit (section 2.1.1.6.) except 
the STAT3 5' UTR where a single band was not obtained. In this case the 
fragment of the anticipated size was excised from a 2% agarose gel and purified 
(section 2.1.1.2.1.). 0.2 ng of the purified fragment was amplified by PCR and 
cloned into pCR2.1. 
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Gene Target Source of DNA Accession Cycling Number 
for PCR Numbers temperature of 
(Lab No. (°C) Cycles 
of vectors)  
5'UTR Jo2(311) AF014933 45 20 
LIFR  
3'UTR pDIARgM2 S81861 45 25 
B52.1 _(301)  
5'UTR E14TG2a U08378 43 25 
STAT3  ES cells  
3'UTR STAT3 1306922 41 20 
PRC/cmv (735)  
5'UTR Oct4 pNLacF S58422S1 60 20 
Oct4  (215)  
3'UTR pBluescript II X52437 45 25 
SK-Oct4 (121)  
2.1.8.1. Primers used in PCR 
# Description Sequence 
238 LIFR GCGGCCGCCGGAGCGTCTCGGCAGT 
5'IJTR -5'  
239 LIFR ACGCGTTGCCATTGTCCTTGCTGTT 
5'UTR -3'  
240 LIFR GCGGCCGCCCAGGTCACCCTTTGTCA 
3'UTR -5'  
241 LffR ACGCGTACAGTAGGCACAGAAATCAG 
3 'UTR -3'  
253 STAT3 GCGGCCGCCTGGAGGGGCTGTAATTCA 
5'UTR-5'  
254 STAT3 ACGCGTAGCCATCCTGCTGCAGTCAGGGGTCTCGAC 
5 'UTR-3' TGTCTCCGGGGCTGAGG 
245 STAT3 GCGGCCGCGGAGCTGAAACCAGAA 
3'UTR-5'  
246 STAT3 ACGCGTAATTTAAAGAGGAACCTC 
3 'UTR-3'  
247 Oct4 GCGGCCGCGAAACCGTCCCTAGGTGAGC 
S'UTR-S'  
248 Oct4 ACGCGTAGCCATGGGGAAGGTGGGCA 
5 'UTR-3'  
242 Oct4 GCGGCCGCGGCACCAGCCCTCC 
3 'UTR-5'  
243 Oct4 ACGCGTACTGTGTGTCCCAGTCTTTATTTAAGAACA 
3'UTR-3' 	IA 
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2.1.9. RNA1 Oligonucleotides 
Description Sequence 
293 GL2F CGUACGCGGAAUACUUCGATT 
(Photinus pyralis 
luciferase)  
294 GL2R UCGAAGUAUTJCCGCGUACGTT 
(Photinus pyralis 
luciferase)  
295 GL3F CLIUACGCUGAGUACUUCGATT 
(Photinus pyralis 
luciferase)  
296 GL3R UCGAAGUACUCAGCGUAAGTT 
(Photinus pyralis 
luciferase)  
297 RLF AAACAUGCAGAAAAUGCUGTT 
(Renilla renformis 
luciferase)  
298 RLR CAGCAUUUUCUGCAUGUUUTT 
(Renilla renformis 
luciferase)  
2.2. Tissue Culture 
2.2.1. ES Cell Culture 
Methods for the routine culture of ES cells are based upon those described by 
Smith (1991). All ES cell culture was performed using sterile techniques within a 
laminar flow hood (GELAIRE®, Flow Laboratories). Cells were incubated in a 
humidified incubator (fleraeus Instruments) at 37°C with 7.5% CO2. All solutions 
were tested for sterility and pre-warmed to 37°C prior to use. ES cells were 
viewed under a microscope (Olympus CK2). 
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2.2.1.1. Reagents 
Media for growing ES cells is IX GMEM containing 15% sodium bicarbonate, 
0.1% MEM non essential amino acids, 4 mlvi glutamine, 2 mlvi sodium pyruvate, 
0.1 mlvi 2-mercaptoethanol and 10% FCS. ES  cells were maintained in an 
undifferentiated state by addition of LW to the media at 100U/ml. LW conditioned 
medium was prepared within the lab by transient expression of murine or human 
LW expression plasmids in COS-7, as described by Smith (1991). 1L6 together 
with soluble ITLÔ/R (sIL-6R) also maintains ES cells in an undifferentiated state 
(Yoshida et al.] 994). 1L6 was prepared by transient transfection of a human IL-6 
expression plasmid in COS-7 cells. slL-6R conditioned medium was prepared by 
selecting in methotrexate, CHOIH27 cells transiently transfected with a sIL6-R 
expression construct linked to the dihydrofolate reductase (Dhfr) gene (Saito et 
al.1991). 
2.2.1.2. Thawing ES cells 
Frozen ES cell vials were taken directly from liquid nitrogen storage and thawed 
immediately in a 37°C water bath. The cells were transferred to a 20ml 
centrifugation tube to which lOmI of pre-warmed medium was added and then 
centrifuged at 250 x g for 3 minutes. The pellet was resuspended in lOmI of 
medium and transferred to a gelatinised 25 cm  flask. Medium was changed the 
next day to remove dead cells. 
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2.2.1.3. Passage and Expansion of ES cells 
Cells were normally passaged every two days. The culture medium was aspirated 
and cells rinsed with PBS. ImI of trypsin solution was added to cells grown in a 
25 cm2 flask (2mls for 75 cm  flask; 3mls for 175 cm 2 flask) and incubated at 
37°C for 2-3 minutes until the cells detached from the plastic. 9mls of medium 
was added to neutralise imI of trypsin (18 mIs or 17 mIs for 2 or 3 mIs of trypsin 
solution respectively) and the cell suspension centrifuged for 3 minutes at 250 x g. 
The cell pellet was resuspended in ES cell medium, pipetted vigorously to ensure 
a single cell suspension and transferred to freshly gelatinised flasks at a dilution of 
1:10. 
2.2.1.4. Freezing ES cells 
Cells were trypsinised and pelleted as described in section 2.2.1.3. and counted in 
a haemocytometer by resuspending in an appropriate amount of medium. After 
centrifugation, the cell pellet was resuspended at a density of 5x 106  cells/ml in 
freezing solution (10% DMSO in cell culture medium) and ImI was aliquoted into 
cryotubes (Nunc). Cryotubes were transferred to -80°C overnight and the next day 
removed to liquid nitrogen for long term storage. 
2.2.1.5. Transfer of DNA to ES cells 
2.2.1.5.1. Supertransfection of E14/T ES cells 
E14/T cells were trypsinised (section 2.2.1.3.) washed twice with PBS and 
counted. Cell density was then adjusted to 6.25x10 6/ml and 0.8 ml (5x10 6 cells) 
mixed with 20 Vg of episomal vector in an electroporation cuvette and incubated 
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at room temperature for 3 minutes. The mixture was then pulsed using a Gene 
Pulser (Bio-rad) set at 0.2 kV and 960 MF, typically giving a time constant of 13-
15. The cells were then immediately transferred to a centrifuge tube containing 
24.2 ml of warmed ES cell medium and mixed thoroughly. Cells were plated at an 
appropriate density, usually 5x104 and 2x105 per 9cm gelatinised plate and 
incubated at 37°C overnight. Appropriate selection was applied 30 hrs after and 
subsequently replaced every 2 days. 
2.2.1.5.2. Effectene 
Transient transfection of ES cells was achieved by using a non-liposomal reagent, 
Effectene (Qiagen) following the manufacturers guide. 1x10 6 E14/T ES cells were 
plated per well of a 6-well plate in 3 mIs of medium containing IOOU/ml LW. For 
each transfection 20 ltl of DNA (3 rig), 24 pI of enhancer and 430 .tl of EC buffer 
were pipetted into an eppendorf and vortexed for 1 second. This mixture was left 
for 2 minutes at room temperature before transferring into an eppendorf 
containing 25M1  of effectene reagent. Again the mixture was vortexed, this time 
for 10 seconds before leaving at room temperature for 9 minutes to allow DNA-
Effectene complexes to form. The transfection complex was then added to 4 mIs 
of pre-warmed medium containing IOOU/ml LW and transferred to the plated 
cells. Cells were incubated at 37°C for an appropriate length of time before 
analysis. 
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2.2.1.5.3. LIPOFECTAMINE 2000 
Lipofectamine 2000 (LF2000) (Life Technologies-GibcoBRL) was used to 
transiently co-transfect COS-7 cells, E14/T and E14TG2a ES cells with firefly 
luciferase (pGL3-Control, Promega) and sea pansy luciferase (pRL-TK, Promega) 
reporter plasmids and siRNA. The annealing of siRNAs was achieved by 
incubating 20 liM single stranded RNAs in annealing buffer (100 mM potassium 
acetate, 30 mlvi HEPES-KOH at pH 7.4, 2 mlvi magnesium acetate) for 1 minute 
at 90°C followed by lhr at 37°C. 
A day before transfection cells were trypsinised and seeded into 24-well plates at 
8x104 for COS-7 cells or 2x10 5 for ES cells. Cells were plated in 0.5 ml of 
UMEM medium containing 10% FCS, where ES cells were additionally 
supplemented with 100U/ml LW. The medium was replaced on the day of 
transfection. For each well 1 tg pGL3-Control, 0.1 jtg pRL-TK and 0.21 .tg 
siRNA duplex were diluted into 50 il  of serum free UMEM. This mixture was 
then added to 3 jil of LF2000 diluted in 50jil of serum free GMEM that had been 
previously incubated at room temperature for 5 minutes. The final mixture was 
incubated at room temperature for 20 minutes before adding to cells. Cells were 
incubated for 20 hrs and assayed for luciferase expression with the Dual luciferase 
assay (Promega) as outlined by the manufacturer. 
2.2.1.6. Induction of ES cell differentiation 
2.2.1.6.1. Retinoic acid Induction 
ES cells were seeded at 1x10 3 or 5x103 per well of a 6-well plate and allowed to 
grow for 1 day. Stock retinoic acid at 102  M (Aldrich) was diluted to 106  M or 
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io lvi in ES cell medium supplemented with lOOU/ml LIF. The culture medium 
was replaced with this medium and changed every 2 days for up to 6 days. 
2.2.1.7. Induction of ES cells 
2.2.1.7.1. SOCS3 Inductions 
For SOCS3 inductions, ES cells were trypsinised and plated at 1x10 6 density into 
25 cm2 flasks. The next day medium was replaced with OMEM containing 10% 
FCS without LW for 1 hr. Cells were then washed and incubated in GMEM alone 
for 6 hrs. Medium was then replaced with GMEM alone or supplemented with 
1 OOU/ml LW for the specified length of time, at which point cells were lysed for 
RNA analysis. 
2.2.2. Staining of ES cells 
2.2.2.1. Leishman Staining 
ES cells were stained with Leishmans reagent (BDH) by removing the cell culture 
medium and replacing it with enough Leishmans reagent to cover the surface of 
the plate. The cells were left at room temperature for 5 minutes before diluting the 
stain with an equal volume of water, which again was left for 5 minutes before 
rinsing with water. 
2.2.2.2. Alkaline Phosphatase Staining 
Alkaline phosphatase staining was achieved by using the Leukocyte Alkaline 
Phosphatase kit (Sigma Diagnostics) following manufacturer's instructions. The 
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Alkaline Phosphatase assay kit works by reacting a sodium nitrite solution with a 
fast red violet Alkaline solution to form a diazonium salt solution. This in 
combination with a solution containing naphthol AS-BI phosphate stains sites of 
alkaline phosphatase activity red, the colouration is dependent upon the choice of 
diazonium salt. 
2.3. Flow Cytometry 
2.3.1. Preparation of cells for Flow Cytometry 
Cells were trypsinised as described in section 2.2.1.3. The cells were counted in a 
haemocytometer, resuspended at 1x10 6 cells/ml in ice cold PBS/10% FCS and 
analysed on FACSCalibur (Becton Dickinson). 
2.3.2. Staining with Annexin V-PE and 7-AAD 
Cells were prepared for staining as described in section 2.3.1. and stained with 
AnnexinV-PE and 7-AAD from the Annexin V-PE Apoptosis Detection Kit I 
according to the manufacturer's instructions (BD Biosciences). 
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Chapter 3: 
Construction of an inducible episomal 
expression system in ES cells 
3.1. Introduction 
The feasibility of antisense, ribozyme and dsRNA as efficient mRNA 
ablation strategies in ES cells are investigated in subsequent results chapters. 
These sequences are to be introduced by continuous expression from an 
episomally maintained vector. This has the advantage that potential ablation 
effects will last longer compared to transfection of pre-synthesised ablation 
sequences and therefore produce clearer ablation phenotypes. This chapter focuses 
on developing an inducible episomal system with which to direct expression, 
giving a greater versatility to the expression system. 
Generation of an inducible vector to express RNA ablation sequences is 
favourable as the knock down of gene expression is made regulatable. Having an 
inducible system will allow ablation to be controlled in a temporal manner. This is 
important for determining the function of genes in ES cells especially if the gene 
products are required for either cell viability or self renewal. An inducible system 
will allow cells transfected with vectors expressing ablation sequences to be 
propagated and maintained prior to induction so that ablation of genes required for 
self renewal will produce a differentiated phenotype, while genes required for cell 
viability will result in a reduction in colony number. An inducible system can also 
be potentially used to express ablation sequences in a screen to identify genes 
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involved in the self renewal of ES cells. If a successful ablation strategy is 
developed in ES cells, inducible expression will allow a replica plate of the 
uninduced cell population to be maintained for the isolation and characterisation 
of cDNA sequences responsible. Ablation of genes required for self renewal will 
cause ES cells to differentiate, which may limit the yield of recoverable episomal 
DNA. Generation of an inducible episomal expression system is therefore 
important. Additional applications of an inducible expression system is its 
possible use for temporal or spatial over or mis-expression of other interesting 
cDNA sequences. 
The inducible system investigated in this chapter makes use of the Cre-
loxP recombination system. This was done by generating an inducible episomally 
maintained vector by inserting an effective foxed transcription terminating 
sequence between the promoter and the cDNA to prevent its expression. Excision 
of the foxed sequence was then induced with Cre recombinase allowing the 
subsequent transcription and expression of the cDNA sequence downstream of the 
promoter. 
3.2. Experimental Strategy 
3.2.1. Design of an Inducible vector 
The inducible vector contains a polyoma origin of replication and the 
CAG promoter to drive expression (described in section 1.3.1.). The test sequence 
to be expressed from the vector is the enhanced form of the green fluorescent 
protein (eGFP). eGFP is used because its expression is easily detected and can 
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therefore be used to investigate whether the transcriptional termination sequence 
is working efficiently. Subsequently eGFP could be replaced with appropriate 
sequences of interest. A foxed transcriptional terminating sequence is inserted 
between the promoter and eGFP, consisting of a synthetic polyadenylation (SPA) 
signal followed by a C2MAZ sequence. A functional polyadenylation signal is an 
essential component of the RNA polymerase 11 termination signal (Proudfoot and 
Brownlee 1976) while sequences located downstream of the polyadenylation site 
have also been implicated in the termination process (McDevitt et al.1984). The 
SPA C2MAZ transcription terminating sequence was chosen because it efficiently 
prevents transcription in vitro (Eggermont and Proudfoot 1993). It was found that 
the C2MAZ sequence potentiates polyadenylation at the upstream SPA site and 
that the effect is additive as inclusion of both sequences terminates transcription 
more efficiently than either sequence alone (Eggermont and Proudfoot 1993). 
Eggermont and Proudfoot (1993) assayed for transcription termination by 
constructing an expression vector containing two HIV-1 long terminal repeats 
(LTRs) in tandem each driving the expression of an a2 globin gene. Transcription 
of each a2 globin gene from this vector resulted in transcriptional interference of 
the LT.R promoters when transfected into HeLa cells, which was alleviated by 
insertion of the SPA and C2MAZ sequences between the globin genes 
(Eggermont and Proudfoot 1993). Initially the SPA and C2MAZ sequences were 
characterised individually, as summarised below. 
The SPA signal is based upon the highly efficient polyadenylation signal 
of the rabbit 3-globin gene and contains the AATAAA sequence, a CT-rich 
sequence and a T-rich sequence (Levitt et al.1989). The SPA signal differs from 
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the rabbit 3-globin polyadenylation signal in that the GT and T rich sequences 
normally separated by two AA nucleotides are fused. In addition sequences 
between AATAAA and the GT/T-rich sequence differ slightly, although the 
correct spacing is maintained. Inclusion of these three elements was found to be 
required for efficient polyadenylation (Levitt et al. 1989). The SPA signal is better 
than natural polyadenylation sites that may not have either a GT- or T-rich 
downstream element or that possess only one. For example when the SPA signal 
was placed 3' to the polyadenylation site of the human a2-globin gene, the SPA 
site was used exclusively, indicating that SPA is a more efficient polyadenylation 
site than a-globin, which does not possess a T-rich downstream sequence (Levitt 
et al. 1989). 
The C2MAZ sequence was discovered between two closely spaced 
human complement genes, C2 and Factor B, located in the MHC class III locus by 
Ashfield et al.(1991). These genes are expressed simultaneously in the adult liver, 
but are very close together, 421 bp from the C2 polyadenylation site to the Factor 
B cap site (Wu et al. 1987). This suggested that there may be efficient termination 
of the C2 transcripts as read-through of a polymerase into the promoter of the 
downstream gene, Factor B might have been expected to result in a down-
regulation of that gene. This is known as transcriptional interference or promoter 
occlusion and has been observed in vitro and in vivo (Eggermont and Proudfoot 
1993; Cullen et al. 1984). In addition to the polyadenylation signal of the C2 gene 
a functionally defined sequence was found downstream, 160 bp in length required 
for efficient termination of the C2 transcript. Subsequently this sequence was 
found to bind the zinc finger protein MAZ, which was shown to halt or slow the 
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progression of the transcribing polymerase by bending the DNA to which it is 
bound (Ashfield et al. 1994). MAZ dependent termination occurs in the presence 
of an upstream polyadenylation site, so the SPA site was utilised in the 
transcriptional terminating sequence. Hence the combined transcriptional 
terminating sequence is referred to as SPA C2MAZ. 
The pPyHCAGeGFP vector was initially constructed in two steps. In the 
first step eGFP from the commercially available vector, peGFP-N1 was cloned as 
a SaIT/NotI fragment into pCAGGS-ori (lab number 577) digested with XhoIfNotI 
to generate an eGFP expression vector driven by the CAG promoter (see appendix 
1). The second step involved subcloning the CAG eGFP expression cassette from 
the newly cloned pCAGGSeGFP plasmid (lab number 444) as a SalTlSfiI 
fragment into the backbone of pPHCAGGS to generate a CAG eGFP expression 
vector also containing a polyoma origin of replication and a hygromycin 
resistance cassette (see appendix 2). The completed pPyHCAGeGFP vector is 
shown in figure 3.1. 
The transcriptional terminating sequence was cloned into pBluescript 
loxP (lab number 885) between two loxP sites using BamHI restricted fragments 
(see appendix 3). The loxP sites are in the same direction as each other and the 
terminating sequence is inserted in the opposite orientation with respect to the 
IoxP sites. This is important because the loxP sequence contains an ATG in the 5' 
to 3' direction which can potentially act as an alternative start codon to that of the 
gene to be expressed. Therefore the loxP sequences have to be inserted in a 3' to 
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Figure 3.1. pPyHCAGeGFP Vector 
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The GAG promoter contains an intron derived from a splice donor site 
from the chicken 3-actin gene and a splice acceptor site from the rabbit -globin 
gene (see figure 3.2.). In order to effectively prevent eGFP expression the foxed 
SPA G2MAZ sequence should be cloned between the GAG promoter and the 
eGFP gene. There is therefore an opportunity to determine whether placement of 
the termination cassette in an intronic or an exonic location would differentially 
affect expression of downstream sequences. Plasmids in which the SPA G2MAZ 
was placed in the CAG intron or downstream of the intron were therefore 
generated (Appendices 4 and 5). This was done by cloning the foxed SPA 
G2MAZ sequence as an AvrII fragment into either the intron or the exon of the 
CAG promoter present in vector pPyHCAGeGFP (Lab number 719) linearised 
with XbaI or Smal respectively. The terminating sequence is upstream of eGFP in 
both cases. 
3.3. Results 
3.3.1. Testing transcriptional termination by SPA C2MAZ in intronic 
and exonic locations 
The inducible eGFP expressing vector, pFlox-C2MAZ-Exon was 
electroporated into E14/T, the polyoma large T protein expressing cell line. Cells 
were grown in LW (100 units/ml) and G418 (200 jig/ml) and selected in 
hygromycin (200 jig/ml) for 7 days until stable transfectants were obtained. At 
this hygromycin concentration control untransfected E14/T cells were killed after 
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Figure 3.2. The CAG cassette construct 
The CAG cassette consists of the human cytomegalovirus immediate early 
(hCMVIE) enhancer, and the AG promoter. The previously characterised AG 
promoter (Miyazaki et al. 1989) was fused to the CMV IE enhancer sequence, to 
generate a strong transcriptional regulator that is ubiquitous in a wide variety of cell 
lines, including ES cells. The AG promoter consists of sequences from chicken P- 
actin including the promoter and first exon, which is untranslated, and most of the 
first intron. This is fused to the 3' portion of the second intron and part of the third 
exon from rabbit -globin. 
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160 pig/mI required to kill untransfected cells alter --10 days. 5x10 4 and 2x10 5 
cells were plated on three 9cm plates at each density. Colonies were viewed under 
bright field and fluorescence and images were taken. No fluorescent colonies were 
detected for ES cells maintaining the pFlox-C2MAZ-Exon vector (figure 3.3.a). 
Identical results were obtained from a duplicate experiment where there were 
approximately 20 colonies growing on plates plated at 5x10 4 density and —70 
colonies growing on plates plated at 2x10 5. This indicates that the transcriptional 
terminating sequence is effective and is able to prevent expression when inserted 
in an exonic location. As the pFlox-C2MAZ-Exon vector proved successful in 
preventing expression of a cloned gene, this vector was used in a subsequent 
analysis to determine if the foxed C2MAZ sequence could be efficiently removed 
with Cre. This was done by electroporating E14/T cells maintaining the pFlox-
C2MAZ-Exon vector with a Cre expression vector, pPyCAGCre]P (lab number 
759). Cells were selected in LW (loounits/ml), hygromycin (200 jig/ml) and 
puromycin (2 pig/ml) for 4 days and examined by fluorescence microscopy (figure 
3.3.b). Expression of GFP indicates that the foxed C2MAZ sequence has been 
removed by Cre expression. Approximately one in five colonies now expresses 
eGFP, where 20 were the total number of colonies growing on plates plated at 
5xlG4 density. Therefore an inducible expression system has been developed, 
activatable with the expression of Cre protein. 
The other eGFP inducible expression vector generated was pFIoç-
C2MAZ-lntron, where the foxed transcriptional terminating sequence was cloned 
within the intron of the CAG cassette. This vector was electroporated into EI4IT 
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Figure 3.3. Determining the effectiveness of the foxed 
transcriptional terminating sequence C2MAZ in preventing 
expression of the downstream gene-eGFP, when cloned within the 
exon of the CAG cassette and its subsequent removal with Cre 
expression. 
E14/T ES cells were electroporated with pFlox-C2MAZ-Exon, where the 
foxed C2MAZ sequence is cloned within the exon of the CAG cassette. Cells 
were selected in LW, G418 and hygromycin (200 4g/ml) for 7 days. 
a) Colonies were viewed under bright field (left panel); with the 
corresponding image under fluorescence (right panel). b) ES cells stably 
maintaining pFlox-C2MAZ-Exon were then electroporated with a Cre 
expression vector, pPyCAGCreIP. Cells were selected in puromycin (2 j.iglml) 
for 4 days and viewed under bright field (left panel) and fluorescence (right 
panel). 
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Figure 3.4. Determining the effectiveness of the transcriptional 
terminating sequence C2MAZ in preventing expression of the 
downstream gene-eGFP, when cloned within the intron of the 
CAG cassette. 
E14/T ES cells were electroporated with pFlox-C2MAZ-Intron. Cells were 
selected in LIF, G418 and hygromycin (200 [tg/ml) for 7 days. A 
representative image of a colony observed is viewed under bright field 
(left panel); with the corresponding image under fluorescence (right panel). 
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described for pFlox-C2MAZ-Exon vector. However, most of the colonies stably 
maintaining the pFlox-C2MAZ-Intron vector were green (figure 3.4.), where the 
transfection efficiency is similar to that of pFlox-C2MAZ-Exon vector. A lack of 
eGFP expression from the pFlox-C2MAZ-Exon vector indicates that the 
transcriptional terminating sequence itself is effective and that the difference in 
the ability to prevent expression is due to the insertion location of SPA C2MAZ. 
3.4. Discussion 
In this chapter I have investigated the development of an inducible 
expression system based upon the Cre-loxP recombination system. This was used 
to generate an inducible episomal expression system from which RNA ablation 
sequences to be investigated in subsequent chapters could be expressed. 
Inducibility relied upon cloning a previously determined transcriptional 
terminating sequence, SPA C2MAZ (Ashfield et al.1991) into a polyoma on 
containing vector between the promoter and the gene to be expressed, eGFP. The 
foxed sequence was cloned into either the intron or exon of the CAG cassette. 
Only when positioned within the exon could SPA C2MAZ prevent eGEP 
expression. The reason for the ineffectiveness of the transcriptional terminating 
sequence when cloned into the intron is likely to be that the SPA signal is not 
utilised in this configuration. This notion fits with current ideas about how 
modules within genes are recognised (Berget et al.1995). Exon definition 
proposes that splicing of pre-mRNAs occurs by defining exons rather than introns. 
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Internal exons are defined by biochemical interactions between the splicing 
machinery recognizing a 3' splice acceptor site and the downstream 5' splice 
donor site. The first and last exons however are defined slightly differently. In the 
former case the 7-methyl guanosine cap is recognised instead of a splice acceptor 
site, in the latter a polyadenylation signal is recognised instead of a splice donor 
site. The 5' cap and nuclear proteins that bind the cap structure are essential along 
with the downstream splice donor site for definition of the first exon and removal 
of the first intron in vitro (izaurralde et al.1994). Definition of the last exon 
involves recognition of the splice acceptor site of the last intron and the 
polyadenylation signal. The consequences of this model for the plasmids I have 
tested are shown in figure 3.5.a) and b), which are diagrams of the proposed 
splicing events that are presumed to occur when the SPA C2MAZ sequence is 
cloned into either the intron or exon of the CAG cassette respectively. The 
diagrams depict two exons and an intron, where the first exon is defined by the 5' 
cap and the 5' splice donor site and the last exon is defined by the 3' splice 
acceptor site and a polyadenylation signal in both instances (figure 3.5.a) and b)). 
However, the source of the polyadenylation signal used depends upon whether the 
SPA C2MAZ sequence is cloned upstream or downstream of 3' splice acceptor 
site. According to this model, when cloned into the intron, the polyadenylation 
signal downstream of eGFP is used as it defines the last exon and eGFP is 
expressed. However, when cloned into the exon, the polyadenylation signal from 
the SPA C2MAZ sequence is the first recognised polyadenylation signal so that 
eGFP is not included in the mature message. 
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Figure 3.5. Diagram of splicing event and polyadenylation signal 
used when the C2MAZ transcriptional terminating sequence is 
cloned within the intron or exon of the GAG cassette. 
The CMVIE, -actin promoter and 5' part of intron I and the first -globin 
sequence shown form the CAG cassette. There is a splice donor (SD) site and 
a splice acceptor (SA) site within the -actin and -globin sequences of the 
cassette respectively. Downstream is eGFP. The C2MAZ sequence is cloned 
either within the a) intron or the b) exon as defined by the SD and SA site 
within the promoter. Cloning C2MAZ into the intron results in the sequence 
being spliced out and polyadenylation (PA) occurring at the PA site 
downstream of eGFP. However, cloning within the exon results in the PA site 
present in the C2MAZ sequence being used and causing efficient 
transcriptional termination upstream of the eGFP sequence. 
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Evidence in support of the exon definition model and the recognition and 
definition of the last exon has been the demonstration that polyadenylation is 
coupled to splicing. In vitro splicing and polyadenylation reactions reveal that 
polyadenylation efficiency is significantly reduced when the terminal splice 
acceptor is mutated (Cooke et al.1999). A synthetic pre-mRNA substrate 
containing an adenovirus splicing cassette and the simian virus 40 late 
polyadenylation signal was used and found that a point mutation in the splice 
acceptor site, which completely eliminates splicing also reduces polyadenylation 
by a third compared to wild type substrates (Cooke et al.1999). This study also 
demonstrated mutating polyadenylation elements such as the hexanucleotide 
consensus element AAUAAA, which is absolutely required for polyadenylation, 
also decreased splicing confirming that splicing and polyadenylation are coupled. 
Requirement of an upstream splice acceptor site for efficient in vitro 
polyadenylation was initially identified by Berget and colleagues. The chimeric 
precursor RNA used for processing in BeLa nuclear extracts consisted of two 
exons and an intron from the major late transcription unit of human adenovirus 
fused to a polyadenylation cassette from the late transcription unit of SV40 (Niwa 
et al.1990). Mutant precursor RNAs lacking the splice acceptor resulted in less 
polyadenylated transcript compared to the wild type RNA. 
The foxed episome was made inducible by the direct expression of Cre 
protein from a stably selected vector. This is an adequate system to induce 
expression. However, the percentage of cells expressing Cre could be increased 
by generating an ES cell line with an integrated regulatable Cre construct, which 
would result in more efficient induction. Such regulation is routinely achieved by 
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fusing Cre to a mutated hormone binding domain of the human estrogen receptor 
(called Cre-ER), which is then activated by anti-oestrogen drugs such as 4-
hydroxy tamoxifen. Originally a ligand dependent recombinase CreERT  was 
constructed where the glycine residue at position 521 was mutated to an arginine 
residue making it inducible with 4-hydroxy tamoxifen (Feil et al. 1996). However, 
Cre-ER' 2 has since been generated, which has a triple mutation, mutated at 
positions 400 from a glycine to a valine, 543 from a methionine to an alanine and 
position 544 from a leucine to an alanine (Feil et al. 1997), which make the fusion 
protein 10-fold more sensitive to 4-hydroxy tamoxifen (Indra et aI.1999). 
Savatier's group (Valuer et al.2001) have demonstrated conditional gene 
expression using the ligand dependent recombinase CreERT2  in ES cells as well 
as differentiated cells both in vitro and in vivo. ES cell lines were generated stably 
expressing CreERT2  and an integrated reporter transgene, conditionally 
expressing human alkaline phosphatase (hAP). Efficient recombination of a loxP 
flanked cassette containing a selection marker as well as three tandemly repeated 
transcriptional termination sequences was detected as hAP expression following 
24 hr treatment with 4-hydoxy tamoxifen at concentrations as low as lOnM 
(Valuer et al.2001). A few ES cell clones that displayed strong hAP activation 
after addition of 4-hydroxy tarnoxifen also displayed no or very little background 
expression prior to induction, making this system highly regullatable for 
conditional gene expression in ES cells. So future work could be the generation of 
a 4-hydroxy tamoxifen regulatable CreERT2  fusion protein expressing ES cell 
line. 
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In conclusion a tightly regulated inducible system for the expression of 
sequences from episomally maintained vectors has been successfully developed in 
this chapter. 
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Chapter 4: Results 
Investigation of Antisense RNA as a method 
to ablate gene function in ES cells 
4.1. Introduction 
Antisense RNA has potential to inhibit gene function by hybridising 
specifically to complementary mRNA target sequences and preventing protein 
expression. The advantage of antisense RNA as an ablation strategy is that it is 
rapid and relatively more easy than the traditional transgenic technology available 
in mice to uncover gene function. Recent findings have indicated that antisense 
RNA can be used to ablate gene function in ES cells (Niwa et al. 1998; Ernst et 
aI.1999; Wulf et aI.1993). In this chapter I investigate the ability of antisense 
RNA to produce an ablation phenotype in ES cells. 
To assess this three genes LIFR, STAT3 and Oct4, whose functions and 
ablation phenotypes are established in ES cells (see chapter 1 section 1.5.2., 1.5.3. 
and 1.5.5.) were chosen as antisense targets. As all the genes chosen are required 
for a self renewal phenotype, ablation induced by antisense should be revealed by 
the differentiation of ES cells while grown under self renewing conditions. 
Antisense sequences targeting both the 5' and 3' UTRs were stably expressed 
from vectors that took advantage of a polyoma virus based expression system that 
maintains the vector episomally (Gassrnann et al. 1995). A possible application of 
a successful antisense RNA strategy would be its use in a library screen for genes 
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that are important in either ES cell self renewal or differentiation as assessed by 
function. 
4.2. Background 
4.2.1. Targeting the UTRs of the antisense target genes 
Both 5' and 3' UTRs are to be investigated as effective antisense ablation 
targets in this thesis. An advantage of targeting UTRs are that they allow for 
rescue of an ablation phenotype by expression of coding sequence for the targeted 
gene. This would conclusively demonstrate that an observed phenotype was 
specific to the gene targeted and not due to cross-hybridisation to a related gene. 
Antisense RNAs specific to the UTRs for each target gene investigated 
are defined as follows. 5' UTR specific antiseiise begin from the transcription 
start site and extend to three bases 3' of the ATG translational start site, included 
to maximise ablation efficiency (see chapter 1 section 1.2.2.4.). The rationale for 
including a maximum of 6 nts of coding sequence, including the ATG site in the 
5' UTR directed antisense is based on evidence that oligonucleotides as short as 7 
nts are able to inhibit gene expression (Wagner et al.1996). Wagner et al.(1996) 
demonstrated selective and potent inhibition of exogenous SV40 large T antigen 
expression, expressed from a vector co-injected with 7 nt oligonucleotides into 
African green monkey kidney cells. Inclusion of 7 nts complementary to the 
coding sequence for 5' UTR specific antisense might therefore not allow the 
potential rescue of an observed ablation phenotype. Where there are two 
transcription start sites identified i.e. for Oct4 (Okazawa et al.1991), then the 
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antisense extends from the first start site, and so encompasses the smaller 
transcript. 
Antisense sequences to the 3 'UTR begin after the stop codon and extend 
to the stretch of A residues in the poly A tail. The poly A tail for both the LIFR 
and Oct4 mRNA have been identified, as they possess the hexanucleotide 
polyadenylation signal, AAUAAA. Although the STAT3 sequence cloned by 
Zhong et al.(1994a) from a mouse thymus eDNA library possesses a stretch of 
poly As downstream of the stop codon, the hexanucleotide polyadenylation signal 
is absent. 
The LIFR exists in two forms, soluble and transmembrane, of which there 
are two LIFR transcripts for each, which differ in size. The sizes of the transcripts 
for the transmembrane form are 11 and 4.4 kb and those for the soluble form are 3 
and 2.8 kb. The 5'UTR specific antisense to LIFR is directed to the 11, 4.4 and 
3kb transcripts. It does not include the 2.8 kb transcript, which uses an alternative 
exon la promoter, and is expressed predominantly in the liver (Chambers et 
al.1997). The 3' UTR specific antisense to LIFR is directed to one of the 
transmembrane forms of the message, the smaller 4.4 kb, as the 3'UTR sequence 
of the 4.4 kb transcript is also present in the 11 kb 3' UTR. The transmembrane 
forms of the LIFR are targeted because it is this form of the LIFR that delivers the 
self renewal signal. The soluble form of the LIFR is unable to deliver a self 
renewal signal and is therefore not targeted. In fact soluble LIFR has been shown 
to inhibit the ability of LIF to induce terminal macrophage differentiation of the 
Ml myeloid leukemic cell line (Layton et al.1992). The possible role that the 
TS 
soluble LIFR has to play in LIF signalling may be to prevent any systemic effects 
of locally produced LIF. 
Although the lengths of antisense used for each target are different, which 
may contribute to differences in potency, the constant are that the complete UTR 
sequences are targeted for the target genes. Exceptions are the 11kb form of the 
LIFR and the STAT3 3 'UTR. 
Table 1. Table of sizes of 5' and 3' UTRs, including coding sequence 
and the predicted size of the mRNA of the target genes 
Target Length of Length of Length of Size of 
genes 5 'UTR coding 3 'UTR (bp) mRNA (bp) 
(bp) sequence (including 
(bp) 23Obp poly A 
tail) 
LIFR 279 3278 575 4362 
STAT3 235 2312 472* 4.8 or 5kb** 
Oct4 69 974 218 1491 
* As determined by Zhong et al. 1994 a) b), accession number U06922. 
**However, the 3' UTR is longer, as the size of the STAT3 mRNA is about 5kb 
or 4.8kb, as determined by Northern blot analysis by Zhong et al.(1994a) and 
Akira et al.(1994) respectively. 
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4.3. Experimental Strategy 
4.3.1. Vector Design 
Generation of antisense vectors to 5' and 3' UTR sequences 
The vector into which antisense sequences have been cloned is 
pPyHCAG-S (poly2) vector (Lab plasmid number 403). The construct includes a 
polyoma origin of replication, a hygromycin resistance gene and a CAG promoter 
(see chapter 1, section 1.3.1). The vector also contains a stuffer fragment 
downstream of the promoter with convenient cloning sites. 
Two forms of the antisense vectors for each target gene were made, one 
that constitutively expresses antisense and one in which the antisense sequence is 
cloned but is not expressed due to the presence of a Stop sequence. The Stop 
sequence consists of a premature polyadenylation site and termination sequence, 
cloned upstream of the antisense sequence, downstream of the CAG promoter and 
was originally characterised in section 3.3.1. (see Appendix 6a). An inducible 
vector gives the option for more detailed analyses of phenotypic effects, as a self 
renewing population transfected with inducible antisense vectors can be 
maintained before transiently expressing Cre and causing differentiation. The 
inducible antisense expression vectors were constructed by cloning the antisense 
sequences into the vector containing the Stop sequence, pPyHCAGS-flox 
C2MAZ-S(poly2). Derivation of the constitutive expressing form was then 
generated by excising the loxP flanked Stop sequence by an in vitro cre 
recombinase reaction (see Appendix 6b) and 6c). The loxP flanked Stop sequence 
was cloned into the exon of the CAG promoter of pPyHCAG-S (poly2) which 
efficiently prevented transcription of downstream sequences as analysed in 
82 
chapter 3 section 3.3.1. A unique Xhol site present in the multiple cloning site 
downstream of the CAG promoter, was cut to produce a linearised vector that was 
then subsequently blunt ended by a Kienow reaction. The loxP flanked Stop 
sequence digested with AvrII was also blunt ended by using the Kienow fragment 
of DNA polymerase and the fragment ligated into the linearised vector. Correctly 
ligated vectors, with the Stop sequence cloned in a coding orientation were then 
identified by appropriate restriction digests. See appendix 6a) for the cloning 
strategy. 
5' and 3' UTR sequences were generated as PCR fragments with 5' NotI 
and 3' MluI restriction sites, for cloning into unique MluI and NotI sites 
downstream of the CAG promoter and Stop sequence (see Appendix 6 b). The 
UTR specific PCR fragments are inserted in an antisense orientation with respect 
to the promoter. PCR primers were designed to amplify the 5' or 3' UTR 
sequence as defined in section 4.2.1. UTR sequences were amplified from 
plasmids available in the lab, except STAT3 S'UTR for which the cloned vector 
sequence was unavailable. Genomic DNA from E14TG2a cells was therefore 
used as a source to amplify STAT3 5'UTR. The primer sequences used to 
generate the UTRs of targeted genes with 5' NotI and 3' MluI ends are shown in 
chapter 2 section 2.1.8.1. PCR reaction conditions were optimised to amplify only 
the band of interest for the direct cloning into the vector pCR2.1 (TOPO TA 
Cloning Kit-with pCR2. 1 -TOPO vector. Invitrogen). Recombinant white colonies 
were picked for the identification of correctly ligated vectors. Correct vector 
constructs identified by restriction digests were verified by sequencing. For 
vectors that showed no mutations of the amplified UTR sequence, a large scale 
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plasmid preparation was made from which the inserts were removed by Noti/Miul 
digestion for ligation into pPyH-flox C2MAZ-CAG-S (poly2) (vector number 
877). Correctly ligated vectors were identified and used in subsequent 
supertransfection experiments (see 4.3.2.) along with the constitutive antisense 
expressing vectors where the Stop sequence was excised by in vitro cre 
recombinase reactions. A strategy diagram of the cloning of 5' and 3' UTR PCR 
fragments into appropriate vectors is shown in figure 4.1. 
4.3.2. Cell Culture 
The experimental strategy was to supertransfect into 5 x106 E14/T ES 
cells 20 p.g of a control vector which does not contain any antisense sequences, 
pPyH-flox C2 MAZ-CAG-S (poly2) (the parental vector from which the antisense 
vectors are derived), and the constitutive and non expressing 5' or 3' UTR 
specific antisense vectors for each target gene. Cells were plated at 5 x104 and 2 
X105 densities on 9cm diameter gelatin coated tissue culture plates to allow easy 
identification of the different morphologies of ES cell colonies. Transfectants 
were selected in hygromycin (4004g/ml) and G418 (200tg/ml) for 7 days, and 
stained with Leishman's reagent which reveals both undifferentiated and 
differentiated cells to determine total colony counts. The phenotypic screen when 
targeting STAT3 and Oct4 was to grow transfected cells in either 0 or I 00units/ml 
of LIF. Phenotypic ablation of these targets was assayed by the differentiation of 
cells supertransfected with an antisense expressing vector when grown in LIF. For 
the LIFR ablation experiments, transfected cells were additionally grown in 
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Figure 4.1. Antisense strategy diagram 
Strategy diagram to outline the generation of 5' or 3' UTR 
expressing vectors from initial PCR fragments. 
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expression vectors will be the differentiation of ES cells grown in LW. Targeting 
the LIFR has the advantage that cells can be maintained in an undifferentiated 
state by growing in a combination of 1L6/sIL6R (Yoshida et al. 1994), in which 
case the signal for stem cell self renewal occurs via the formation of gp130 
homodimers i.e. independent of the LIFR. 
Additional plates were also set up for each electroporated vector, so that 
total RNA of the pooled population could be extracted and used subsequently in 
Northern analyses to determine the level of antisense expression and whether 
expression of the targeted mRNA is reduced. 
4.4. Results 
4.4.1. Phenotypic effect of antisense to target genes 
To determine the phenotypic effect of UTR specific antisense targeting 
LIFR, STAT3 or Oct4, stably selected colonies were stained with Leishman's 
reagent. Colonies were scored based on one of three morphologies; those which 
were self renewing only; those which had a self renewing core with differentiated 
extremities; or those that were totally differentiated. These results are shown as a 
percentage of cells with a purely differentiated morphology, for each of the three 
vectors, pPyH-flox C2MAZ-CAG-S (poly2) (parental vector, containing no 
antisense sequences), pPyH-flox C2MAZ-CAG-5 '/3' UTR (antisense containing 
vector, but not expressed) and pPyHCAG-5'/3' UTR (constitutive antisense 
expressing vector), for each of the cytokine conditions used. The results shown in 
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Figure 4.2. A Lack of phenotypic effect with Antisense directed to 
UTRs of target genes 
Effect of Antisense on ES Cell differentiation in the presence or absence of a 
cytokine, LIIF for all targets, and additionally 1L6/sIL6R for LIFR targets. 
E14/T ES Cells were supertransfected with 20tg of DNA of 
pPyH-flox C2 MAZ-CAG-S(poly2) (purple bar), pPyH-flox C2 MAZ-CAG -
5'/3' UTR (mauve bar) or pPyHCAG 5'/3' UTR (yellow bar). Colonies were 
fixed and stained with Leishman's reagent after 7 days of selection at 
400tg/rnl of hygromycin. The number of stem cell colonies and differentiated 
colonies were scored based on morphology observed with Leishman stain, and 
the percentage of those cells which had differentiated are shown. Data are the 
mean for two independent transfections. 
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Figure 4.2. shows a Jack of phenotypic ablation with antisense directed 
towards the UTRs of all the genes targeted. Growing supertransfected ES cells in 
the absence of cytokine results in the expected differentiation of cells, where the 
percentages of fully differentiated colonies is 58% and greater. Supertransfected 
cells grown in either LIF or 1L6/sIL6R showed similar degrees of self renewal 
irrespective of whether the supertransfecting DNA was empty vector, foxed Stop 
or the antisense expression vector. This result was confirmed using an appropriate 
paired t statistical test to analyse the data verifying that there is no significant 
difference at the 5% level. Therefore there is no evidence of these antisense 
plasmids inducing an effect of sufficient strength to be visible in this phenotypic 
screen. 
4.4.2. Northern hybridisation analyses to determine transcript levels 
of endogenous target genes and those from supertransfected 
vectors 
The lack of phenotype may be due to either low or no expression of the 
aritisense transcript. To determine if this was the case, antisense transcript levels 
were analysed. Total RNA was prepared from pooled populations of cells 
supertransfected with vectors pPyH-flox C2MAZ-CAG-S (poly2), pPyH-flox 
C2MAZ-CAG 573' UTR or pPyHCAG-5'/3' UTR for each gene targeted. RNA 
(lO.tg) was fractionated on a denaturing agarose gel and probed for 5' or 3' UTR 
antisense transcripts with a UTR specific probe. Only those cells supertransfected 
with the constitutively expressing antisense vector i.e. pPyHCAG-5'/3' UTR, 
produced an antisense transcript of a correctly predicted size (figures 4.3., 4.4. and 
[a;] 
4.5.). Transcript sizes are predicted based upon transcription beginning from the 
f3-actin transcription start site present in the CAG promoter and ending at the 3-
globin polyadenylation site downstream of the cloned antisense fragment. The 
fact that antisense transcripts are only detected with the constitutive antisense 
vector demonstrates that the stop sequence present in the pPyH-flox C2 MAZ-
CAG-5 '/3' UTR vectors is working efficiently and prevents transcription of 
downstream sequences, as determined in the initial characterisation of the 
inducible vector (chapter 3). 
As antisense RNA is being expressed in cell culture the levels of 
endogenous mRNA were then examined for Oct4 and STAT3 to see if a 
corresponding ablation could be detected. The levels of LIFR transcript are too 
low in ES cells to determine readily by Northern blotting and so were not 
analysed. The appropriate Northems were subsequently stripped and probed for 
either endogenous Oct4 or STAT3 mRNA levels with a coding sequence specific 
probe. Oct4 mRNA was readily detected as a 1.4kb transcript, however the levels 
had not decreased with respect to the Oct4 directed antisense (figure 4.5.). 
Analysis of STAT3 mRNA levels using total RNA yielded no detectable message. 
However, STAT3 mR.NA had been determined previously by Zhong et al.(1994a) 
and Akira et al.(1994) in mouse liver, spleen and kidney using poly(A) + RNA 
derived from these tissues. Therefore 3sg of poly(A) RNA from the STAT3 
3'UTR ablation experiment was fractionated on a gel and probed for STAT3 
mRNA. The STAT3 mRNA was now detectable as seen in figure 4.4. as a 
transcript of approximately 5kb as observed by Akira et al.(1994) and Zhong et 
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Figure 4.3. Relative antisense transcript levels of LIFR 5' and 
3'UTR 
E14/T ES cells were electroporated with 20jig of the indicated plasmids:- 
1) pPyH-flox C2 MAZ-CAG- S(poly2); 2) pPyH-flox C2 MAZ-CAG-LIFR 
5'UTR; 3) pPyHCAG-LIFR 5'UTR; 4) pPyH-flox C2 MAZ-CAG-LIFR 
3'UTR and 5) pPyHCAG-LIFR 3'UTR. 
Total RNA was prepared after 7 days of selection in 400tgIml hygromycin, 
G418 and LIF. The LIFR 5'UTR northern was probed with a probe specific 
to a) The LIFR 5'UTR and b) GAPDH. The LIFR3'UTR northern was 
probed with a probe specific to c) The LIFR 3'UTR and d) GAPDH. Brackets 
indicate the size of the LIFR 5' and 3' antisense transcripts 888bp and 
11 84bp respectively (inclusive of a polyA tail). Blot a) and c) were exposed 
for I day on a phosphorimager screen; b) and d) for 1 day on 
autoradiographic film. 
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Figure 4.4. Relative levels of endogenous STAT3 transcript 
compared to UTR specific Antisense transcript. 
E14/T ES cells were electroporated with 20p.g of the indicated plasmids:- 
1) pPyI-I-flox C2 MAZ-CAG.-S(poly2); 2) pPyH-flox C2 MAZ-CAG-STAT3 
5'UTR; 3) pPyHCAG-STAT3 5'UTR; 4) pPyH-flox C2 MAZ-CAG-STAT3 
3'UTR and 5) pPyHCAG-STAT3 3'UTR. 
Total RNA was prepared after 7 days of selection in 400.igIrnl hygromycin, 
G418 and LIF. The STAT3 5 'UTR northern was probed with a probe specific 
to a) The STAT3 5'UTR and b) GAPDH. The STAT3 3'UTR northern was 
probed with probe specific to c) The STAT3 3'UTR and d) GAPDH. 
PolyA RNA was prepared from total RNA from the STAT3 3'UTR antisense 
ablation experiment and the northern was probed with a probe specific to 
e) the Coding sequence to STAT3 and GAPDH. An arrowhead indicates 
the size of full length STAT3 rnRNA -4.8-5 kb. Brackets indicate the size of 
the STAT3 5' and 3' antisense transcripts 873bp and 1081bp respectively 
(inclusive of a polyA tail). Blots a, c) and e) were exposed for 1 day on a 
phosphorimager screen; b) and d) for 4 days on autoradiographic film; 0 for 
1 day on autoradiographic film. 
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Figure 4.5. Relative levels of endogenous Oct4 transcript compared 
to UTR specific Antisense transcript. 
E14/T ES cells were electroporated with 20ig of the indicated plasmids:- 
1) pPyH-flox C2 MAZ-CAG-S(poly2); 2) pPyH-flox C2 MAZ-CAG-Oct4 
5'UTR; 3) pPyHCAG-Oct4 5'UTR; 4) pPyH-flox C2 MAZ-CAG-Oct4 3'UTR 
and 5) pPyFICAG-Oct4 3 'UTR. 
Total RNA was prepared after 7 days of selection in 400tg/ml hygromycin, 
G418 and LIF. The Oct4 5'UTR northern was probed with a probe specific to 
a) The Coding sequence to Oct4; b) The Oct4 5'UTR; and c) GAPDH. 
The Oct4 3'UTR northern was probed with probe specific to d) The Coding 
sequence to Oct4; e) The Oct4 3'UTR; and f) GAPDH. An arrowhead indicates 
the size of full length Oct4 rnRNA —1.4kb. While the bracket indicates the size 
of the Oct4 5' and 3' antisense transcripts 678bp and 827bp respectively 
(inclusive of a polyA tail). Blots a), b), d) and e) were exposed for I day; c) and 
0 for 2 days on a phosphorirnager screen. 
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expression of STAT3 3 'UTR specific antisense. So although the antisense 
transcripts are being expressed the level of expression may be insufficient to 
ablate the targeted message. However, both the STAT3 and LIFR antisense 
transcripts are well in excess of their endogenous targets as the STAT3 mRNA is 
only detectable as a faint band while the LJFR message is undetectable by 
Northern hybridisation analysis. The Oct4 antisense transcripts are also in excess 
of the Oct4 mRNA (Figures 4.5.b) and e)) which are Northern blots probed with 
either Oct4 5' or 3' UTR specific probes detecting both the specific antisense 
transcript and endogenous Oct4. Therefore, the lack of a phenotypic effect with 
UTR specific antisense is not due to the steady state levels of antisense in the cell 
being below those of the target transcripts. 
4.5. Discussion 
The data presented here addresses the ability of antisense RNA to ablate 
gene function of known targets in ES cells and produce an expected ablation 
phenotype, based upon previous evidence that antisense is able to cause 
phenotypic ablation in ES cells (Niwa et al.1998; Ernst et al.1999; Wulf et 
al. 1993). My results have however, indicated that there is a lack of an expected 
phenotype with the use of antisenseto both the 5' and 3' TJTRs of the target genes 
LIFR, STAT3 and Oct4. The lack of ablation is not due to a lack of antisense 
RNA being transcribed. In fact in all cases the levels of antisense RNA are in 
excess of the target they are directed to ablate. The lack of ablation may be the 
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result of the choice of sites targeted which may be poor ablation sites either in 
terms of possible inaccessibility due to mRNA secondary structure or in terms of 
the UTRs being ineffective target sites. 
This study focused upon antisense specific to UTRs, which have been 
predicted and demonstrated to be good targets for antisense ablation (Pepin et 
al.1992; Moxham et al.1993). There are however, some examples where UTRs 
are ineffective targets. For example Munir et al.(1990) were unable to show a 
reduction in the activity of the HPRT target gene with either a 544 bp or a 1390 
bp antisense directed to 5' UTR, first coding exon and intron of which 136 bp or 
963 bp is specific to the 5 'UTR respectively. This was demonstrated by 
generating transgenic mice expressing these antisense sequences under the control 
of the metallothionein I promoter. Not all of the mice generated produced 
detectable quantities of antisense RNA by Northern analysis, but of those that did 
none showed a reduction in HPRT activity. This corresponded to a lack of 
reduction of endogenous HPRT mRNA in all but one transgenic line which 
expressed the longer antisense construct in the brain and showed a corresponding 
reduction of the HPRT mRNA in this tissue. However, there are many reports of 
UTR specific antisense being successful. For example a 50-70% reduction in type 
II glucocorticoid receptor mRNA in the hypothalmus and cerebral cortex was 
observed with a 1815bp antisense directed to the 3' UTR of rat type II 
glucocorticoid receptor cDNA (Pepin et al. 1992). Transgenic mice of the type II 
glucocorticoid receptor were created, made by microinjecting into mouse oocytes 
the antisense cDNA fragment cloned downstream of the human neurofilament L 
gene promoter, to restrict expression of the antisense transgene to the brain 
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(although expression was also seen in the heart, kidney and adrenal tissues). 
Transgenic mice expressing a 5' UTR and start codon specific antisense RNA to 
Ga12 efficiently reduced Ga12 expression in liver and adipose tissues when 
expressed by the phosphoenolpyruvate carboxykinase promoter (Moxham et 
al.1993). The antisense used was only 39 bp long and was sufficient to cause 
almost complete ablation. Therefore UTRs are not necessarily ineffective target 
sites and whether protein expression can be effectively inhibited by targeting 
either the 5' or 3' UTR of a message has to be determined for the individual 
mRNA. The effectiveness of an antisense mediated ablation may however depend 
upon the length of the antisense RNA used. Although constructs utilised to date 
have varied in length, the general trend in antisense experiments has been the use 
of longer antisense constructs --1kb (see reviews Sokol and Murray 1996; 
Erickson 1999). The requirement of longer antisense to ablate gene function may 
be a reason why the antisense RNAs used in my experiments were unsuccessful. 
The antisense used were relatively short, ranging from 69-575 bp. 
The failure of IJTR specific antisense to ablate gene function may also be 
due to the presence of mRNA secondary structures preventing access of antisense 
RNA to these regions. However, although accessible target sites are required for 
efficient antisense hybridisation it has been found that some secondary structure is 
required for heteroduplex formation between oligonucleotides and mRNA (Mir 
and Southern 1999). Mir and Southern (1999) have shown that efficient duplex 
formation between short oligonucleotides and RNA requires both single and 
double stranded regions of the target sequence. They propose that for duplex 
formation to occur a small number of bases that are accessible in single stranded 
95 
regions of the target are required for initial hybridisation between two 
complementary strands, in a step known as nucleation. Duplex formation is then 
propagated from this site, which may be facilitated by double stranded helically 
configured regions. Of the four regions of the tRNA target analysed that 
produced high yields of heteroduplexes, all contained double stranded stems (Mir 
and Southern 1999). 
Methods of identifying the most suitable sites on the mRNA to be 
targeted will therefore be highly desirable, as the efficiency of antisense ablation 
is largely dependent upon these chosen target sites. A couple of approaches have 
been developed to identify potentially accessible sites. One involves a computer 
programme to predict secondary structures of antisense RNA molecules (Patzel 
and Sczakiel 1998). The other approach involves mapping the mRNA transcript 
for accessible sites with oligonucleotide libraries (Ho et al.1998). For the first 
approach antisense RNA with favourable secondary structures against an HIV-1 
target were predicted by computer. This was based upon the selection of 
parameters from effective hepatitis B virus directed antisense sequences found 
previously, i.e. a high number of terminal unpaired nucleotides. Effectiveness of 
the chosen antisense RNA sequences to inhibit HIV-1 replication in 293T 
mammalian cells was confirmed, where a reduction of up to 96% of HIV-1 
replication was observed. The second approach which is commonly employed to 
identify effective antisense sequence is the use of random libraries of antisense 
oligodeoxyribonucleotides (ODN5). An example of this technique was 
investigated by Ho et al.(1998), to identify sites on their target message, the 
angiotensin type-I receptor, that are most accessible to hybridization with 
Oil 
antisense ODNs. Their method involved probing the entire coding sequence of the 
targeted mRNA with four semirandom libraries composed of three randomized 2'-
deoxyribonucleotides in the centre, the fourth position fixed with one of the four 
deoxyribonucleotides, flanked by three and four randomized 2'-
methoxyribonucleotides at either side. Once annealed, accessible sites were 
determined by cleavage of the RNA by addition of RNase H and then sequencing 
of the cleaved fragments by primer extension. The active antisense ODNs 
identified in this way were tested in vitro and in vivo and found to efficiently 
inhibit receptor expression. Angiotensin receptor levels were reduced by at least 
50% compared to a negative control in cell culture, with a 70-80% maximum 
reduction seen in some cases. When injected into the brains of rats, ODNs 
inhibited receptor levels by 65%. These two methods show that there is a link 
between the accessibility of the target mRNA to antisense RNA and the 
subsequent ability of the antisense to mediate ablation. However, the situation in 
vivo may be more complex as proteins may occlude potential hybridisation sites, 
which cannot be accounted for by in vitro selection methods. Although such 
methods can be used to find potential sites for efficient antisense hybridization 
with regard to the targets used in this thesis, the work is not trivial and ultimately 
the predicted accessible sites still have to be tested individually. Determining the 
most efficient sites in this way will therefore be contradictory to the aim of this 
thesis which was to develop a rapid and efficient ablation method. Had antisense 
RNA ablation been successfully established in ES cells the ablation strategy could 
potentially be used to identify genes required for either pluripotency or 
differentiation. Such screens could be set up by constructing antisense cDNA 
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libraries, where the source of cDNAs are derived from either self renewing or 
differentiating ES cells. A potential screen would be for colonies that differentiate 
in the presence of LW or those that self renew in the absence of L1F respectively. 
Library expression from the polyoma based episomal vector, investigated for 
target gene ablation studies, would have allowed cDNAs of interest to be 
recovered as episomes from Hirt extracts (see section 1.3.). 
It may be more profitable to target coding sequences of the gene to be 
ablated as longer antisense RNA can be generated, which as described earlier in 
the discussion may be better at ablation. UTRs may still be effective as antisense 
targets of a gene, as the number analysed in this study is too small to rule out their 
potential as a target for antisense ablation. This study has however been unable to 
ablate the gene function of three targeted genes in ES cells using antisense RNA 
directed to the UTRs. Therefore it seems unlikely that this could be developed as 
a general approach for testing gene function in ES cells. 
W. 
Chapter 5: Results 
Investigation of the ability of ribozymes to 
ablate gene function in ES cells 
5.1. Introduction 
Ribozymes are an established ablation technology (reviewed in Sokol and 
Murray 1996). Here the ability of ribozymes to ablate gene function in ES cells 
was determined using a previously described ribozyme sequence shown to 
generate a defined phenotype under set conditions in EC cells (Kawasaki et 
al. 1998). 
5.1.1. Ribozyme Target - p300 
Kawasaki and colleagues (1998) defined a critical role for p300 in 
mediating retinoic acid (RA) induced differentiation of embryonal carcinoma P9 
cells. p300 is a transcriptional coactivator of 300 kD. It is closely related to CBP 
(CREB-binding protein) with 57% amino acid identity. p300/CBP possess three 
conserved cysteine/histidine rich regions and a bromodomain interposed between 
two of them. These domains serve as binding sites for sequence specific 
transcription factors and other components regulating gene expression. Originally 
p300 was identified as a consequence of its ability to interact with the adenovirus 
EIA oncoprotein. Subsequently, a variety of different DNA binding transcription 
factors and coactivators have been shown to rely on p300 to function in vivo. For 
example members of the Jun family, STAT3 and ligand dependent nuclear 
receptors such as retinoic acid, oestrogen and progesterone receptors are but a few 
examples (reviewed by Shikama et al.1997). p300 is intimately involved in 
growth control, transformation and cell differentiation. This is evident by the 
interaction of p300 with the tumor suppressor p53 (Lill et al.1997)and the viral 
oncoprotein El A (Arany et al. 1995). p53 interacts with the carboxy terminal 
region of p300 leading to activation of the p53 responsive promoters, thus 
attributing p300 growth suppressor activities with enhancement of p53 mediated 
transcription (Lill et al.1997). E1A directly binds to the third cysteine/histidine 
rich domain of p300 and is important for cell transformation (Smits et al. 1996). In 
addition, p300 also has a histone acetyltransferase activity (Bannister and 
Kouzarides 1996; Ogryzko et al. 1996), suggesting that p300 may facilitate 
transcription of p300 responsive genes by regulating the chromatin environment. 
Further insights into the developmental importance of p300 have been 
gained from gene knockout studies (Yao et al.1998). The homozygous p300 
knockout is embryonic lethal, with the lethality occurring between E9 and El 1.5. 
The cause of death appears to be multifactorial, as knockout mice have defects in 
neural tube closure, cell proliferation and cardiac development. p300 
heterozygotes were also underrepresented assuming normal Mendelian 
inheritance. p300/CBP double heterozygotes were embryonic lethal, 
demonstrating an absolute requirement of p300 and CBP for normal animal 
development (Yao et al. 1998). Moreover mouse development is sensitive to the 
overall gene dosage of p300 and CBP. As these proteins interact with numerous 
transcription factors involved in many signalling pathways it could be that a 
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reduction in the combined level of these proteins is sufficient to result in 
embryonic lethality. 
5.1.2. Rationale of Ribozyme screen 
The ability of ribozymes to ablate ES cell gene function was assessed by 
reproducing an experiment set up by Kawasaki and colleagues (1998) targeting 
p300 mIRNA in EC cells with a p300 specific ribozyme. Their aim was to 
investigate the role of p300 during retinoic acid induction in EC cells. In their 
experiment Kawasaki et al.(1998) established stable F9 cell lines expressing a 
p300 directed ribozyme specific to part of the N-terminal region of p300. This 
targeted region of the p300 gene had been characterised in previous experiments 
and shown to be a successful ribozyme target (Kawasaki et al.1996). The 
ribozyme was expressed from a vector driven by the human tRNA" promoter, 
which is suitable for expressing ribozymes because of its small size and high rate 
of transcription (section 1.2.3.2.). F9 cells were transfected with the ribozyme 
expression vector using the LipofectAMiNE reagent (GIBCO-BRL). The level of 
p300 mRNA was shown to be reduced compared to wild type F9 cells as 
determined by competitive RT-PCR. Nuclear hormone receptors including those 
for retinoic acid (RA) are known to bind p300, so p300 deficient F9 cells were 
examined to determine if they were still able to respond to RA. However, these 
cells failed to undergo RA induced differentiation as determined by morphology 
and a lack of downregulation of SSEA-1, a stem cell specific surface antigen 
(Solter and Knowles, 1978). In addition synthesis of either collagen IV or laminin 
BI, which are extracellular matrix proteins, used as markers of differentiation was 
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not observed. However, cells that contained a CBP specific ribozyme sequence or 
those that contained the p300 ribozyrne and a vector expressing a non-cleavable 
form of p300 mRNA (i.e. where the GIJC cleavage site was mutated to GCC) 
were able to differentiate. Firstly this demonstrates that only p300 and not CBP is 
required for RA induced differentiation. Secondly that the p300 ribozyme is 
specific as the stable introduction of the non cleavable form of p300 into cells 
expressing p300 ribozyme effectively rescued p300 mB.NA expression. p300 is 
therefore required for RA induced differentiation of F9 cells. The same p300 
specific ribozyme sequence was used in a similar RA induced differentiation 
screen in ES cells to determine the feasibility of ribozyme mediated ablation in ES 
cells. 
5.2. Experimental Strategy 
5.2.1. Vector Design 
The ribozyme sequence was cloned into a polyoma origin containing 
vector for episomal expression. The vector from which the p300 ribozyme 
sequence was cloned was p300 ribozyme in TRS-Neo obtained from Dr. 
Kawasaki. It contains the tRNA v" promoter driving expression of a p300 
ribozyme sequence followed by a polymerase III termination sequence (Kawasaki 
et a]. 1996). The ribozyme sequence is complementary to nucleotides 1392-1410 
of the p300 message (numbering according to Ecker et al. 1994 where ATG is nt 
1200) and includes the catalytic loop (figure 5.1.a) and b). This whole fragment 
was excised as a HindIIII Sall I 66bp fragment and cloned into 
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Figure 5.1. Sequences of p300 mRNA targeted, specific ribozyme 
and oligonucleotide probe for ribozyme detection 
p300 sequence targeted. 
Position of target site within p300 mRNA is indicated above the target. 
Secondary structure of p300 ribozyme with its target. 
The arrow defines the site of cleavage. Nucleotides in red denote those to 
which the oligonucleotide shown in c) are complementary to. 
Sequence of oligonucleotide probe to detect p300 ribozyme. 
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Target sequence:. 	5'-CAGACAAGUCUUGGCAUGG-3' 
 















pPHC2MAZ-CAGeGFP (Lab piasmid number 477) cut with Hindill and Sail to 
remove the CAG-eGFP and -g1obin polyadenylation site of the vector (see 
Appendix 7.). 
The p300 ribozyme expression unit was cloned into this polyoma on 
containing vector with a C2 MAZ transcriptional stop sequence downstream of 
the hygromycin resistance gene. This was to circumvent any possible promoter 
occlusion of the tRNAVaT  promoter by the upstream hygromycin 
phosphotransferase transcription unit. Promoter occlusion has been observed in 
various eukaryotic systems and is due to inefficient transcriptional termination of 
an upstream gene, which can interfere with transcription from a downstream 
promoter (Proudfoot 1986). However, Greger et al.(l998) have demonstrated that 
insertion of the same transcriptional termination element used here, SPA C2MAZ, 
consisting of a strong polyadenylation site and the C2 MAZ pause element 
between two HIV-1 promoters integrated into the genome of HeLa cells, 
alleviated interference. The p300 ribozyme sequence was verified by sequencing. 
5.2.2. Cell Culture 
E14/T ES cells were electroporated with either 20j.tg of pPHC2MAZ-
p300R (Lab plasmid number 879) or 20 ltg of pPHCAGGSBstXSv40ori, the 
control vector (Lab plasmid number 470). Cells were selected 30 Irs after 
supertransfection in 100 units/ml of LIF, 200 g/ml of 0418 and 200 g/ml of 
hygromycin for 9 days and both total population and clones of each 
electroporation were established. Transfected cells were selected in 0418 to 
maintain cells expressing polyoma large T and in hygromycin to select for the 
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electroporated vectors. A clone maintaining either the ribozyme or the control 
vectors were then treated with RA. Kawasaki et al. (1998) used 3 x 10-7  M of RA 
to induce differentiation of F9 cells. I x lO and I x 10-7M  of RA are typically 
used to induce differentiation of ES cells (Smith 1991) and as these molarities are 
similar to that used by Kawasaki et al. (1998) both of these concentrations were 
used in subsequent RA induced differentiation assays. 1 x 10 3 or 5 x 103 cells of 
the stably maintained clone were plated into wells of a 6-well plate. p300 
ribozyme and control vector expressing cells were grown in LIF (100 units/ml), 
G418 (200 .tg/ml), hygromycin (200 pg/mI) and RA at 1 x 10.6  or 1 x 10-7M. 
This was to determine if p300 ribozyme expressing cells are able to maintain a 
self renewal phenotype in the presence of RA. The same cells were also grown 
without BA as a control to show that these cell lines maintain a self renewal 
phenotype in the absence of RA. Cells were plated in triplicate for the same clone 
and selective media was replaced every two days. After 6 days of selection 
morphologies were observed by staining cells plated at I x 10 3 with alkaline 
phosphatase, a stem cell marker, and cells plated at 5 x 103 with Leishman stain, 
which stains all cells (see figures 5.2. and 5.3. and 5.4. and 5.5. respectively). 
In addition to the phenotypic screen set up to observe p300 ablation, total 
RNA was also extracted from both the total and clonal population of control and 
p300 ribozyme expressing cells for Northern analysis. This was so that the 




5.3.1. RA induced phenotypic screen of p300 ablation 
Stable ES cell lines expressing either the p300 directed ribozyme or the 
control vector without ribozyme sequences were established with a similar 
transfection efficiency of 0.5%. It was thought that ablation of p300 could prevent 
ES cell differentiation based on the findings by Kawasaki et al.(1998), who 
showed that F9 cells expressing the same p300 specific ribozyme, blocked RA 
induced differentiation. As seen from both alkaline phosphatase staining and 
Leishman staining of a clonal p300 ribozyme expressing cell line, there is no 
prevention of RA induced differentiation. Figures 5.2. and 5.3. are colonies 
stained with alkaline phosphatase. When grown without RA, but in the presence 
of LIF and hygromycin selection (to maintain the vector) the clonal p300 
ribozyme expressing cells maintain a self renewal phenotype. However, when the 
same cells were additionally grown in the presence of RA (10-6or 10-7M)  and 
LIF, the RA was sufficient to cause the cells to differentiate. This was also true 
for cells containing the control vector as there were no cells (or very few) that 
stained positive for alkaline phosphatase. However, there were still cells growing 
in RA in the sane experiment evident by staining with Leishman's reagent 
(Figures 5.4. and 5.5.). As the controls demonstrate that these cells are able to self 
renew in the absence of RA, failure of self renewal in the presence of RA may be 
due to lack of or poor expression of the p300 ribozyme. To determine this and to 
see if any ablation of p300 mRNA can be detected, RNAs were prepared and 
analysed by filter hybridisation. 
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Figure 5.2. Effect of p300 directed ribozyme on ES cell RA induced 
differentiation. 
A stably maintained clone derived from ES cells electroporated with either a 
control vector a) pPHCAGGSBstXTSV40ori; or b) pPHC2MA7--p300R were plated 
at I x 103  density per well of a 6-well plate in triplicate. Cells were grown in LIF 
(100 units /ml), G418 (200 jtg/ml), hygromycin (200 ig/m1) alone or with RA at 
10-' M. Cells were grown for 6 days before staining with alkaline phosphatase, a 










Phenotypic screen of p300 ribozyme 
a) pPHCAGGSBstXISV40ori 
I 
I 	 -- 	 - 
L[F, G418, 
Hygromycin, 







Figure 53. Effect of p300 directed ribozyme on ES cell RA induced 
differentiation. 
A stably maintained clone derived from ES cells electroporated with either a 
control vector a) pPHCAGGSBstXISV40ori; or b) pPHC2MAZ-p300R were plated 
at 1 x 103  density per well of a 6-well plate in triplicate. Cells were grown in LIF 
(100 units /ml), G418 (200 tg/ml), hygromycin (200 jig/ml) alone or with RA at 
10-' M. Cells were grown for 6 days before staining with alkaline phosphatase, a 
marker of undifferentiated cells. 
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Figure 5.4. Effect of p300 directed ribozyme on ES cell RA induced 
differentiation. 
A stably maintained clone derived from ES cells electroporated with either a 
control vector a) pPHCAGGSBstXISV40ori; or b) pPHC2MAZ-p300R were plated 
at 5 x 103  density per well of a 6-well plate in triplicate. Cells were grown in LIF 
(100 units /ml), 0418 (200jig/ml), hygromycin (200 jig/ml) alone or with RA at 
10-6 M. Cells were grown for 6 days before stainin g with Leishmans stain, staining 
all cell morphologies. 
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Figure 5.5. Effect of p300 directed ribozyme on ES cell RA induced 
differentiation. 
A stably maintained clone derived from ES cells electroporated with either a 
control vector a) pPI-ICAGGSBst)USV40ori; or b) pPHC2MAZ-p300R were plated 
at 5 x 101 density per well of a 6-well plate in triplicate. Cells were grown in LIF 
(100 units /ml), G418 (200 jig/ml), hygromycin (200 jig/ml) alone or with RA at 
10' M. Cells were grown for 6 days before staining with Leishmans stain, staining 
all cell morphologies. 
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5.3.2. Northerns to detect p300 ribozyme transcript levels and 
endogenous p300 mRNA 
Total RNA was extracted from both pooled populations and a clone of ES 
cells supertransfected with either pPHCAGGSBstXISV40ori or pPHC2MAZ-
p300R. RNA from the same p300 ribozyme expressing ES cell clone that was 
used for the phenotypic screen was analysed. Northern analysis was performed to 
detect either p300 ribozyme transcript levels or endogenous p300 mRNA. 10 pig 
of total RNA was loaded onto a 2% formaldehyde gel and probed for p300 
ribozyme with an oligoriucleotide probe complementary to the 3' flanking arm of 
the ribozyme and part of the catalytic domain (see figure 5.1. showing the p300 
target, ribozyme and oligonucleotide probe sequence specific to the given 
ribozyme). As seen from figure 5.6.a) ES cells maintaining the ribozyme 
expression vector, pPHC2MA7--p300R express the p300 ribozyme transcript, 
while those cells maintaining the control vector do not. Interestingly the pooled 
population of ribozyme expressing cells express more ribozyme than the clone of 
the ribozyme expression vector. This may indicate a variation of expression levels 
between individual clones. However, RNA from the p300 ribozyme expressing 
clone was prepared at a later time post transfection than RNA from the 
population. It is known that the episomal copy number decreases with time 
(J.Chambers, unpublished) so that a decrease in p300 ribozyme RNA might be 
expected. 
For detection of p300 mRNA levels the Northern was stripped and 
subsequently re-probed with a 5018 bp NdeI cDNA fragment of the human p300 
gene from vector p300HA (lab plasmid number 880). Figure 5.6.b) shows that 
I-, 
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Figure 5.6. Expression of p300 mRNA in comparison to p300 Ribozyme levels. 
E14/T ES Cells were electroporated with i) pPHCAGGSBSTXSV400ri and ii) pPHC2MAZ-p300R and both 
total and clonal populations were isolated. Total RNA was prepared after 2 weeks of selection and growth in 
200xg/m1 hygrornycin and 100 units/ml of LIF and probed for:- a) p300 Ribozyme ; b) p300 endogeous 
mRNA ; or c) GAPDH. 
there is no obvious decrease in p300 mRNA level for either the total population or 
the clone of cells expressing p300 ribozyme. Subsequent probing of the same blot 
with a GAPDH probe shows that loading is almost equivalent in all lanes (figure 
5.6.c). These data establish that p300 ribozyme is being expressed in cells 
selected for this expression vector, however, a decrease of p300 mRNA levels is 
not observed. Although the clonal p300 ribozyme expressing cell line was used in 
the phenotypic screen, for which there was less ribozyme expression compared to 
the pooled population, p300 mRNA ablation was not seen for either of the p300 
ribozyme expressing cell lines. 
5.4. Discussion 
There is both a lack of an ablation phenotype and any mRNA reduction of 
p300 when targeted with a p300 specific ribozyme. One possible reason for the 
lack of p300 ablation may be that the phenotypic screen used to measure p300 
ablation is inappropriate in ES cells. p300 protein may not be required for RA 
induced differentiation of ES cells as it is in EC cells. There have been no direct 
studies of the effect of p300 ablation on the ability of ES cells to differentiate. 
However, retinoic acid does induce both ES and BC cells to differentiate and into 
similar cell types. There is evidence that ES cells exposed to RA (10-6  M) in the 
presence of LW resemble F9 EC cells grown in RA (10.6  M) after 5 days as 
determined by changes in expression of extraembryonic endoderm markers such 
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as laminin, type IV collagen and tissue plasminogen activator (Mummery et 
al. 1990). 
Another reason for the lack of p300 ablation may be that although the 
ribozyme is being transcribed as seen in the Northern, figure 5.6.a), the levels may 
be insufficient. In the p300 ribozyme mediated ablation experiments performed by 
Kawasaki et al.(l998) the level of ribozyme expressed was obviously sufficient to 
cause phenotypic ablation. However, it is difficult to compare the level of p300 
ribozyme expressed in F9 cells versus ES cells, especially as the level of p300 
ribozyme produced in F9 cells was not quantitated. It may be useful to repeat the 
transfections performed by Kawasaki et al.(1998) in F9 cells, so that the level of 
ribozyme transcription can be directly compared between their experiment and 
mine. This would help to determine whether a lack of p300 ablation in ES cells is 
due to insufficient ribozyme expression. The level of p300 ribozyme required to 
inhibit luciferase activity in HeLa cells co-transfected with a vector expressing a 
p300 luciferase fusion gene however, has been quantitated (Kawasaki et al.1996). 
This p300 ribozyme targets a region further upstream from the ribozyme used in 
the phenotypic screen. It was found that equimolar amounts of this ribozyme and 
target vector reduced luciferase activity by 50% with almost complete ablation 
observed with a 4:1 ratio. I have looked at p300 ribozyme expression levels using 
an oligonucleotide probe and endogenous p300 mRNA using a much longer DNA 
probe. However, it is not possible to accurately compare the results since the 
probes are of different specific activities and the hybridisation kinetics of the two 
probes differ widely. All that can be determined is that this level may not be 
sufficient to ablate p300 message or produce a predicted ablation phenotype. 
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Another possible explanation for the lack of ablation may be that although 
the ribozyme forms properly in EC cells it may not be doing so in ES cells as they 
possess different cellular environments. There may be additional proteins present 
in ES cells that bind non-specifically and either prevent correct ribozyme folding 
or occlude the ribozyme binding site. The secondary structure of the p300 
ribozyme was not determined in my experiments, although it could be done by 
extracting RNA from stably selected cells electroporated with the ribozyme 
expression vector, pPHC2MAZ-p300R, and the RNA subjected to denaturing and 
then annealing conditions to allow any secondary structures to form. The folded 
nature of the RNA could then be analysed on a non denaturing gel by hybridising 
to a radiolabelled oligonucleotide probe. Direct comparison of migration of the 
same sample digested with RNase A and RNase T1 will determine whether the 
ribozyme possesses any secondary structure. However, this would only 
demonstrate that the transcribed ribozyme is capable of forming a secondary 
structure, but not that it had formed an active structure in vivo. In addition to the 
ribozyme potentially misfolding into an inactive structure because of additional 
non specific proteins binding, the p300 target site could also be occluded by 
binding of non specific proteins. 
Although ablation of p300 mRNA was unsuccessful in terms of a lack of an 
expected phenotype, the screen and ribozyme used were predefined making this a 
quick test for the ability of ribozymes to ablate gene function in ES cells. 
Therefore I conclude that to determine if ribozyme mediated ablation could be a 
potential strategy to ablate gene function in ES cells more ribozymes will need to 
be investigated, preferably targeting a gene of known function in ES cells. 
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Chapter 6: Results 
Investigation of the feasibility of RNAi as a 
method to ablate gene function in ES cells 
6.1. Introduction 
RNA interference or RNAi as it has been shortened to, is a new and 
emerging tool to ablate gene function. At the start of my investigation of RNA 
ablation strategies to silence gene function in ES cells RNAi had been 
demonstrated to operate in C. elegans, Drosophila and plants, but not in 
mammalian cells. In these organisms RNAi was established as being highly 
specific, functioning by specifically degrading targeted mRNA, promoted by 
dsRNA. However, the biochemical mechanisms underlying RNAi were still 
unknown. Subsequently there has been a large amount of work and interest 
generated in this area due to its potential use as a new and more efficient method 
of ablation. In this chapter I investigate the feasibility of RNAi ablation in ES 
cells by either directly transfecting pre-synthesised oligonucleotide 21nt siRNAs 
or by expressing dsRNA as a hairpin loop from an inverted repeat (IR) containing 
vector against targeted mRNA. 
Transfecting siRNAs directly into ES cells was used to establish whether 
RNAi occurred in ES cells. RNAi ablation was then investigated by stable 
expression of dsRNA taking advantage of the episomal expression system. As 
stated previously transfection efficiencies for the episomal vector system are high 
with stable and long lasting expression of cloned cDNA sequences. This allows 
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the investigation of genes that are required for differentiation, where ablation 
effects have to be propagated for longer. dsRNAs were stably expressed from 
episomally maintained vectors by cloning the mRNA sequence to be targeted as 
an inverted repeat. This method of introducing dsRNA was originally developed 
by Tavernarakis et al.(2000) in C.elegans and subsequently shown to work in 
Drosophila (Kennerdell and Carthew 2000; Piccin et al.2001). Usually a spacer 
(consisting of an unrelated sequence) is included between the two cloned inverted 
repeat sequences. 
The ability of RNAi to cause specific gene ablation in ES cells was 
assessed by targeting the coding sequences of LJFR, eGFP and SOCS3. LIFR was 
chosen because it is an endogenous target for which there is a clear ablation 
phenotype, the differentiation of ES cells in the presence of LIF (J.Chambers-
Personal Communication). In addition LWR ablation experiments possess an 
internal control, as self renewal can be maintained independently of the LIFR by 
signalling via 1L6/sTL6. eGFP was chosen, because as a visible target its ablation 
is readily detectable by eye and can be quantitated by flow cytometry. SOCS3 was 
chosen because it is not continuously expressed and can be induced by stimulation 
of gpl 30, after 6-7 hrs of LW withdrawal, with peak mRNA levels occurring 
approximately 45 minutes post-stimulation. Coding sequences of these genes are 
targeted rather than the UTRs, which were targeted previously in the antisense 
experiments. The reasons for not using the UTRs is that that there is evidence that 
for RNAi experiments, longer dsRNA are disproportionally able to ablate gene 
function, at least in Drosophila (Yang et al.2000). injections of dsRNAs varying 
in size from SObp to 928 bp resulted in a linear relationship between dsRNA 
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length and the log value of inhibition for dsRNAs in a single embryo assay 
expressing a luciferase target from an injected plasmid. The regions targeted are 
the entire coding sequence of eGFP, the 5'region of SOCS3 (471 bp out of 678bp) 
and the 5' region of LIFR (1071 bp out of 3279 bp). All include the ATG 
translational start site. 
Determining whether RNAi is a feasible technology to ablate gene 
function in ES cells is important because it has been demonstrated to possess great 
potential as a quick yet reliable tool to determine gene function in organisms such 
as C.elegans and Drosophila. If RNAi can be developed as such a tool in ES cells 
it could be used to study the role of genes in either self renewal or differentiation 
to gain a better understanding of these processes. 
6.2. Background 
6.2.1. Expression of dsRNA as a hairpin loop 
- inclusion of a spacer sequence 
As already described part of the investigation of this chapter will be to 
study the potency of RNAi ablation from continuous in vitro expression of 
dsRNA hairpin loops via transfection of inverted repeat containing vectors. An 
unrelated spacer sequence can be cloned between the IRs, the advantages for 
which are three fold. Firstly the sequence can be that of a selectable marker, thus 
allowing easy isolation of correctly ligated vectors at the cloning stage. Secondly 
the sequence also acts as a spacer between the IRs which should facilitate the 
transcript forming a stable hairpin loop structure, where this sequence forms the 
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loop. The third and most important reason for inclusion of a spacer sequence is 
that it allows replication of the IR in E.coli. This is because it has been well 
documented that long DNA palindromes are unstable in E.coii (Leach 1996), 
where there is an upper limit of -150 bps total length for a palindromic DNA 
sequence that can be cloned in wild type E.coli (Warren and Green 1985). There 
are one of two fates associated with trying to clone IRs into E.coli; either clones 
containing the palindrome are not recovered or a low frequency of clones with 
either complete or partial deletion are propagated to circumvent palindromic 
inviability (Hagan and Warren 1983). These effects are the direct result of hairpin 
structures forming, as these structures have been shown to stop the progression of 
the replication fork in vitro (LaDuca et al.1983). However, both inviability and 
instability of a palindrome can be reduced with the inclusion of a central spacer 
between the repeats (Warren and Green 1985). A possible way in which all or part 
of the palindromic sequence is removed is explained by strand slippage. This is 
where palindromes are hilly or partially deleted by recombination between 
complementary sequences found either downstream or within the palindrome 
respectively (Leach 1996). Recombination can occur as a result of the stalling of 
DNA replication by the hairpin secondary structure. 
Tavernarakis et al.(2000) performed RNAi ablation experiments in 
C.elegans using IRs without a spacer. The cloning efficiency was found to be low 
in the E.coli, DH5a strain, only a few per hundred screened, but a I in 20 
efficiency was observed when the E.coli SURE strain (Stratagene) was 
transformed. Kennerdell and Carthew (2000) included a Sbp spacer sequence, 
which was sufficient to allow the stable maintenance the JR vectors even in E.coli, 
119 
DH5ct. Piccin et al.(2001) included a much larger unrelated DNA sequence, a 330 
bp spacer from part of the coding region of the green fluorescent protein. They 
noted that inclusion of the spacer greatly increased cloning efficiency. The spacer 
at 330 bps was about one third of one repeat length implying that relatively long 
spacers can be used without interfering with the ability of dsRNA hairpins to 
mediate RNAi. The zeocin resistance cassette to be used as the spacer in my 
subsequent RNAi experiments is 568 bp which ranges from being about the size 
of one repeat length to about four times its length. This is larger than the spacer 
used by Piccin et al.(2001) and may interfere with the correct formation of the 
dsRNA hairpin structure. However, there have not been any experiments that have 
determined if the size of spacer used affects RNA interference. After the 
completion of the work presented in this thesis, Paddison et al.(2002) used a 
similar GFP hairpin plasmid specific to the first 500 coding base pairs with a 
zeocin resistance gene between, and were able to show down regulation of GFP 
expression in P19 cells. This demonstrates that long spacer sequences of 
approximately equal length to the hybridising arms of a hairpin can be included 
between inverted repeats to form effective dsRNA hairpin structures. 
6.3. Experimental strategy 
6.3.1. Vector design 
The vector into which 1X sequences were cloned was pPyCAGIP (Lab 
plasmid number 564). It contains a polyoma origin of replication and the CAG 
promoter upstream of a stuffer fragment with unique BstXT restriction sites for 
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cloning of desired sequences, followed by an IRES puromycin resistance cassette. 
IRES linked selection was chosen for the direct selection of gene expression to 
give higher levels of expression compared to selection from a separate drug 
resistance marker. 
The spacer sequence cloned between the IRs was a zeocin selection 
cassette with a bacterial EM7 promoter driving its expression to facilitate isolation 
of correctly ligated JR vector constructs. The cloning strategy involved a four way 
ligation of the vector backbone, the target sequence which forms the IR, and the 
zeocin selection cassette. This was achieved by cutting the cloning vector, 
pPyCAGIP with BstXI and the eGFP and LIFR target sequence with 
BstXJIEcoRV or BstXIISmaI for SOCS3 and the zeocin selection cassette with 
PvuJIIEcoRV. Constructs where the zeocin cassette had ligated in either a sense or 
antisense orientation with respect to the promoter were isolated and both were 
used in ES cell supertransfections (See appendix 8 for the cloning strategy). 
6.4. Results 
6.4.1. Establishing RNAi in ES cells 
- Ablation of exogenous luciferase target in ES cells using 21 nt 
siRNAs 
To establish RNAi ablation in ES cells 21 nt 5iRNA duplexes were used 
to suppress luciferase expression from transfected luciferase reporter plasmids. 
RNAi using 21 nt siRNAs by Elbashir et al.(2001b) was first demonstrated in 
cultured mammalian cells including COS-7, NIW3T3 mouse fibroblasts, HeLa S3 
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and 293 human embryonic kidney cells. The same assay used by Elbashir et 
al.(2001b) was used to establish whether RNAi operated in ES cells. Two ES cell 
lines E14/T cells which have the polyoma large T protein expressed from a 
randomly integrated transgene and E14TG2a were both investigated. COS-7 cells 
were included as a control to compare the efficiency of ablation and confirm 
reproducibility. 
The targeted reporter genes were those coding for sea pansy (Renilla 
renjformis, RL) and two sequence variants of firefly (Phozinus pyralis, 0L2 and 
0L3) luciferases. The luciferase reporter genes were expressed from piasmids 
pGL2-Control, pGL3-Control and pRL-TK (Promega). Elbashir et al.(2001b) 
synthesized five siRNA duplexes targeting GL2, GL3 and RL luciferase as well as 
a control inverted GL2 duplex and a 0L2 duplex with ribo-uridine 3' overhangs, 
instead of the 2'-deoxythymidine 3' overhangs present in all other siRNA 
duplexes. Thymidine overhangs were chosen because they reduce costs of 
synthesizing the duplexes and may increase nuclease resistance. 
In my experiments I chose to make duplexes to (3L2, GL3 and RL 
luciferase and to target only pGL3-Control and pRL-TK vectors (Promega). The 
regions of the luciferase gene reporters targeted were those used by Elbashir et 
al.(2001b) and the method of annealing the oligos was the same. Cells were co-
transfected with the luciferase reporter plasmids and the siRNAs using 
Lipofectamine 2000 reagent (Life Technologies), and luciferase expression 
analysed 20hrs after with the Dual luciferase assay (Promega). The assay was 
carried out in three separate experiments for each ES cell line in conjunction with 
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Figure 6.1. RNA Interference by s1RNA duplexes. 
Ratios of target to control luciferase were normalized to a buffer control 
(Bu, black bars); Purple bars show ratios of Photinus pyralis (Pp-luc) GL3 
luciferase to Renilla reniformis (Rr-luc) luciferase (left axis), mauve bars show 
RL to GL3 ratios (right axis). The cell lines used for each experiment are 
designated as a) COS-7 cells; b) E14TG2a; c) E14/T ES cells. The data were 
averaged from three independent experiments + s.d. 
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In COS cells specific inhibition of luciferases was observed and to a 
similar level as demonstrated by Elbashir et al.(2001b). Transfection of GL3 
specific siRNA alone reduced Photinus pyralis luciferase (Pp-luc) expression 
from the pGL3-Control plasmid, whilst 0L2 specific 5iRNA is without effect, 
giving similar levels of luciferase expression as the buffer control (that is pGL3-
Control and pRL-TK transfected with water alone). This result was confirmed 
using an appropriate statistical test, a single analysis of variance test to analyse the 
data verifying that the result is significant at the 0.1% level. The ratio of Pp-luc 
when normalised to the transfeetion control Renilla renforrnis luciferase (lRr-luc) 
is below 0.2 (where 1 unit is arbitrarily given as the maximum value when buffer 
alone is transfected). This value is similar to that seen by Elbashir et al.(2001b) 
for COS cells. The ratio of Rr-luc reduction normalised to Pp-luc as a transfection 
control was not as great however, 0.5 compared to a 0.4 ratio observed by 
Elbashir et al.(2001b). 
In both ES cell lines investigated the levels of Pp-luc are also reduced to 
the same amount as observed with COS cells. However, Rr-luc reduction was not 
as great in ES cells where the ratio of luciferase expression were 0.6 to 0.7 
compared to 0.5 seen with COS cells. These results indicate that RNAi does 
operate in ES cells. 
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6.4.2. LIFR as a target for RNA1 Ablation 
6.4.2.1. Strategy for LIFR ablation experiments - A functional readout 
RNAi has been established in ES cells using 21 nt siRNAs. However, the 
usefulness of this approach to investigate gene function phenotypically is limited 
as ablation effects are not long lasting. The focus from this point was therefore the 
investigation of a stable expression system for continuous expression of dsRNA 
as a double stranded hairpin loop. 
LTFR was chosen as a target for ablation because it is an endogenous 
target for which ablation can be screened phenotypically, as its requirement for 
ES cell self renewal is well characterised. Ablation of LIFR can also be internally 
controlled for as the self renewal phenotype can be maintained by growing ES 
cells in 1L6 and sIL6R, which signals self renewal independently of LW ind the 
LIFR. Also levels of LJFR mRNA are very low, detectable by RNAse protection 
which may increase the likelihood of LIFR ablation. The strategy was to ablate 
gene function by continuous in vitro expression of a LIFR specific dsRNA hairpin 
from an episomally maintained LIFR inverted repeat containing vector. The 5' 
region of the coding sequence of the LIFR including the ATU site, 1162 bp in 
total was targeted. 
E14/T ES cells were supertransfected with pPyCAGIP, the control 
parental vector and two forms of the LIFR inverted repeat containing vectors, 
pPyCAG-S LIFR IRzeo-TP and pPyCAG-AS LIFR IRzeo-IP, and grown in LW or 
1L6/sIL6R. The prefix S or AS before the gene name denotes either a sense or 
antisense orientation of the zeocin cassette with respect to the direction of the 
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Figure 6.2. A Lack of phenotypic effect with LIFR specific dsRNA 
Effect of in vitro transcribed L[FR specific dsRNA upon ES cell 
differentiation grown in 1L6/sIL6R or LIF. E14/T ES cells were 
supertransfected with 20pg of DNA of; pPyCAGIP (blue bar), pPyCAG-S 
LIFR IRzeo-[P (mauve bar) or pPyCAG-AS LIFR IRzeo-IP (yellow bar). 
Colonies were fixed and stained with Leishman's reagent after 8 days of 
selection at 1 .4jtg/mI of puromycin. The number of differentiated colonies 
were scored based on morphology observed with Leishman stain, and are 
shown as a percentage of the total number of colonies scored. 
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plates and selected in puromycin (1 .4igIml) for 8 days before staining with 
Leishmans stain. At 1 .4.tg/ml puromycin concentration control untransfected 
E14/T cells were killed. The number of stem cell colonies propagated in either 
cytokine, LW or 1L6/sIL-6R were similar at this concentration of puromycin for 
LIFR JR transfected cells. However, there was no increase observed in the 
numberof differentiated cells when grown in LW compared to those grown in 
1L6/sJL6R (Figure 6.2.). This result was confirmed using an appropriate paired t 
statistical test to analyse the data verifying that there is no significant difference at 
the 5% level. Therefore this particular LIFR dsRNA targeting the 5' region of the 
LIFR coding sequence was unable to produce a specific ablation phenotype. 
6.4.3. eGFP as a Target for RNAi Ablation 
6.4.3.1. FAGS Analysis Data 
eGFP was chosen as a target because it has been previously ablated from 
a transgene in both C.elegans in the adult (Parrish et al.2000) and in the mouse at 
the preimplantation stage (Wiaimy and Zernicka-Goetz, 2000). Fluorescence also 
provides a sensitive and accurate means of quantitating eGFP ablation. Ablation 
of eGFP was examined by electroporating eGFP inverted repeat expression 
vectors into a constitutively expressing eGFP ES cell line, GFPzeo-E14/T. The 
cell line was made by Dr. Ian Chambers with technical assistance from Morag 
Robertson and Douglas Colby. The construct pCAGGsEGFP[Z was randomly 
integrated into E14/T cells. The clone was shown to express eGFP as well as 
remaining supertransfectable. The GFPzeo-E14/T cell line was selected in 
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20 jig/mI of zeocin to maintain high eGFP expression before electroporation with 
inverted repeat containing vectors at which point zeocin selection was removed. 
eGFP inverted repeat vectors cloned as pPyCAG-S eGFP IRzeo-TP or 
pPyCAG-AS eGFP IRzeo-IIP as well as the parental control vector, pPyCAGIP 
were electroporated individually into GFP-zeo-E14/T ES cells. The cells were 
then selected in 3pg/ml of puromycin for 3 days. At this time cells had been 
grown for 5 days post electroporation and were analysed by FACS. This was to 
determine whether those cells that expressed the eGFP inverted repeat reduced 
eGFP expression from the random CAG-eGFP IRES zeoein transgene. Figure 6.3. 
shows the results for this FACS analysis. A population of cells with reduced 
fluorescence (indicated as M2), of the order of two magnitudes lower than the 
level of eGFP expression observed normally is seen. This population is confined 
to only those cells transfected with eGFP JR vectors. The percentages of the cells 
expressing reduced eGFP is 33.3% for pPyCAG-S eGFP IRzeo-IP and 39.6% for 
pPyCAGIP-AS eGFP IIRzeo-IP vector (percentages are based upon the total 
number of gated cells). The percentage of cells expressing less eGFP for 
pPyCAGIIP vector is 6.7%, which is comparable to the background levels 
observed for the untransfected GFPzeo-E14/T cell line control. 
These initial results suggest that RNAi may be induced in ES cells by 
stable expression of a long hairpin dsRNA against an integrated eGFP transgene. 
A separate eGFP ablation experiment was therefore carried out to confirm 
reproducibility. An additional control was included in the form of LIFR inverted 
repeat vectors. The concentration of puromycin used for selection was 1 .Sjig/mI, 
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Figure 6.3. Sequence specific inhibition of eGFP fluorescence 
from a GFPzeo-E14/T ES cell line by expression of 
an eGFP double stranded hairpin RNA. 
FACS analysis of eGFP expression from the stable GFP-zeo-E14/T ES cell 
line supertransfected with the control vector, pPyCAGJP or two of the eGFP 
IR expressing vectors, pPyCAG-S eGFP IRzeo-IP and pPyCAG-AS eGFP 
IRzeo-IP. The untransfected E14/T ES cell line was analysed as a negative 
control for no eGFP expression, while the non transfected GFP-zeo-E14/T 
cell line acted as a positive control. Cells were analysed 5 days post 
supertransfection, selected in 3 jig/mi of purornycin. Ml indicates the gating 
of eGFP negative cells, M2 the gating of cells with reduced fluorescence 
and M3 the gating of cells expressing high eGFP. The data are the results 
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Figure 6.4. Sequence specific inhibition of eGFP expression from 
a GFP-zeo-EI4IT ES cell line by transcription of an 
eGFP double stranded hairpin RNA. 
FACS analysis of eGFP expression from the stable GFP-zeo-E14/T ES cell 
line supertransfected with the control vector, pPyCAGIP and pPyCAG-S 
LIIFR 5'UTR IRzeo-1P or two of the eGFP FR expressing vectors, pPyCAG-S 
eGFP IRzeo-IP and pPyCAG-AS eGFP IRzeo-IP. The untransfected E14IT 
ES cell line was analysed as a negative control for no eGFP expression. Cells 
were analysed 6 days post supertransfection, selected in I .5ig/m1 of 
puromycin. pPyCAGIP and the LIFR 5'UTR FR vector was additionally 
grown in 1L6/sIL6R, as well as LIF as for all other vectors. Ml indicates the 
gating of eGFP negative cells, M2 the gating of cells with reduced 
fluorescence and M3 the gating of cells expressing high eGFP. 
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compared to pPyCAGJP (discussed in 6.4.4.2.). Cells were selected for 5 days, a 
total of 6 days post electroporation. Figure 6.4. shows the results of the FACS 
analyses. Cells transfected with the eGFP inverted repeat vectors possess two 
distinct peaks of eGFP. The low eGFP expressing population at 10.1  comprises 
about a third of those gated. 
To determine when reduced eGFP is first detected and how long the 
effects last, eGFP expression was analysed over 1-10 days post electroporation. 
ES cells were electroporated individually with pPyCAGIP, pPyCAG-S eGFP 
IRzeo-IP, pPyCAG-AS eGFP IRzeo-TP and pPyCAG-S SOCS3 IRzeo-IP and 
analysed by FACS at 1, 2, 3, 4, 5, 8 and 10 days post electroporation. As seen 
from figure 6.5.a) the low expressing eGFP population emerges at day 8 
comprising 30.3% and 26.4% of the total number of gated cells for pPyCAG-S 
eGFP lIRzeo-IP and pPyCAG-AS eGFP IRzeo-IP respectively. However, by day 
10 fewer cells expressing less eGFP are observed, where the population has 
decreased to 12.6% and 14.7%. The experiment was repeated looking more 
specifically at time points just before and after 8 days post electroporation when a 
reduced eGFP population was seen (figure 6.5.b). At 6 days the population of low 
expressing eGFP cells for both eGFP IX vectors is -41% compared to control 
vectors (-2-3%) which increases to a maximum of —42% at 7 days. By day 8 this 
population begins to decrease to 21% and continues to fall to 11-13% at day 10. 
So the loss of eGFP appears to be transitory, occurring at a specific time after the 
transfection of an eGFP specific inverted repeat vector. A possible explanation for 
the transitory effect may be that the level of dsRNA expression differs from day 6 
to day 10. This is a possibility as it is known that the copy number of episomes 
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Figure 6.5. Time course for specific ablation of eGFP from a 
constitutively expressing eGFP ES cell line by in vitro dsRNA 
expression from inverted repeat vectors. 
A constitutively expressing eGFP ES cell line, GFPzeo-E14IT was 
electroporated with the following vectors:- pPyCAGIP, pPyCAG-S eGFP 
IRzeo-IP, pPyCAG-AS eGFP IRzeo-IP and pPyCAG-S SOCS3 IRzeoIP and 
selected in LIF, G418 and 1.5g/ml of puromycin. The cells were then analysed 
by FACS for eGFP expression after a) 1, 2, 3, 4, 5, 8 and 10 days; or b) 6, 7, 8, 
9 and 10 post electroporation. The data presented are each from a single 
experiment and are shown as those cells expressing less eGFP as a percentage 
of gated cells. 
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decreases from day 10 to day 35 of selection (I.Chambers, unpublished). A 
reduction of eGFP expression might therefore only be seen when there is highest 
episomal copy number. However, reduced fluorescence may not be immediately 
apparent if GFP has a long half-life. 
6.4.3.2. Staining cells with Annexin V conjugated PE and 7-AAD 
It was apparent from the forward and side scatter plots of the FACS 
analysis data for all the eGFP ablation experiments that there were two 
populations of cells within the gated region analysed whenever a reduction of 
eGFP was observed. The low eGFP expressing population was entirely within the 
smaller of the two populations as determined by the lower forward scatter. The 
small size of these cells may be indicative of the cells either dying or undergoing 
apoptosis, which is a specific mechanism of induced cell death. 
Annexin V-PE staining was used as an indication of whether the reduced 
eGFP expressing cells are apoptotic. eGFP ablation experiments were repeated 
and cells stained with Annexin V-PE (Annexin V-PE apoptosis detection kit, BD 
PharMingen). Annexin V is a phospholipid binding protein with a high affinity for 
phosphatidylserine (PS). PS is a membrane phospholipid that is translocated from 
the inner to the outer leaflet of the plasma membrane during the early stages of 
apoptosis when the membrane begins to loose its integrity (Martin et al.1995). 
The Annexin V used in this experiment is conjugated to the fluorochrome 
phycoerythrin (PE) so that it can be detected by flow cytometry simultaneously 
with the vital dye 7-Amino-actinomycin (7-AAD) (which is usually included to 
detect the loss of membrane integrity) and eGFP expression. Inclusion of 7-AAD 
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distinguishes early apoptotic cells from late apoptotic, as early apoptotic cells are 
Annexin V-PE positive and 7-AAD negative, while late apoptotic are positive for 
both. 
E14/T ES cells were supertransfected as before. Cells were plated at I x 
106 per 9cm plate for analysis by flow cytometry at 5-8 days post electroporation 
and selected with 1.5 pg/mI of puromycin. At 5 and 6 days post electroporation 
the low expressing eGFP population was not observed. By day 8 this population 
was seen for cells expressing the eGFP dsRNA hairpin (see figure 6.6.). As there 
are three variables to compare they were analysed on separate plots i.e. eGFP 
against Annexin V-PE and Annexin V-PE against 7-AAD. R6 is the gating of 
supposed live cells as determined by the size distribution from the forward and 
side scatter plots. The reduced eGFP population (designated as R9) stain highly 
with Annexin V-PE and at an intermediate level with 7-AAD (figure 6.6.). This is 
in comparison to equivalent plots obtained for cells supertransfected with 
pPyCAG-S SOCS3 IRzeo-IP (figure 6.7.). This staining profile indicates that the 
low eGFP population of cells are dying, most likely via apoptosis. 
6.4.3.3. Northern Analysis to look for ablation of eGFP mRNA 
As low eGFP cells are dying, possibly by apoptosis, the ablation observed 
may not be specific. Therefore to establish whether ablation is occurring via an 
RNAi mechanism, evidence of mRNA cleavage into predicted product sizes was 
investigated. Previously it had been shown by Zamore et al.(2000) that RNAi acts 
by specifically cleaving target mRNA at regions of homology with the introduced 














FL 1-H 	 10 
d) 	 eGFP 
2 ........... 





- 	••.•>.. Iu_ 
:2 
ri 	 • 	
t,••1.) 
10 10 	10 10••' 	10 -i 	- 10 U 	10' 	io ef iU 
FLI-H 	 FL2-H 
eGFP Annexin V-PE 
Figure 66. Low eGFP expressing ES cells generated by 
constitutive transcription of eGFP dsRNA hairpin from 
IR vectors are apoptotic, as determined by 
Annexin V-PE and 7-AAD staining. 
The stable eGFP expressing cell line, GFP-zeo-E14/T supertransfected with 
pPyCAG-S eGFP IRzeo-IP were stained with Annexin V-PE and 7-AAD to 
determine apoptotic cells. Cells were analysed 8 days post electroporation, 
selected in 1.5j.tg/ml of puromycin. Cells determined as live cells from the 
forward/side scatter plot (a) were gated as R6, and analysed for eGFP 
expression (b). Low eGFP expressing cells are gated as R9 and high eGFP 
expressing as RIO. The "live" low eGFP expressing cells, R6 and R9, are 
coloured blue, while the "live" high eGFP expressing cells, R6 and RIO are 
coloured green. These are then subsequently analysed on c) eGFP Vs 
AnnexinV-PE plot; and d) Annexin V-PE Vs 7-AAD plot. 
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Figure 6.7. Specific eGFP reduction of stable eGFP expressing ES 
cells as demonstrated with a control vector, 
pPCAG-S SOCS3 lRzeo-IP determined by Annexin V-PE 
and 7-AAD staining. 
The stable eGFP expressing cell line, GFP-zeo-E14/T supertransfected with 
pPyCAG-S SOCS3 IRzeo-IP were stained with Annexin V-PE and 7-AAD to 
determine apoptotic cells. Cells were analysed 8 days post electroporation, 
selected in 1.5j.ig/ml of puromycin. Cells determined as live cells from the 
forward/side scatter plot (a) were gated as R6, and analysed for eGFP 
expression (b). Low eGFP expressing cells are gated as R9 and high eGFP 
expressing as RIO. The "live" low eGFP expressing cells, R6 and R9, are 
coloured blue, while the "live" high eGFP expressing cells, R6 and RIO are 
coloured green. These are then subsequently analysed on c) eGFP Vs 
AimexinV-PE plot; and d) Annexin V-PE Vs 7-AAD plot. 
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al.(2001) in different systems, either C.elegans or a cell free extract of Drosophila 
embryos respectively, have demonstrated the existence of transitive RNAi. That is 
a secondary RNAi effect, where regions upstream of the original target site for 
dsRNA are ablated. This is due to an RNA dependent RNA polymerase (RdRP) 
amplification step primed by the siRNA, which results in elongation of regions 
upstream of the target and the subsequent generation of secondary siRNAs (see 
chapter 1 section 1.2.4.2.4.). 
Although, transitive RNAi effects may be a factor in the eGFP ablation 
experiments, the main cleavage products of both target eGFP mRNA and the 
eGFP hairpin itself will be those expected from the initial hairpin sequences 
introduced (figure 6.8. and 6.9.). So to try to correlate the observed down 
regulation of eGFP expression seen with vectors expressing eGFP specific 
inverted repeats, RNA was extracted at 6 days post electroporation from the same 
experiment analysed in figure 6.4. At this time point for this experiment a 
population of cells expressing less eGFP is clearly seen. In addition, RNA was 
also prepared from a separate experiment at 13 days post electroporation at which 
time the lower eGFP expressing population had disappeared, as a negative 
control. These RNA samples were run on the same formaldehyde gel and probed 
sequentially (where the blot is stripped between probes) for eGFP mRNA with a 
probe specific to the P globin polyadenylation sequence and for equal loading by 
probing with GAPDH. The results are shown in figure 6.10. The expected sizes of 
the largest and smallest cleavage products of eGFP mRNA generated from the 
introduced eGFP hairpin have been determined as 2072bp and 1353bp. This is 
based upon the eGFP 1k sequence, which is complementary to the entire coding 
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Probe to detect eGFP transcript and cleavage products 









Figure 6.8. Diagram to show predicted sizes of the eGFP transcript from a 
randomly integrated CAG-eGFP IRES zeocin transgene and its 
primary cleavage products, generated through RNAi. 
The CAG promoter contains a splice site, which is shown in the transcript below and is 
taken into account when calculating the size of the full length transcript. The two other 
transcripts show the sizes of the primary cleavage products formed, as the eGFP inverted 
repeat vector used to ablate eGFP is directed to the whole of the eGFP coding sequence. 
The probe used is a 459bp 3-globin polyadenylation sequence specific probe. 
a) pPyCAGIP transcript 
Cap site SD 	SA 
	 Probe 
I 	I 
FcMv,E] 3-Actin 3-g1 1 	Stuffer 	IRESPa bGHpA 
225 1 b 
Figure 6.9. Diagram to show predicted sizes of the inverted repeat transcripts 
and their primary cleavage products, generated through RNAI. 
The CAG promoter contains a splice site, which is shown in the full length transcripts and 
is taken into account when calculating the size. Transcript sizes also include the poly A tail 
—230bp. Below the full length transcript of the inverted repeats only are shown the 
extremes in sizes of two primary cleavage products:- a) pPyCAGJP transcripts; b) 
pPyCAG-S eGFP IRzeo-IP or pPyCAG-AS eGFP IRzeo IP transcripts; and c) pPyCAG-S 
SOCS3 IRzeo-IP or pPyCAG-AS SOCS3 IRzeo-IP transcripts. The eGFP inverted repeat 
vector used to ablate eGFP is directed to the whole of the eGFP coding sequence, while that 
to SOCS3 is directed to 471bp of the 5'region. The probe used is a 668bp puromycin 
specific probe. 
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Figure 6.10. Northerns to detect ablation of eGFP from a randomly 
integrated CAG-eGFP IRES zeocin transgene. 
GFP-zeo-E I 4/T ES cells were supertransfected with the following inverted 
repeat containing vectors which were either eGFP specific i.e. pPyCAG-S eGFP 
IRzeo-IP (EGFP-S) and pPyCAG-AS eGFP IRzeo-IP (EGFP-AS) or a non 
specific inverted repeat control i.e. pPyCAG-S SOCS3 IRzeo-IP (SOCS3-S) 
and pPyCAG-AS SOCS3 IRzeo-IP (SOCS3-AS). A non inverted repeat 
containing vector, pPyCAGIP was also included as a control. Total cell 
populations were selected for either 6 or 13 days as indicated with 1.51g/ml of 
puromycin. 1 Ojg of total RNA was loaded onto each lane along with 
untransfected E14/T ES cells and untransfected GFP-zeo-E14/T cells selected 
with (U +zeo) or without zeocin (U -zeo) (20j.iglml), where all other 
supertransfections are not selected in zeocin. The blot was then sequentially 
probed for a) eGFP with a 459bp -globin specific probe; and b) equal loading 
with a GAPDH probe. Blot a) was exposed for 1 day on a phosphorimager 
screen; b) for 2 days. 
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sequence of eGFP, cleaving eGFP at its 5' or 3' most end (see figure 6.8.). These 
define the maximum and minimum sizes of expected eGFP mRNA cleavage 
products, however, products between these sizes will also be observed. 
As seen from the eGFP mRNA probed blot, figure 6.10. a), the predicted 
eGFP full length transcript is detected at about 2533bp. However, no eGFPmRNA 
cleavage products were detected. The level of eGFP transcript between the lanes 
was then compared. This was done taking into account the GAPDH levels 
observed for each, so that a true level of eGFP message was noted, taking into 
account variations in loading. However, no specific ablation of eGFP mRNA was 
apparent for either of the eGFP inverted repeat vectors compared to the control 
vectors. It therefore seems unlikely that the reduced eGFP expression observed for 
cells transfected with an eGFP specific dsRNA is occurring via an RNAi 
mechanism. 
6.4.3.4. Transfection efficiencies of eGFP inverted repeat vectors in a non-
eGFP vs. an eGFP expressing cell line 
All of my experiments to ablate integrated copy(ies) of eGFP with either 
of the eGFP inverted repeat vectors have consistently given more cells expressing 
less eGFP than any of the control vectors, including other vectors expressing a 
non specific inverted repeat. A possible reason for this may be that these cells are 
undergoing cell death due to a specific response of eGFP dsRNA to its target. To 
determine whether this is true the transfection efficiency of vectors was compared 
when electroporated into two different cell lines either expressing the eGFP target 
gene or not. The two different cell lines used were either GFPzeo-El4/T or E14/T 
ES cells from which the GEP expressing cell line was derived. These cell lines 
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were electroporated on the same day with the following vectors;- pPyCAGIP, 
pPyCAG-S eGFP IRzeo-IP and pPyCAG-AS eGFP IRzeo-IP. The cells were 
plated at three different densities into a 9cm dish, 5x10 4, 2x105 and 5x10 5 in 
duplicate and then selected 30hours after transfection with LW, G418 and 
1 .5ig!ml of puromycin. The results are shown below in table 2. 
Table 2. Transfection efficiencies of eGFP inverted repeat vectors in a 















pPyCAGIP 5x104 256 0.512 Av.= 
0.513 
398 0.796 Av.= 
0.791 257 0.514 393 0.786 
pPyCAG-S 
eGFP IRzeo-IP 
2x105 31 0.016 Av.= 
0.013 
49 0.025 Av. 
0.025 19 0.01 48 0.024 
5x105 124 0.025 Av.= 
0.024 
200 0.04 Av.= 
0.043 114 0.023 229 0.046 
pPyCAG-AS 
eGFP IRzeo-IP 
2x105 17 0.009 Av.= 
0.008 
39 0.02 Av.= 
0.019 12 0.006 34 0.017 
5x105 72 0.014 Av.= 
0.013 
157 0.031 Av.= 
0.029 59 0.012 132 0.026 
The transfection efficiency for all vectors electroporated into the GFPzeo-
E14/T cell line, i.e. containing an eGFP target, were about twice that of E14/T. 
However, as the control vector pPyCAGIP also has a higher transfection 
efficiency when electroporated into GFPzeo-E14/T cells, this indicates that this 
cell line is inherently more amenable for transfection. So taking this into account 
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and instead comparing the ratios of transfection efficiency (TxE) obtained for the 
higher plating density:- 
1.E14/T Cell line 
pPyCAGJP pPyCAG-SeGFP IRzeo-JP 
TxE 	0.513 	 0.024 
Ratio 	I 	: 	0.047 
2. GFPzeo-E14/T 
pPyCAGIP pPyCAG-SeGFP IRzeo-EP 
ThE 	0.791 	 0.043 







Comparing the ratios of transfection efficiency where the transfection 
efficiency of pPyCAGIP is given the value of 1, the transfection efficiencies of 
the eGFP specific inverted repeat vectors are about the same whether the eGFP 
target is present or not. So it would appear that the low transfection efficiency of 
eGFP JR vectors is not due to a specific response of eGFP dsRNA to its target and 
that the greater number of dying cells seen is not due to a specific RNAi response. 
6.4.4. SOCS3 as a target for RNA1 Ablation 
6.4.4.1. Rationale and Strategy for SOCS3 ablation experiments 
The rationale for choosing SOCS3 as a target for ablation is that SOCS3 
mRNA is an endogenous target that can be induced with the addition of LIF 
(I.Chambers-Personal Communication). This is achieved by withdrawing LIF for 
6-7 firs before reapplication. The ability to induce SOCS3 mIRNA was thought to 
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increase the likelihood of detecting ablation. In many model RNAi ablation 
experiments the targets are exogenous, which allows dsRNA directed against the 
target to be added to the system first and become processed before addition of the 
target. For example Tuschl et al.(1999) developed a Drosophila embryo lysate in 
vitro system and found that preincubation of a luciferase dsRNA specific to its 
target, in the lysate before addition of the target inRNA potentiates its RNAi 
activity. This allows time for the long dsRNA to be cleaved into 21-23nt siRNAs, 
which are the mediators of RNAi that direct the cleavage of the target mRNA. 
SOCS3 is a good target, because it is endogenous yet can be depleted from cells 
allowing time for the dsRNA hairpin to be transcribed and processed into active 
siRNAs, before its subsequent induction. 
The strategy for SOCS3 ablation experiments was to supertransfect 
individually into E14/T ES cells both the SOCS3 inverted repeat containing 
vectors pPyCAG-S SOCS3 IRzeo-IP and pPyCAG-AS SOCS3 IRzeo-IP as well 
as two control vectors, one without an inverted repeat, pPyCAGIP and one with 
an irrelevant inverted repeat sequence i.e. pPyCAG-S eGFP IRzeo-IP. Stably 
maintained populations from these supertransfections were selected with 1.5igIml 
of puromycin for 18-24 days, as the transfection efficiency for each vector was 
different, and expanded until there were enough cells for the subsequent induction 
experiments. Induction experiments involved incubation in GMEM with 10% 
FCS without LIF for 1 hr to remove any residual LIF before replacing the media 
with UMEM alone for 6 hrs. Induction of SOCS3 mRNA was initiated by 
applying GMEM containing LIP, for a certain amount of time. The time required 
for maximal induction had already been analysed previously in the lab 
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(I.Chambers, unpublished). SOCS3 mRNA is maximally induced after addition of 
LIF for 45 minutes, but then is down regulated after 3 hours. A number of 
different time points were included to observe SOCS3 mRNA being induced over 
time and also to determine whether the message is cleaved. The time points 
examined at were 0, 10, 25, 45, 90 and 180 minutes. RNA for Northern analysis 
was extracted at these time points for subsequent analysis. RNA samples were 
loaded on two separate gels, cells stably maintaining pPyCAGIP or pPyCAG-S 
SOCS3 JRzeo-IP on one gel and pPyCAG-AS SOCS3 IRzeo-IP or pPyCAG-S 
eGFP ]IRzeo-EP on another gel. The Northerns were sequentially probed for 
SOCS3 endogenous mRNA (figure 6.11 .a), JR transcript levels using a puromycin 
probe (figure 6.11 .b) and equal loading using a probe directed against GAPDH 
(figure 6.11 .c). 
As can be seen SOCS3 mRNA levels are maximally induced at about 45-
90 minutes and decrease after 3 hours for all the electroporated maintained cell 
lines. However, no cleavage products were observed. The endogenous SOCS3 
transcript is 2.8kb, and predicted primary cleavage products are expected to be 
between 2.3kb and 1.7kb. 
To determine whether transcripts from the introduced vector were being 
expressed and cleaved, the Northems were stripped and probed with a puromycin 
probe. The predicted transcript sizes and their cleavage products are seen in figure 
6.11. The hill length transcripts for both SOCS3 and eGFP inverted repeat vectors 
were detected at -3.5 kb and —4 kb respectively. In addition to the smearing seen 
there is a distinct band at —1.7 kb which is the predicted size of a primary cleavage 
product expected from the cleavage of these inverted repeat transcripts (figure 
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Figure 6.11. Analysis of SOCS3 mRNA and inverted repeat 
transcripts from SOCS3 induction experiments induced with LIF. 
E14/T ES cell lines supertransfected with either two SOCS3 inverted repeat 
containing vectors, pPyCAG-S SOCS3 IRzeo-1P (SOCS3-S) and pPyCAG-AS 
SOCS3 IRzeo-IP (SOCS3-AS) or a non specific inverted repeat containing vector 
pPyCAG-S eGFP [Rzeo-IP or a non inverted repeat containing vector pPyCAGIP 
were established prior to induction. Cell lines were maintained from pooled 
populations for 18-24 days by selecting with 1.5ig/ml of puromycin. The cell 
lines were then induced with LIF for 0, 10, 25, 45, 90 and 180 minutes and 
subsequently lysed and RNA loaded (10ig) onto a formaldehyde gel. Blots were 
then probed for a) endogenous SOCS3 mRNA with a 559bp SOCS3 probe; b) 
levels of inverted repeat transcripts with a 668bp puromycin probe; and c) equal 
loading with a GAPDH probe. The expected size of SOCS3 mRNA is 2.8kb, its 
predicted primary cleavage products are between 1.7 and 2.3kb. SOCS3 inverted 
repeat transcripts are 3470bp and primary cleavage products are between 2237bp 
and 1 767bp. The eGFP inverted repeat transcript is 4049bp, and its predicted 
primary cleavage products are 2507bp-1788bp. The size of pPyCAGIP's main 
transcript is 225 lbp, while due to the presence of two additional polyadenylation 
sites downstream of the main one, additional transcripts are of 283 7-2866bp and 
5432-5461bp are detected. Blot a) was exposed for 1 day on a phosphorimager 
screen; b) the first blot for 4 days, the second blot for 7 or 4 days on 
autoradiographic film; c) for 2 days on autoradiographic film. 
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6.9.b) c). Thus demonstrating that the inverted repeats are being transcribed once 
electroporated into cells and that there is some cleavage taking place. The bands 
detected for pPyCAG-AS SOCS3 IRzeo-JP plasmid are fainter than the 
corresponding SOCS3 JR vector where the zeocin is cloned in the reverse 
orientation as the loading of total RNA was lower than for the other cell lines as 
seen with the GAPDH probe (figure 6.1 1.c). The control vector pPyCAGIP, 
which does not contain an inverted repeat sequence correspondingly does not 
show any cleavage products. The major transcript at 2.25kb is detected as well as 
two minor transcripts at 2.8kb and 5.4kb. The minor transcripts are due to 
termination at two additional SV40 polyadenylation sites found in the vector 
downstream of the major polyadenylation signal. The bands observed for the 
control vector are distinct with no smearing, a further indication that the transcript 
is not being cleaved. 
The transcript level from the eGFP inverted repeat vector appears to be 
higher than those for the SOCS3 inverted repeat vectors. This implies that the 
reduced eGFP expression observed previously with the eGFP JR plasmid may be 
due to this difference in transcript levels. It is known that dsRNA can trigger an 
interferon response in mammalian cells leading to non specific mRNA 
degradation and a global shut down of protein synthesis (Stark et al.] 998). This 
would lead to cell death, which is consistent with the results of my eGFP ablation 
experiments (see discussion). 
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6.4.4.2. Transfection Efficiences of Inverted repeat containing vectors vs. non 
Inverted repeat vectors 
It was noticed that the transfection efficiencies of the inverted repeat 
vectors compared to the control, pPyCAGIP vector were consistently lower. 
Transfection efficiencies are tabulated below, including those of the LIFR, eGFP 
and SOCS3 specific inverted repeat vectors which were used in the previously 
described eGFP ablation experiments. See Table 3. 
Table 3. Transfection efficiencies of inverted repeat containing vectors vs. 
non inverted repeat vectors 
Experiment Vector Plating No.of Colonies Transfection 
density per plate Efficiency (%) 
3p.gIml pPyCAGIP 5x10 499 0.998 
puromycin 
selection; 
pPyCAG-SeGFP 2x105 104 0.052 fluorescence 
analysed at 3 IRzeoAP 
days of selection. 
Equivalent to 
5 days post 
pPyCAG-ASeGFP 
IIRzeo-IP 
2x105 88 0.044 
electroporation ___________  
1.5ig/mlof pPyCAGIP 5x104 804 1.608 
puromycin (grown in LW) 
selection; ____ ________________  
pPyCAGIP 5x104 1027 2.054 fluorescence 
analysed at 5 (grown in 
days of selection. 1L6/5JL6R) ___ ______________  
pPyCAGLIFR 5x104 125 0.25 Equivalent to 6 
days post 5'UTR lRzeo-TP 
electroporation (grown in LW)  
pPyCAGLIFR 5x104 304 0.608 
5'UTR IRzeo-TP 
(grown in 
1L6/5IL6R) ___ ______________ 




pPyCAG-SeGFP 5x104 2 0.004 
IRzeo-IP 
pPyCAG-ASeGFP 5x104 10 0.02 
IRzeo-IP 
1.5pg/ml of pPyCAGIP 5x105 * 
puromycin 
selection; ____  
pPyCAG-SSOCS3 5x105 900 0.18 fluorescence 
analysed at 0-4, JIRzeoIP 
7 and 9 days of ___________  
pPyCAG-SeGFP 5x105 446 0.089 selection. 
Equivalent to IRzeoiIP 
1 -5, 8 and 10  
pPyCAG-ASeGFP 5x105 272 0.054 days post 
electroporation IRzeo-IP 
l.5p.glmlof pPyCAGIP 5x105 * 
puromycin 
selection;  
pPyCAG-SSOCS3 5x105 2920 0.584 fluorescence 
analysed at 4-8 IRzeo-IP 
days of selection.  
pPyCAG-SeGFP 5x105 737 0.147 Equivalent to 
6-10 days post IRzeo-IP 
electroporation 
pPyCAG-ASeGFP 5x105 860 0.172 
IRzeo-IP 
* Too many to count at this plating density. 
Results to note from comparing transfection efficiencies are that the eGFP 
inverted repeat vectors consistently give much lower transfection efficiencies than 
either pPyCAGIP or other inverted repeat containing vectors. The transfection 
efficiency is normally about 20 fold lower than pPyCAGIP (but up to 80-fold 
lower has been seen), and 2-13 fold lower than the other inverted repeat 
containing vectors e.g. SOCS3 and LTFR5'UTR. This implies a general 
phenomenon of a decrease of transfection efficiency with inverted repeat 
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containing vectors, where the transfection efficiency for the eGFP inverted repeat 
vectors are the lowest observed. This suggests that expression of inverted repeat 
transcripts in the cell is either toxic or detrimental for cell growth, possibly by 
inducing an interferon response, or that either the replication of such vectors or 
transcription of inverted repeats is less efficient, as has been observed of the 
replication of direct repeat sequences in bacteria (LaDuca et al. 1983). The lower 
transfection efficiency of the eGFP inverted repeat vectors are consistent with 
more cell death seen with transfection of these vectors which may be attributable 
to the higher transcript levels for these vectors (see section 6.4.3.2. and 6.4.4.1.). 
6.4.4.3. Transfection efficiencies of supertransfected SOCS3 inverted 
repeat vectors vs. integration of these vectors 
As transfection efficiencies for inverted repeat containing vectors are so 
low compared to vectors without the inverted repeat, and the values are similar to 
that observed when the vector has integrated, a comparison of the two situations 
was examined. E14/T ES cells were supertransfected as before with 20ig of 
pPyCAGIP, pPyCAG-S SOCS3 lRzeo-IP, pPyCAG-AS SOCS3 IRzeo-IP and 
pPyCAG-S eGFP IRzeo-EP and selected in 1.5j.tglml of puromycin for 6 days 
before staining with Leishmans. E14TG2a ES cells were electroporated with the 
same vectors linearised by digestion with Scal (100tg). Cells were selected with 
1 .5g/ml of puromycin and stained after 9 days. The transfection efficiencies 
observed are shown in table 4. 
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Table 4.Transfection efficiencies of SOCS3 inverted repeat vectors vs. 
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1x106 1224 0.122 - - 
As can be seen from the results above, the frequency of isolating stable 
integrants is reduced compared to supertransfection, at three to eight fold lower. 
This may indicate that the low transfection efficiency observed with the IR 
containing vectors is not because they cannot be propagated episomally. However, 
to demonstrate this conclusively copy numbers of 1R containing vectors will need 
to be scored. 
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6.5. Discussion 
6.5.1. RNAi ablation in ES cells using siRNA 
Results from the 5iRNA mediated ablation experiments performed in this 
Thesis clearly show that RNAi exists in ES cells. This has subsequently been 
shown to be a general phenomenon of ES cells (Yang et al.2001; Billy et al.2001; 
Paddison et al.2002). Yang et al.(2001) demonstrated RNAi by targeting eGFP by 
either transiently transfecting a plasmid with an eGFP IR directed sequence or by 
directly transfecting eGFP specific dsRNA transcribed in vitro. Billy et al.(2001) 
again targeted eGFP and were able to ablate 60% of GFP fluorescence when 
electroporating ES cells, with a GFP plasmid and a —700bp long GFP specific 
dsRNA. Paddison et al.(2002) were able to show specific suppression of firefly 
and Renilla luciferase by transfecting ES cells with a 500 bp dsRNA 
corresponding to the first 500 nts of each luciferase, where inhibition was 80-90% 
complete. 
6.5.2. The feasibility of stable expression of long hairpin dsRNA for 
gene ablation in ES cells 
Phenotypic ablation of LIFR mRNA target was not observed when 
targeting 1071 bps of 5' region of the coding sequence, including the ATG 
translational start site. The level of transcript needed to ablate LTFR mRNA is 
probably not an issue here, as the level of LIFR mRNA in the cell is very low, as 
it is detectable by RNase protection only. However, to understand more clearly 
what was happening at a biochemical level eGFP and SOCS3 mRNA were 
targeted, as these mRNAs are easily detected by Northern analysis. 
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The first thing to note of the eGFP RNAi experiments is the appearance of 
a population of cells expressing less eGFP when a stable GFP expressing ES cell 
clone is supertransfected with an eGFP specific JR vector. This effect is specific 
as it is only observed with the eGFP IR vectors and not with JR vectors specific to 
SOCS3 or LIFR 5' UTR. The results suggest that the reduction of eGFP 
expression maybe due to an RNAi effect. Similar results have been observed by 
Yang et al.(2001), where they saw specific inhibition of eGFP expression from ES 
cell clones with a single integrated copy of the eGFP gene. However, they 
introduced dsRNA by transfecting 3 x 10 5  ES cells with 3pg of in vitro transcribed 
dsRNA specific to 547 bp beginning from the ATG start codon of eGFP. Similar 
to my data they only observed a new population of cells with reduced 
fluorescence when dsRNA to eGFP was transfected, where their control was 
dsRNA to lacZ. The greatest decrease in fluorescence of over 70% was observed 
at 48 hrs after transfection which diminished steadily until at 124 hrs ablation was 
no longer seen. The authors claim that the transitory population was probably due 
to the dilution of dsRNA per cell as ES cells replicated. As dsRNA was in vitro 
transcribed cells could not be selected so would contain less and less dsRNA. In 
my experiments cells expressing the dsRNA IRES puromycin transcript were 
selected for. The transitory nature of eGFP reduction in my experiments may 
instead be due to a possible decrease in the copy number of the episome resulting 
in a reduction of the inverted repeat transcript level. This could be determined by 
examining both the copy number and transcript levels at time points before and 
after a reduction in eGFP expression is seen. However, there are potential 
complications with the IRES linked selection strategy employed. This is because 
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once the long dsRNA hairpin has been processed the cleaved products are no 
longer selectable with an appropriate drug. However, I have been able to detect 
cleavage products of the inverted repeat transcripts, implying that the cleaved 
products are present in the cell and are not selected against immediately. 
Although it appears that the reduction in eGFP could be due to an RNAi 
effect based upon both my data and published work (Yang et al.2001), I have 
found that those cells expressing less eGFP are dying. This may be by apoptosis 
as determined by staining with Aimexin V-PE and 7-AAD (section 6.4.3.2). The 
first indication of this came initially from observing that the population with 
reduced fluorescence almost entirely had a lower forward scatter, and so were 
smaller than the higher fluorescent cells, as observed in forward/side scatter plots 
from flow cytometric analysis (see figure 6.12.). The difference in size indicated 
that they may be dying, as they are still quite large, but are beginning to loose 
their membrane integrity. This can be seen on the scatter plots as these cells are 
part of a population that joins with the large amount of debris that is present. 
Staining with Annexin V-PE and 7-AAD showed that the cells were either 
apoptotic or necrotic because they stained highly with Annexin V and at an 
intermediate level with 7-AAD, where Aimexin V positive and 7-AAD negative 
cells are defined as being early apoptotic and Annexin V positive 7-AAD positive 
cells are in late apoptosis or are already dead. Staining with Annexin V is an 
indication that the cells are apoptotic, however additional methods of 
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Figure 6.12. Cell morphology of GFP-zeo-EI4IT ES cells 
supertransfected with IR versus non PR containing vectors. 
a)Forward and Side scatter plots of the stable eGFP expressing cell line, 
GFP-zeo-E 1 4/T supertransfected with a control non JR containing vector, 
pPyCAGIP, or two eGFP IR containing vectors, pPyCAG-S eGFP IRzeo-IP 
and pPyCAG-AS eGFP IRzeo-IP. E14/T ES cells are the parental cells from 
which the GFP expressing cell line is derived. Cells were analysed 5 days 
post supertransfection, selected in 3igIm1 of puromycin. b)Analysis of eGFP 
expression from the two populations seen with pPyCAG-S eGFP IRzeo-IP 
transfected cells denoted as R6 and R2. Where R6 are those cells expressing 
reduced eGFP and R2 are those cells expressing high eGFP. 
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As a population of cells expressing reduced eGFP was seen, the most 
conclusive way to prove that it is due to RNAi was to show that the target mRNA 
and dsRNA are being cleaved. Northerns were examined for cleavage of RNA 
extracted from cells which showed two distinct populations in terms of 
fluorescence intensity (figure 6.4.) as well as RNA from cells where the low 
expressing eGFP population had disappeared. Ablation of the eGFP mRNA was 
not seen nor was cleavage of the message. This was also true of another mRNA 
target, SOCS3 targeted in separate SOCS3 ablation experiments. Ablation of the 
eGFP message may not have been detected as the percentage of cells expressing 
less eGFP was —30% at the time point looked at (6 days post electroporation), a 
decrease which may be undetectable by Northern analysis. Alternatively, there 
may be no appreciable ablation for either mRNA target, especially as the reduced 
eGFP expression is probably a consequence of the cells dying. However, cleavage 
of the inverted repeat transcripts for eGFP and SOCS3 were detected, observed as 
smears rather than distinct bands. This is expected as there will be a variety of 
different sized cleavage products generated as is the nature of dsRNA processing 
into siRNAs. Although this shows that the inverted repeat transcripts are being 
processed, siRNAs of 21 -23nt may not be produced or not in sufficient quantity, 
which may be another reason why ablation is not seen. 
The transfection efficiencies of cells supertransfected with inverted repeat 
containing vectors specific to LIFR, eGFP and SOCS3 were much lower 
compared to non inverted repeat containing vectors. This could be due to 
expression of dsRNA from inverted repeat sequences being either toxic or 
detrimental to cell growth as there is evidence that accumulation of small amounts 
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of dsRNA in mammalian cells results in the interferon response and the 
subsequent onset of apoptosis (reviewed in Tan and Katze 1999). The interferon 
response is mediated by two main enzymes: the double stranded RNA protein 
kinase, PKR (Manche et al. 1992), and 2',5'-oligoadenylate synthetase (Minks et 
al. 1979). Both are activated by long dsRNA and interferons (IFNs), typically 
required to mediate an antiviral response, as viruses replicate by producing 
dsRNA. Alternatively, the low transfection efficiencies of inverted repeat 
containing vectors may be due to either poor replication of such vectors or poor 
transcription of inverted repeat sequences. This has been observed of the 
replication of direct repeat sequences in bacteria (LaDuca et al.1983). These 
possibilities will be discussed further here. 
In the first instance there is evidence in the literature that dsRNA induces 
the interferon response causing apoptosis via PKR, a serine/threonine specific 
protein kinase. Presently PK.R has not been identified in ES cells, however it has 
been cloned in the mouse (Tanaka and Samuel 1994). dsRNA activates the 
inactive form of PKR by either causing a conformational change in the PKR 
molecule so that the catalytic domain becomes accessible or by promoting kinase 
dimerization which could lead to NCR activation through a transphosphorylation 
mechanism (Wu and Kaufman 1997). Once activated, PKR acts by 
phosphoiylating the a subunit of the eukaryotic initiation factor (eIF-2). The role 
of elF-2 is to form a complex with a methionine charged tRNA and present it to 
the ribosomal machinery for translation initiation (Merrick 1992). 
Phosphorylation of this protein on Ser51 is thought to result in tighter binding of 
elF-2 to eJF-2B, which is the translation initiation exchange factor required to 
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recycle elF-2-GDP to eJF-2-GTP. During the process of initiation codon 
recognition, eIF-2 is associated to GTP, which is subsequently hydrolysed to GDP 
after each round of initiation. Sequestering eIF2B reduces the rate of elF-2 
nucleotide exchange, thereby inhibiting protein synthesis and viral replication. 
The other pathway activated by dsRNA and interferons is the 2',5'-oligoadenylate 
synthetase (OAS) / RNase L pathway. OAS is activated by binding to dsRNA. 
Once activated, OAS coverts ATP into unusual short 2',5'-oligoadenylates (2-
5A). 2-5A are able to bind to and activate RNase L, which cleaves single stranded 
RNA 3' of UpA, UpTJ and UpU sequences (Floyd-Smith et al. 1981), leading to 
degradation of cellular RNA. 
It is becoming increasingly clear that PKIR triggers apoptosis. The first 
indication for such a role came from a study where HeLa cells expressing a 
catalytically inactive form of PKR did not rapidly undergo apoptosis compared to 
cells overexpressing the wild type PKR (Lee and Esteban 1994). Conversely 
overexpression of wild type human PKR, but not the catalytically inactive form in 
a transient DNA transfection system was sufficient to initiate an apoptotic 
response in COS-1 cells (Srivastava et al. 1998). In addition there is evidence that 
embryo fibroblasts from PKR knock out mice develop resistance to apoptosis 
induced by dsRNA (Der et al. 1997). These findings strongly demonstrate the 
existence of a PKR dependent apoptotic pathway in many cell lines, although its 
existence in ES cells is at present unknown. The apoptotic pathway is thought to 
be mediated in part through phosphorylation of eIF2cz. As already demonstrated 
by Srivastava et al.(1998) with wild type PKR, overexpression of a serine 51 
phosphorylated elF-2 variant was sufficient to trigger apoptosis in COS-1 cells. A 
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possible way in which translational arrest induces apoptosis may be by 
suppression of translation of mRNAs encoding anti-apoptotic functions. In 
addition the apoptotic pathway is also known to be triggered by PKR through the 
FADD-caspase 8 pathway (Fas-associated death domain) (Balaehandran et 
al. 1998). 
RNase L has also been shown to activate apoptosis. Castelli et al.(1997) 
have shown that inducible expression of the human RNase L gene results in the 
loss of NIH3T3 cell viability, which was confirmed as apoptotic cell death by in 
situ DNA fragmentation detection. DNA fragmentation quantitates the number of 
cells dying via DNA cleavage, which is a characteristic of apoptosis. A low rate of 
spontaneous apoptosis was observed prior to induction at 0-2.2%, which then 
increased to 8.8-13.5% of the total cells after induction of RNase L. Transient 
transfection of poliovirus infected HeLa cells with a dominant negative form of 
RNase L prevented virus induced apoptosis, maintaining cell viability at 80% 
compared to only 22% when HeLa cells were transfected with a control vector 
(Castelli et al. 1998). More direct evidence of the role RNase L plays in apoptosis 
was determined from mice with a targeted disruption of the gene, preventing the 
synthesis of a functional ribonuclease (Zhou et al.1997). In addition to the 
antiviral effect of interferon a being impaired in RNase L mice, these mice had 
unusually enlarged thymuses containing excess numbers of thymocytes, which 
was the direct result of the suppression of apoptosis. This was determined by 
measuring levels of apoptosis by in situ assays for DNA fragmentation, where 
there was a 47% decrease in the number of apoptotic cells in the thymuses of 
RNase L mice compared with wild type. 
160 
In the second instance replication or transcription of inverted repeat 
containing vectors may be less efficient compared to non JR containing vectors 
(see section 6.4.4.2.). This phenomenon is well characterised in bacteria (for 
review see Leach 1996). Cloning IRs into E.coli results in either inviability or 
instability, where clones containing the construct are either not recovered or are 
recovered but at a low frequency with partial deletions of the inverted repeat 
sequence. However, inclusion of a spacer sequence between the inverted repeats 
is sufficient to allow E.coli cells to resume the replication of complete sequences 
(Warren and Green 1985). Warren and Green (1985) found that including a spacer 
sequence of at least 50 bp was sufficient to restore viability, while a longer spacer 
of -450 bp was required for stability. This was determined by ligating a range of 
restriction fragments into the centres of inverted repeat sequences of -950 bp. 
Cloning of the inverted repeat sequences specific to LIFR, eGFP and SOCS3 
included a 568 bp zeocin selection cassette as a spacer sequence. The length of 
this spacer could be sufficient in reducing both the inviability and instability of 
replicating inverted repeat sequences in ES cells. However, whether the same 
replication problems are found in mammalian cells as in bacteria is not known. 
The possible replication or transcription problems of inverted repeat vectors may 
also be linked to the poor transfcction efficiencies that have been observed for 
these vectors. Possible replication problems could be determined in ES cells by 
supertransfection of inverted repeat containing vectors into E14!T and preparing 
DNA at various days of selection for digestion with DpnJ as well as maintaining 
an uncut control. Southern analysis of these DNAs can then be performed to 
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determine copy number as any unreplicated DNA will be eliminated by DpnI 
digestion. 
6.6. Summary 
I conclude that RNAi operates in ES cells using 21 nt siRNAs against a 
luciferase target. Reduced expression of an exogenous target, eGFP was also 
observed using an eGFP specific long hairpin dsRNA. However, this does not 
appear to be due to RNAi as cells with reduced fluorescence are dying as 
determined by Annexin V-PE staining. Cell death or apoptosis is most probably 
due to an interferon response activated by long dsRNA. The episomal expression 
system used efficiently expresses dsRNA hairpin loop structures, as determined 
by probing for transcripts from a number of different inverted repeat vectors. 
Expression was highest from the eGFP inverted repeat vector, which may account 
for the reduced eGFP expression specifically observed with this vector. 
Phenotypic ablation of an endogenous target of ES cells, the LIFR was not 
observed and a reduction of targeted messages of either eGFIP or SOCS3 was not 
detected. This was despite efficient transcription of inverted repeat transcripts and 
cleavage of the dsRNA transcripts. 
Chapter 7: CONCLUSIONS 
The aim of this thesis was to develop a rapid and reliable ablation 
expression system in ES cells. The three RNA ablation strategies investigated 
were antisense RNA, ribozymes and dsRNA. Ablation using these various gene 
silencing strategies was investigated principally by looking for a phenotypic effect 
and a corresponding reduction in the targeted mRNA. Antisense RNA was 
directed against three genes that are involved in the self renewal of ES cells, 
ribozyme against p300, and dsRNA against two endogenous genes, LIFR and 
SOCS3, and a transgene eGFP. Genes required for ES cell self renewal were 
expected to produce a differentiated phenotype when propagated in the presence 
of LIF, while p300 ablation in F9 EC cells had been previously shown to result in 
the maintenance of self renewing colonies when induced to differentiate with 
retinoic acid (Kawasaki et a]. 1998). Phenotypic ablation of targeted genes was not 
observed using any of the ablation strategies. A corresponding reduction of the 
targeted mRNAs was also not detected. To determine whether this was due to 
insufficient expression of the RNA ablation transcripts, transcript levels were 
determined. For all ablation strategies transcripts were expressed at appreciable 
levels implying that the lack of phenotypic ablation is probably not due to 
inefficient expression from the episomal vector system. 
A probable explanation for the lack of ablation observed for either 
antisense or ribozyme is the likelihood of secondary structure formation for both 
antisense RNA and ribozyme transcripts. As the antisense RNA investigated are 
quite long, 69-575 bp it is possible that either during or after these sequences are 
transcribed they form secondary structures, which could reduce or prevent 
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hybridisation to the complementary mRNA target, which may also possess 
secondary structure. Transcribed ribozyme sequences on the other hand have to be 
able to be able to form their characteristic functional secondary structure 
consisting of a looped catalytic domain and two binding arms that are 
complementary to the mRNA to be targeted. If the transcribed ribozyme sequence 
does not form this structure the ribozyme will be non functional. Even though the 
p300 ribozyme has been previously shown to work in EC cells, the intracellular 
conditions and the non specific proteins present may be different compared to ES 
cells. In addition, for both ablation strategies the accessibility of the targeted 
message is important, where hybridisation sites could be occluded by either 
secondary structure or the binding of non-specific proteins. 
The antisense ablation strategy presented in this thesis specifically 
targeted the UTRs of genes. However, it seems unlikely that UTR sequences in 
general are poor ablation targets as there are examples in the literature of both 
effective (Pepin et al.1992; Moxham et al.1993) as well as ineffective ablation 
(Munir et al. 1990) when targeting these sequences. 
An alternative explanation for the lack of ablation observed for the 
ribozyme strategy is that the role of p300 in ES cells remains undetermined so the 
phenotypic screen set up may have been inappropriate. Also there may be 
redundancy with CBP, as p300 and CBP are highly homologous (Arany et 
al. 1994) and bind to similar target proteins. Although only p300 and not CBP was 
found to be required for retinoic acid induced differentiation of F9 EC cells 
(Kawasaki et al. 1998) this may not be the situation in ES cells. 
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Although phenotypic ablation was not detected for any of the mRNA 
ablation strategies, reduction of eGFP expression from an integrated transgene 
was observed following transfection with an eGFP specific inverted repeat 
expression vector. A similar reduction of eGFP expression was reported for 
undifferentiated ES cells by in situ production of dsRNA from the transient 
transfection of a plasmid with an eGFP specific inverted repeat (Yang et al.2001). 
However, the FACS profile and Annexin V staining data of cells with reduced 
fluorescence presented in this thesis suggests that the reduction of eGFP 
expression may not be due to RNAi. Annexin V is an apoptotic marker which 
demonstrated that the cells were dying probably by an apoptotic mechanism. So 
the reduced eGFP expression seen is most likely a secondary consequence of the 
cells dying. This data has not been presented previously. Published papers that 
have shown RNAi induced ablation in ES cells of either an eGFP target (Yang et 
al.2001; Billy et al.2001) or luciferase targets (Paddison et al.2002) have not 
commented upon whether cells are dying or if there is more cell death observed 
for dsRNA transfected cells. 
A second result to note from the transfection of inverted repeat containing 
vectors as the method of introducing dsRNA into ES cells was that the 
transfection efficiency of inverted repeat containing vectors compared to non 
inverted repeat control vectors was always reduced. Although reduced 
transfection efficiencies were not dependent upon the presence of a target. A 
further indication that the reduction of eGFP expression observed may not be due 
to RNAi. Transfection efficiencies were reduced by —20 fold for eGFP specific 
inverted repeat vectors and by 2-13 fold for other inverted repeat containing 
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vectors. This suggested that expression of inverted repeat sequences are either 
toxic or detrimental for cell growth, which may be linked to the increase in cell 
death observed for eGFP inverted repeat vectors. Alternatively the replication of 
inverted repeat vectors or the transcription of inverted repeat sequences may be 
less efficient as has been observed for the replication of direct repeat sequences in 
bacteria (LaDuca et al. 1983). Lower stable transfection efficiencies observed 
might also be the result of integration of these vectors. However, the frequency of 
isolating stable integrants was 3-8 fold reduced compared to supertransfeetion 
which may indicate that the inverted repeat vectors have not integrated. To 
demonstrate this conclusively copy numbers of JR containing vectors will need to 
be scored. 
Although inverted repeat sequences may not form dsRNA once 
transcribed this is probably not the reason for the lack of ablation observed when 
investigating dsRNA as an ablation strategy in this thesis. This is unlikely because 
cleavage products were detected from the transcribed inverted repeat sequences 
(figure 6.10.), indicating that a dsRNA hairpin loop structure has probably 
formed. Ablation is most probably not detected because significant expression of 
long dsRNA results in cell death (section 6.4.3.2.). Cell death was specific to cells 
transfected with an eGFP inverted repeat vector, which is probably due to the 
higher expression level of this transcript compared to other tested inverted repeat 
containing vectors (figure 6.10.). The observed cell death is consistent however, 
with the emerging evidence that long dsRNAs are capable of inducing apoptosis 
in mammalian cells (reviewed by Tan and Katze 1999). Evidence that dsRNA 
triggered apoptosis is mediated by PKR is demonstrated by genetic studies with 
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PKR knockout mice, whose embryo fibroblasts are resistant to apoptosis induced 
by dsRNA (Der et al. 1997). In addition PKR is already known to be activated as 
part of the interferon response. At present PKR remains unidentified in ES cells 
however, it has been cloned in the mouse (Tanaka and Samuel 1994). If indeed it 
is expressed in ES cells PKR could be reducing eGFP expression in two ways, by 
inhibiting protein synthesis and by actively inducing apoptosis. 
A possible route therefore for initiating RNAi in ES cells could be the 
additional transfection of dsRNA to mouse PKR which could prevent a non 
specific response. However, a simpler strategy would be the use of siRNAs rather 
than long dsRNA. siRNAs have recently been used successfully to initiate 
effective RNA interference in mammalian cells including ES cells as 
demonstrated in both data presented in this thesis and in published data (Yang et 
al.2001; Billy et al.2001; Paddison et al.2002). siRNAs are more effective than 
dsRNA at inducing a specific RNAi response because dsRNA of 49 nts trigger an 
interferon response that is sequence non-specific (Elbashir et al.2001b). This is 
demonstrated by the activation of both PKR and 2',5'-oligoadenylate synthetase 
by dsRJ"TA longer than 35 nts (Minks et al. 1979). Maximal activation measured in 
terms of phosphorylation for PICR and the synthesis of 2',5'-oligoadenylate 
synthetase by dsRNA was observed with 80 nts and 65 nts respectively (Minks et 
al. 1979). Manche et al.( 1992) found similar results for PKR where 23 and 34 bp 
dsRNAs resulted in little activation of the enzyme. The efficiency of activation 
increased however with increasing dsRNA length, reaching a maximum at —85 bp. 
The usefulness of siRNAs is now being realised with the development of 
vector based expression systems for the expression of siRNAs in cells (Miyagishi 
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and Taira 2002; Lee et al.2002; Paul et al.2002). siRNA expression is driven by 
U6, which is a polymerase III promoter that does not contain internal promoter 
sequences and has a short termination signal of about four uridines. This results in 
4 nt 3' overhangs which make the 5iRNA more potent than corresponding blunt 
ended siRNAs (Elbashir et al.2001a). siRNAs have been generated by either 
expressing sense and antisense sequences from separate U6 promoters on the 
same or two separate plasmids or by including a short tetraloop sequence between 
the sense and antisense strands so that a single transcript is generated. A possible 
way therefore of producing a randomised siRNA library for a functional library 
screen could be to transcribe random 19 nt sequences between U6 promoters 
placed in opposing orientations. The randomised vector library could then be 
transfected into ES cells and the appropriate resistance marker present on the 
vector selected for (figure 7.1). Both the sense and antisense strands of the 
random library would be transcribed allowing them to hybridise and form 
siRNAs. The effect of these siRNAs could then be assayed in an appropriate 
functional screen. For example by growing transfected cells in media without LW 
to screen for genes involved in the differentiation of ES cell. To identify the 
sequence of the effective 5iRNA(s) individual self renewing colonies can be 
picked and grown from which the stably maintained episomes are isolated and 
sequenced. However, the potential strategy for screening novel genes by 
expressing a randomised siRNA library is not trivial. The efficiency of siRNA 
ablation must first be determined using such a U6 promoter driven siRNA 
expression system. Another consideration is that individual siRNA sequences may 
target a number of mRNAs if the sequence is complementary to a conserved 
168 
Random 
19 nt library 
SV4O on/pA 
PGK-R pA 	CoIEI On 
SV4O pA 
P F101 AmpR 
on 
Polyoma ori expression Vector Electroporation 
and selection of 
supentransfected 
E1411 ES cells 
Isolation of 
episomal DNA 
Identification of siRNA sequences 
Figure 7.1. Strategy for novel gene function in ES cells 
using a randomised siRNA library generated by 
opposing U6 promoters. 
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domain. This may make identification of the ablated targets responsible for the 
phenotype difficult. Identification of the targeted mRNA(s) could be further 
complicated by the generation of secondary siRNAs complementary to regions 
upstream of the original trigger siRNA by an RdRP reaction and the induction of 
transitive RNAi. Although an RdRP homolog has yet to be identified in the 
mammalian or Drosophila genome an RdRP-like activity has been demonstrated 
in Drosophila embryo extracts (Lipardi et al.2001) which does not rule out the 
possibility that mammalian cells may also be able to generate secondary siRNAs. 
Therefore the ablation efficiency of siRNA as well as secondary ablation effects 
must first be investigated before the potential of siRNAs as a tool to uncover 
novel gene function in ES cells as well as other mammalian cells can be exploited. 
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Appendix 3: 
Cloning Strategy for pBluescript loxP C2 MAZ 
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Appendix 6: 
b) Cloning Strategy for pPyHCAG-S fox C2MAZ 513' UTR vectors 
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